ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000441.1|Teicoplanin_1 # 138 # 473 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.705	BGC0000441.1|Teicoplanin_1 	138	473	-	Loose	1700	24.6386	LpeB	43.48	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGACGAAGATCACCCCGGCGGCCGAAGCGGCGTCGCTCGACGAGTACTGGTCCCAGCGGGTCCTGACGGCCGCGAACGGCAACCTGTTCAAGGTGGCCAAGGGCCTCGGTTCCACGCGATGGCACGCGCATGACGATCAGGACGAGACGTTCCTGATGCTGGCCGGAACGCTGACCGTGCACCTGCGGGACGGCTCGGTCGAGCTGACCCCGGGTGACCTGCTGGTCATCCCGCGCGGGGTGGAGCACCGCCCGGAGGCGGCCGGCGAGGCCCGTTTCCTGCTCGTCGGACCGGAGGTCACCTCGACCGAGGCGGGCGGGAAGCCGGCCTGA	MLTKITPAAEAASLDEYWSQRVLTAANGNLFKVAKGLGSTRWHAHDDQDETFLMLAGTLTVHLRDGSVELTPGDLLVIPRGVEHRPEAAGEARFLLVGPEVTSTEAGGKPA	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	10.95	gnl|BL_ORD_ID|2387|hsp_num:0	2759			2307	2376	erythromycin; spiramycin; azithromycin
BGC0000441.1|Teicoplanin_2 # 552 # 1517 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAAGG;rbs_spacer=4bp;gc_cont=0.753	BGC0000441.1|Teicoplanin_2 	552	1517	-	Loose	400	42.3578	mtrA	26.19	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCCGCGGCGGGTCGCGCTGATAGTCGACGAACATTCCAACCCGTTCGAGGTGGGCTGTGCCTGCGAGATCTTCGGCGGCCGCCGGCGCCCACAGATCGGCTACGAGCTGTACGAACTCACCGTCGTCAGCCCGACCAGATCGGTACCGATGCGGGACCGGCTGTTCCGCGTCAGCGCGCCCGGGCGGCTGAGCGACCTGGACCGGGCCGACATGATCATCGTGCCGAACCGGCCGGATGTCGACGTCCCGTCCCGCGGCGCGGTCCTGGCGGCGATCCGGCGGGCCCACGCGCGGGGCGCCCGCCTGGTCGGCCTCTGCACCGGCGCCTTCACGCTCGCCGAGGCGGGGGTGCTCGACGGCCGCCGCGCGGCGGTGCACTGGCAGCTGGCTCCGGACTTCCACCGGCGCTTCCCGGCCGTACGGCTGGAGCCGGACGTGCTGTTCGTCGATGACGGCGACATCCTGACCTCGGCGGGCAGCGCGGCGGCGCTCGACCTCGGCCTGCACATCGTCCGCCGCGACCACGGCACCGAGGTGGCCAACCGGGTCGGCCGGCAGCTGGTGTTCGCCGCGTTCCGCGACGGCGGCCAGCGGCAGTTCGTCGAACGCCCGCTGCCGGCGCCGGCGACGAGCCCGCTCGCGCCGGTCCTGCAGTGGGCGCAGGAGCGCCTGCACCTGCGGCTGTCGGTCGACGACCTGGCCCGGCACGGCCGGATGAGCACCGCCACGCTGCACCGGCGCTTCCGCAACGAGGTGGGCAGCACCCCGCTGGCGTGGCTGACCGCGCAGCGCGTCGCGCTGGCGTGCCGCCTGATCGAGCAGGGCGCCGCGGGCGTGGACGCCGTGGCCCGGCAGTCCGGTCTGGGCACCGCCGCCAACCTGCGCGCCCTGCTGCGTAAGCACGTGGGCCTGAGCCCGTCGGAGTACCGCCGGCGCTTCGCCGCCGACGGCGCGCGGTGA	MVPRRVALIVDEHSNPFEVGCACEIFGGRRRPQIGYELYELTVVSPTRSVPMRDRLFRVSAPGRLSDLDRADMIIVPNRPDVDVPSRGAVLAAIRRAHARGARLVGLCTGAFTLAEAGVLDGRRAAVHWQLAPDFHRRFPAVRLEPDVLFVDDGDILTSAGSAAALDLGLHIVRRDHGTEVANRVGRQLVFAAFRDGGQRQFVERPLPAPATSPLAPVLQWAQERLHLRLSVDDLARHGRMSTATLHRRFRNEVGSTPLAWLTAQRVALACRLIEQGAAGVDAVARQSGLGTAANLRALLRKHVGLSPSEYRRRFAADGAR	MDILDKLVDLAQLTGSADVQCLLGGQWSVRHETLQCEGLVHIVTAGSGYLCIDGETSPRPVGTGDIVFFPRGLGHVLSHDGKYGESLQPDIRQNGTFMVKQCGNGLDMSLFCARFRYDTHADLMNGLPETVFLNIAHPSLQYVVSMLQLESEKPLTGTVSVVNALPSVLLVLILRAYLEQDKDVELSGVLKGWQDKRLGHLIQKVIDKPEDEWNIDKMVAAANMSRAQLMRRFKSQVGLSPHAFVNHIRLQKGALLLKKTPDSVLEVALSVGFQSETHFGKAFKRQYHVSPGQYRKEGGQK	106.64	gnl|BL_ORD_ID|1431|hsp_num:0	1559			639	891	erythromycin; penicillin; azithromycin
BGC0000441.1|Teicoplanin_3 # 1820 # 2572 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000441.1|Teicoplanin_3 	1820	2572	-	Loose	400	38.891	tetR	33.33	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGTGCTACGCAGGAGCCCGGCACGTCCTCCCGGCGGCGTGGCGGTGCGGGGCCCGTCGACGACGCCACCGTCCGCGCCGCCCTGATCCAGGCCGCCGAGCGGCAGCTGACCGCCTCCCCGGACGGCGACATCGCCACCCGCGCCGTCAGCGAGGAGGCCGGCGTCACCCAGCCGGTGCTGTACCGGCTGTTCGGTGACAAACGCGGCCTGCTGGACGCCGTCGCCGACGCCGGATTCGACCGCTACGCCCGGCGCAAGAGCGAACTGGAGGTCACCGACAACCCGGTCGGCGACCTGTACGCGGGATGGGACGACCACATGGCGTTCGCCACCGAGAACCCGGCCCTCTACCAGCTGATGTTCGCGCCCCGGCCGCGTTCGGGCGCGACCACCTACCGCCGCATCCTGACACTGCTCGAGGCCACCCTCCTGCGCTGCGCCGCCGCCGGCGCGCTCACCACGACGCCCCGGGCAGCCGCCCAGCTGATCCTGAGCGCCAACATCGGCGTCGCTCTCGGCCGCATCGCCGCGCCGGAGCTCTTCGACGACCCGGCGCTGTCGCACCGCGCCCGCGACGCCGCCTTCGCCACCGTGCTCACCCACCCCGCCACGCCGAGCGGGCCGGACCCGCTCCGCGACGCCGCCCGCCAGCTGCGCTCGCAGCTCTCGCTCAGCGGCACCGACCGGCTGGAACCGGCCGAGACCGTGCTGCTCGACCGGTGGCTGGAGCGCATCGACCAGCCGGAGTGA	MSATQEPGTSSRRRGGAGPVDDATVRAALIQAAERQLTASPDGDIATRAVSEEAGVTQPVLYRLFGDKRGLLDAVADAGFDRYARRKSELEVTDNPVGDLYAGWDDHMAFATENPALYQLMFAPRPRSGATTYRRILTLLEATLLRCAAAGALTTTPRAAAQLILSANIGVALGRIAAPELFDDPALSHRARDAAFATVLTHPATPSGPDPLRDAARQLRSQLSLSGTDRLEPAETVLLDRWLERIDQPE	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	120.19	gnl|BL_ORD_ID|442|hsp_num:0	276			18	216	tetracycline
BGC0000441.1|Teicoplanin_4 # 2684 # 3418 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=8bp;gc_cont=0.751	BGC0000441.1|Teicoplanin_4 	2684	3418	+	Loose	500	43.5134	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	28.3	3003393	protein variant model	V78A, I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGGGTGATCACCGAGTCGCCGTCGTCACCGGGGCTTCGCGTGGCATCGGCCGTGCCGTCGCCACCGCGCTGGCCGGCGCCGGGCACGCCGTCGTCGTCGGCTACGCCGGCAATGAGGCGGCCGCGAAGGAGGTCGTCGACCGGATCGCCGCCACCGGTGGCCGGGCCGTCGCCGCCCGGGCCGACGTCGCCGACGAGAACGCGGTCGCCGCTCTGTTCGACACCGCCACCGAGGCCTTCGGCGGGGTCGACGTCGTGGTCAACTCGGCCGGCCGGATGGCCCTGTCCCCGATCGCCGACCTCGATCTGGCCGACCTGGACGCCCTGCACCGCACCAACATCCGCGGCACGTTCGTCGTCGCCCGCGAGGCCGCCCGCCGGGTCCGCCCGGGCGGCGCGATCGTGCTGGTGTCCACCTCGATCCTCGGCCTGCAGTTCCCCGGCTACGGCGCGTACGCCGCCAGCAAGGGGGCCGTCGAGGCGATGACGCTGATCCTGGCGCGGGAGATGCGCGGCCGGGACATCACGGTCAACACCGTCGCGCCCGGCCCCACCGCCACCGAGCTGTTCCTGGAGGGCAAGGACGAGGCGACCGTCGAGCACCTGGCCAAGCAGCCGCCGCTGGAGCGGCTCGGCACCCCGGCCGACATCGCCGGGGTCGTCGCCTTCCTCGCCGGGCCGGGCGGGCGCTGGGTCAACGGCCAGGTGCTCCGGGCCAACGGCGGCATCGTCTGA	MGDHRVAVVTGASRGIGRAVATALAGAGHAVVVGYAGNEAAAKEVVDRIAATGGRAVAARADVADENAVAALFDTATEAFGGVDVVVNSAGRMALSPIADLDLADLDALHRTNIRGTFVVAREAARRVRPGGAIVLVSTSILGLQFPGYGAYAASKGAVEAMTLILAREMRGRDITVNTVAPGPTATELFLEGKDEATVEHLAKQPPLERLGTPADIAGVVAFLAGPGGRWVNGQVLRANGGIV	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	90.71	gnl|BL_ORD_ID|1964|hsp_num:0	1574			141	588	isoniazid
BGC0000441.1|Teicoplanin_5 # 4070 # 5413 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000441.1|Teicoplanin_5 	4070	5413	+	Loose	500	26.9498	OXA-640	26.42	3005861	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCCCGCTCAGCCTCGAGGCGATCGCCGCTGTTGTCGGGGGGACGGTCGAGGGAGACCACACGGTGACGGTCACCGCGCCGGCCGTGCTCGACGGTCGGCAGGCCGAGCCGGGCGGCCTCTTCGTCGCCTTCGCCGGCGAGCACGTCGACGGCCACGACTACGCCGGCCAGGCCGGCCAGGCGGGCGCGGTCGCCGTGCTCGGCTCGCGGCCCACGGCGCTTCCCACCGTCGTCGTCGAAGACGCCCGGACCGCGCTGCAGGCCCTCGCCGCCGACGTCGTGGCGCGGCTGCGTGAACGGTTGACGCTCGTCGGGGTGACCGGCTCCCAGGGCAAGACGAGCACCAAGGACCTGCTGGCCGCCGTGCTGTCGAGCGCCGCGCCGACGATCGCCACCAAGGGCAACCTCAACAACGAGCTCGGCGTGCCCCTCACCATGCTGCGCGCCGGTGCGGCCACCCGGTTCCTCGTCGTCGAGATGGGCGCCCGCCGCATCGGTGACCTCGCCAAGCTCACCGACCTGGTTCCGCTCGACGTCGCCGTCGTCCTCAACGTCGGCGAGGCCCACCTCGGCGTGTTCGGATCGCGTGCGGCCATCGCCGAGGGCAAGGGGGAGCTGGTACGAGGGCTGGTGCCCGGGGGTACCGCGATCCTCAACGCGGACGACCCCAGGGTGGTCGCGATGCGCTCGCTCACCGATGGCCCGGTGTTGACGTTCGGGCACGCGGAAGACGCGGATGTGCGGGTGCGCGACCTGACCCTGGACCGGCTCGGCCGACCGTCCTTCACGCTGCGCACCGCGGACGCCACGGCCCGGGTCAAGTTGCCGATCGTGGGCGCCCACCAGGCACTCAACGCCGCAGCCGCGGTGGCGGCGGCGCTTTCCGCCGGCCTGACGCTCGACGCGGCCGCGGCCACCTTGGCCACCGCCTCACTGACGAGGTGGCGCTTGGAGCTACGTGACATCGCCGGCGGCGTGACACTGCTCAACGACTCCTACAACGCCAGCCCCGGGTCGACGCGAGCCGCGCTGGACGCCCTGGCCGCGATCGAGGGTGGCCGCCGCGTCGCCGTCCTCGGCCAGATGCTGGAGCTGGGGGACGAGAGCGAGGCCGAGCACCGCGCCGTCGGGGAGTACGCCGCCGCCCGGGCCGACGTGGTGGTCACCGTCGGCGAGGCGGTTCGTCCGCTTGCCGTCGGCGCGGGGGAGCGGGCGGTGGCAGTGGCGGACAACGGCGCGGCCGTCGATTGGCTTCGTGGCCACCTCGCCCCCGGCGATGTGGTGCTCGTCAAGGCATCCCGTGGGGCGCGCCTCGATGAAGTCGCCGCCGCGCTGTCCTAG	MIPLSLEAIAAVVGGTVEGDHTVTVTAPAVLDGRQAEPGGLFVAFAGEHVDGHDYAGQAGQAGAVAVLGSRPTALPTVVVEDARTALQALAADVVARLRERLTLVGVTGSQGKTSTKDLLAAVLSSAAPTIATKGNLNNELGVPLTMLRAGAATRFLVVEMGARRIGDLAKLTDLVPLDVAVVLNVGEAHLGVFGSRAAIAEGKGELVRGLVPGGTAILNADDPRVVAMRSLTDGPVLTFGHAEDADVRVRDLTLDRLGRPSFTLRTADATARVKLPIVGAHQALNAAAAVAAALSAGLTLDAAAATLATASLTRWRLELRDIAGGVTLLNDSYNASPGSTRAALDALAAIEGGRRVAVLGQMLELGDESEAEHRAVGEYAAARADVVVTVGEAVRPLAVGAGERAVAVADNGAAVDWLRGHLAPGDVVLVKASRGARLDEVAAALS	MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGVFITFDGKHYASNDFKRAKQAFSPASTFKIFNALIALDNDVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN	179.52	gnl|BL_ORD_ID|3896|hsp_num:0	4966			75	234	cloxacillin; oxacillin; cefalotin
BGC0000441.1|Teicoplanin_6 # 5612 # 6652 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=3bp;gc_cont=0.604	BGC0000441.1|Teicoplanin_6	5612	6652	+	Strict	200	514.612	vanH gene in vanO cluster	73.11	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGGGTTACAGCGAACCAGTACGAGCAGCGGCCCCCCGCACCCGATCGCTGGCCTCGTCGTCCTCCCCGGTCGTTCCGGCAACGGGGATCACGATCTATGGATGCGGCCCGGATGAGGCCGCCCTGTTCCGTGAGCTGGCGCCTCGCTTCGGCGTACTGCCGATCATCACGGAAGCGGCGGTATCCGAGGCCAATGTGAATCTGGCATCCGGAAATCGATGCATCAGCGTCGGGCATAAGACTCAGATCACGAATGGCACGCTTCTCGCGCTGAGCCGATCCGGTGTGAAATACATCTCTACGCGGAGCATAGGCTACAACCACATCGATGTGGCGTATGCGCAGAGCGTGGGTATCTCCGTCGGCAACGTCGCCTACTCGCCGGACAGCGTGGCCGATTACACGCTGATGCTGATGCTGATGGCCGTACGCCATATGAAAGCCATGATCCGCCGCGCGGACGTTCACGATTATCGATTGAACGACGTGCGCGGGAAGGAACTGCGCGATCTGACCGTCGGGGTGGTCGGGACGGGGCGTATCGGTTCGGCCGTCATGGACCGGCTGTGGGGTTTCGGCTGCCGTGTGCTCGCCTACGACAATCGACGTTCGGATTCCGCTCATTATGTTCCGCTCGATGATTTGGTGCGGCAGAGCGACATCGTCACACTTCACACCCCGCTCACCGCGGCCACGCACCATCTTCTCAACCAGGACCGTATCGCGCAGATGAGGAACGGTGCGTTCGTCATCAACACCGGGCGCGGTTCGCTTATCGACACCGAGGCCCTCGTCGCAGCGCTGGAAAGCGACAAACTGGGTGGCGCGGCGCTCGATGTCCTGGAAGGGGAGGAGGGGGTATTCTATGCCGACTGCCGTAACAAGCTCATTGAGAGCAAGGCGCTGTTACGGCTACAGGAAATGCCCAATGTGATCATCAGCCCGCACATGGCCTACTACACGGACCATGCGCTCAGCGACACTGTCGAGAACAGTCTCGTCAACTGCATGAACTTCGAGAGGGAACAACAGCATGGGTAA	MGYSEPVRAAAPRTRSLASSSSPVVPATGITIYGCGPDEAALFRELAPRFGVLPIITEAAVSEANVNLASGNRCISVGHKTQITNGTLLALSRSGVKYISTRSIGYNHIDVAYAQSVGISVGNVAYSPDSVADYTLMLMLMAVRHMKAMIRRADVHDYRLNDVRGKELRDLTVGVVGTGRIGSAVMDRLWGFGCRVLAYDNRRSDSAHYVPLDDLVRQSDIVTLHTPLTAATHHLLNQDRIAQMRNGAFVINTGRGSLIDTEALVAALESDKLGGAALDVLEGEEGVFYADCRNKLIESKALLRLQEMPNVIISPHMAYYTDHALSDTVENSLVNCMNFEREQQHG	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	98.86	gnl|BL_ORD_ID|761|hsp_num:0	786			42	1035	vancomycin
BGC0000441.1|Teicoplanin_7 # 6645 # 7682 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.683	BGC0000441.1|Teicoplanin_7	6645	7682	+	Strict	350	526.939	vanO	72.59	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGGGTAAGTTGAAGATCGGCATCATCTTCGGCGGCGTCTCCGAAGAGCACCCCGTCTCGATCAAGTCCGCGCAGGAGGTCGCCAAGAGCCTGGACGCCGAGAAGTACGAGCCGTACTGGATCGGCATCACGAAGGACGGCGCCTGGCGGCTGTGCGACGGCCCGGGCGCGGACTGGGAGATCAGCAGCGCCCGGCCGGCCATGCTGTCGCCGGACCGCAACGTCCACGGGCTGCTGGTCCAGGAGGACGGCCGGTACCGGGAGATCCGCCTGGACGTCGTGCTGCCGGTTCTGCACGGCAAGCTGGGCGAGGACGGCGCGATGCAGGGCCTGTTCGAGCTGTCCGGCATCCCCTACGTCGGCTGTGACGTGCAGAGCTCCGCGGTCTGCATGGACAAGTCGCTGACCTACGCCGTGGTCAGCAGCGCGGGCATCGCCGCCGCGACGTTCTGGGTCGTCACGCCGGACGAGGCGCCGGACCCCGCGCAGCTCACCTACCCGGTCTTCGTGAAGCCGGCCCGCTCGGGCTCCTCCTTCGGCGTCACCAAGGTGTCGACCGAGCAGGAGCTGAAGGCCGCGCTGGAGACCGCGCGGGAGTTCGACTCGAAGGTGCTGATCGAAGAGGCCGTGGTCGGCAGCGAGATCGGTTGCGCCATCATGGGCAACGACCCGGACCTGGTCGCCGGCGAGGTGGACCGGGTCGCCCTGTCCCACGGCTTCTTCCGGATCCACCAGGAGAGCGAGCCGGAGCGCGGTTCCGAGAACTCGACCTTCATCTGTCCCGCCGACATCCCGGCCGAGGCGCGCTCGCTGGTCCAGGAGACGGCGAAGGCCATCTACCGTGCTCTGGGATGCCGCGGGATCGCCCGGGTGGACATGTTCCTCAAGGAGGACGGAACAGTTGTCCTCAACGAGGTCAACACCCTGCCCGGCCTGACCTCGTACAGCCGTTACCCGCGCATGATGGCGGCTGCCGGGATTCCGCTCTCCGCGGTGATCGACCAGATCGTGTCGCTGGCCCTGCCGGGGGACATCTGA	MGKLKIGIIFGGVSEEHPVSIKSAQEVAKSLDAEKYEPYWIGITKDGAWRLCDGPGADWEISSARPAMLSPDRNVHGLLVQEDGRYREIRLDVVLPVLHGKLGEDGAMQGLFELSGIPYVGCDVQSSAVCMDKSLTYAVVSSAGIAAATFWVVTPDEAPDPAQLTYPVFVKPARSGSSFGVTKVSTEQELKAALETAREFDSKVLIEEAVVGSEIGCAIMGNDPDLVAGEVDRVALSHGFFRIHQESEPERGSENSTFICPADIPAEARSLVQETAKAIYRALGCRGIARVDMFLKEDGTVVLNEVNTLPGLTSYSRYPRMMAAAGIPLSAVIDQIVSLALPGDI	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	99.71	gnl|BL_ORD_ID|1607|hsp_num:0	1754			0	1029	vancomycin
BGC0000441.1|Teicoplanin_8 # 7682 # 8290 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGGGGA;rbs_spacer=6bp;gc_cont=0.617	BGC0000441.1|Teicoplanin_8	7682	8290	+	Strict	200	348.206	vanX gene in vanO cluster	80.2	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGAAAGACGACTTCGCGTTCGTGGACGAGCTCGTGCCAGGCATACGCTGGGATGCCAAGTACGCCACCTGGGACAATTTCACCGGCAAGCCGGTGGACGGTTACGTTGCGAATCGGATCGTCGGAACGAAGGCGTTGTGCGCTGCCCTGGCGCGCGCCCAGGAAGAGGCCGAGACGCTTGGCTTCGGTCTGCTTCTCTGGGATGGGTATCGGCCGCAACGCGCCGTGGACTGCTTCATGCGCTGGGCGGAGCAGCCGGAGGACGGCCGCAAGAAGCTGCGGCACTACCCGAACATCGGCAGGCCCGAGATGTTCGAGAAGGGGTATGTCGCCACCAAGTCCGGTCACAGCCGCGGCAGCACCGTCGACTTGACGCTCTACAACCTTGCCACCGGCGAACTGGCGTCGATGGGCGGCGACCACGACCTGATGGATCCGATCTCCCACCACGGGGCCAGCGGAATCACGCCGATCGAAGCGAAGAACCGTGAATACCTCTGCTCGATCATGGAGGGCTGCGGATTCGCCAGGTACGACTACGAGTGGTGGCACTACACCCTGAAGAACGAACCCTATCCCGACACATATTTTGATTTTCCGATCGTGTAG	MKDDFAFVDELVPGIRWDAKYATWDNFTGKPVDGYVANRIVGTKALCAALARAQEEAETLGFGLLLWDGYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIGRPEMFEKGYVATKSGHSRGSTVDLTLYNLATGELASMGGDHDLMDPISHHGASGITPIEAKNREYLCSIMEGCGFARYDYEWWHYTLKNEPYPDTYFDFPIV	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	100.00	gnl|BL_ORD_ID|1672|hsp_num:0	1699			0	606	vancomycin
BGC0000441.1|Teicoplanin_9 # 9052 # 9591 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.667	BGC0000441.1|Teicoplanin_9 	9052	9591	-	Loose	600	28.1054	emtA	26.42	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAGCGATGTGAGCGGCGCCGGCAAAGTGGTCGTGAACAGGGCGATGTCGCTGGACGGGTTCATCGCCGGTCCCGGCCACGCGATGGACTGGATCTTCGAATACCTGACTGGGGACATGTTCCCGGAGGTTATGGCGTCCACGGGCGCCATGCTCATCGGCCGAGGCACGTACGAGGTCGCCAAGCGTATGGCCGGCCAGGGCACCCCCTACGACGGGGGAGCACAGTTCGTCCTCACGCACGAGCCTCCCCACGAGCCGGACCCTGCCGTCACGTTCCTCAGCTGTGACATCGAGGAAGCCGTTGCCACGGCACGCAGCGCCGCGGGCGGCAAGAACTTGGAAATCCTCGGTGCTGACGTGGCCGCCCAGTGCCTGCGGCGCGGGCTCGTCGACGAGATCCTGGTGTATGTCGTACCGGTGCTGCTCGGCGACGGTGTCCGCTTCTCGCCCCCAAGCCTCGACAGGATCGACCTGGAACCTCTCAGCAACACCCGGTCCGGCGCCGTCACGATGCTGCGCTTCCGCGTGCGAAAGTAG	MSDVSGAGKVVVNRAMSLDGFIAGPGHAMDWIFEYLTGDMFPEVMASTGAMLIGRGTYEVAKRMAGQGTPYDGGAQFVLTHEPPHEPDPAVTFLSCDIEEAVATARSAAGGKNLEILGADVAAQCLRRGLVDEILVYVVPVLLGDGVRFSPPSLDRIDLEPLSNTRSGAVTMLRFRVRK	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	52.49	gnl|BL_ORD_ID|2212|hsp_num:0	3368			492	651	evernimicin
BGC0000441.1|Teicoplanin_10 # 9704 # 10810 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.652	BGC0000441.1|Teicoplanin_10 	9704	10810	-	Loose	650	412.149	vanS gene in vanO cluster	67.63	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGCGTGAAGAGACCGTGGACCGAGCCCCCGGCTTGAGCGTGCGCCTCAAACTCACGTTGAGCTACGCCGGCTTCCTCATGCTCGCCGGCGCCTCGTTGCTCGCCACCGTGTGGGTGTACCTCCTGCGCGGCCTACCGGACACCGCGATGAGCAGTCGTGGTCTCGTGCCCATCAAGACCATCGTCTTGCACGCCTTCGCCCCGGCGACGGCCGGAGTCCTGCTGTTCCTACTGGTGTTCGGCCTGCTCGGCGGGTGGCTTCTGGCCGGTCGGATGCTCGCTCCTCTGACCCGCATCACAGAGGCCACCCGCATGGCCGCGAACGGTTCGCTCTCGCACCGCATCGAGTTGGATGGCCGCAAGGATGAGTTCCGCGAGCTCGCCGACGCCTTCGACATCATGCTGACGCGACTCGAAGCACACATCGCCGAGCACCAGAGATTCGCAGCCAACGCCTCTCACGAGCTGCGTACGCCGCTGGCGATCACGAAAACGCTTCTCGACGTCGCCCGCACCGACCCGGCACGAAGCACCCACGAGCTCATCGGTCGCCTTCACACCGTCAACACCCGGGCAATCGACCTCACCGAGGCACTGCTTCTGCTGAGCCGCGCCGACCGGCGATCGTTCAAGCGCGAGTATGTCGACCTGTCGCTGAACGTCGAAGAAGCCATCGAGACGCTCCTACCGCTGGCGGAGAAGCACGGCGTCACCATCGAAGCCTCCGGCGACATCACCCCGACCGTCGGCTCACGTGCCCTGCTGTTACAAATGACGATCAACCTCTTGCACAACGCGATCGTGCATAACGTGGCGGAAGAGCGCATCGTGTGGGTCACGACCAGCGTCCATCCCAAGAGTGTGACCCTCACCGTGGAAAACACCGGCGAGCAGCTCTCCGCACAGCTGGTCTCGACACTCACCGAACCGTTCCAGCGCGGCACCGAGCGCATACACCACGATCATGCAGGTGTCGGCCTCGGCCTGGCGATCGTCAAGAGCATCGCCCACGCGCACGACGGAACACTCACCACCGCCCCGCGCGCTGGAGGCGGCCTGCACGTCACGGTGCAGCTGCCAGCCGCGACAACGCCTCCGAGAAACTGA	MREETVDRAPGLSVRLKLTLSYAGFLMLAGASLLATVWVYLLRGLPDTAMSSRGLVPIKTIVLHAFAPATAGVLLFLLVFGLLGGWLLAGRMLAPLTRITEATRMAANGSLSHRIELDGRKDEFRELADAFDIMLTRLEAHIAEHQRFAANASHELRTPLAITKTLLDVARTDPARSTHELIGRLHTVNTRAIDLTEALLLLSRADRRSFKREYVDLSLNVEEAIETLLPLAEKHGVTIEASGDITPTVGSRALLLQMTINLLHNAIVHNVAEERIVWVTTSVHPKSVTLTVENTGEQLSAQLVSTLTEPFQRGTERIHHDHAGVGLGLAIVKSIAHAHDGTLTTAPRAGGGLHVTVQLPAATTPPRN	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	106.67	gnl|BL_ORD_ID|4732|hsp_num:0	465			0	1035	vancomycin
BGC0000441.1|Teicoplanin_11 # 10803 # 11450 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.671	BGC0000441.1|Teicoplanin_11 	10803	11450	-	Loose	400	342.813	vanR gene in vanO cluster	89.05	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGCGGAGGCTATCCGGGATGGCCTCCGTTTGGAAGCGATCGCGGCAGACATCGCCGGTGACGGTGACACCGCTCTGGAAATGCTGAGCGTGAACGCCTACGACATCGTCATCCTCGACCGCGACATCCCCGGCACCTCGGGTGATCAGATCGCCGAACGCATCGTCGCCTCCCGGAGCGGTATGCCCATCCTCATGCTCACCGCTGCCGATCGGCTCGACGACAAAGCATCCGGGTTCGAGCTCGGCGCCGACGACTACCTCACCAAGCCGTTCGAACTGCGGGAGCTCGTGCTCAGGCTCAGGGCACTCGACCGCAGGCGCGCCTACAGCAGGCCACCTGTACGGGAGATCGCGGGCCTGCGACTGGACCCGTTCCGCCGCGAGGTCTACCGCGACGACCGCTACGTCGCGCTGACCCGGAAGCAGTTCGCCGTGCTCGCCGTCCTCGTAGCCGCCGAAGGCGGCGTCGTCAGCGCCGAGGAACTGCTGGAACGGGCTTGGGACGAGAACGCGGACCCGTTCACCAACGCCGTCCGCATCACCGTTTCGGCCCTGCGCAAACGGCTCGGCGAGCCCCAGATCATCGCCACCGTGCCCGGCGTCGGGTATCGCATAACCACGCAACCAGGCAGCGGGCGTGCGTGA	MAEAIRDGLRLEAIAADIAGDGDTALEMLSVNAYDIVILDRDIPGTSGDQIAERIVASRSGMPILMLTAADRLDDKASGFELGADDYLTKPFELRELVLRLRALDRRRAYSRPPVREIAGLRLDPFRREVYRDDRYVALTRKQFAVLAVLVAAEGGVVSAEELLERAWDENADPFTNAVRITVSALRKRLGEPQIIATVPGVGYRITTQPGSGRA	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	92.27	gnl|BL_ORD_ID|4742|hsp_num:0	1689			42	672	vancomycin
BGC0000441.1|Teicoplanin_12 # 12342 # 13523 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.730	BGC0000441.1|Teicoplanin_12 	12342	13523	+	Loose	600	352.058	rgt1438	55.39	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGCGTGCTGTTTTCGTCCTACGGGACACGCGGAGATGTCGAGCCCCTGGTGGCATTGGCCGTGCGACTGCGGGAACTCGGTGCGGAGGTCCGGATGTGCGCGTCGCCGGACTACGTGGAGCGGCTGGCCGAGGTCGAAGTGCCGATGGTGCCGATCGGCCAGCCGGTGCGCGCGGGGGCCCGCAAGGGTGCAGCGCCTCCGGGGGCGCCCGAGGCCGTGGCCGAGGTGATCGCCGAGCAGTTCGACAGGGTCCCGCCGTTCGCCGAAGGGTGTGACGCGGTGGTGGCCAGCGGTCTGGTGTCCACCGCCGTCGCCGTGCGGTCGGTCGCCGAGAAGCTGGGCATCCACCACTACGCCTACGCCGTGCTCTCGCCGTCCTTTCTGCGCGCGCCCGGCGTGACCGACAGCCGGGACCTGCGGGCCCGGGCCAACCAGGGCGCCTATCGACAGTTCGGTGGCCCGCTCAACAGCCATCGGGCCGCGGTCGGCCTGCCGCCGGTGGAGAAGGTCATCGACTACGCCTTCACCGAGCGCCCCTGGTTGGCGGCGGACCCGGTCCTGGACCCGCTGCGGCCGACGGACCCGGACGTGGTGCAGACCGGCGCGTGGATCCTGCCCGACCAGCGGCCGTTGTCGGCGGAGTTGGAGGGGTTCTTGAGGGCTGGCTCGCCTCCGGTGTACGTGGGTTTCGGCAGTGGGCCGGCGCCTGCCGAGGCCGCGCGGGTGGCCATCGAGGCGGTTCGGGCTCAGGGCCGCCGGGTGGTGCTGTCCAGTGGTTGGGCCGGGTTGGGCCGGATCGACGAGGGGGATGACTGTCTGGTGGTGGGCGAGGTGAACCATCAGGTGCTGTTCGGCCGGGTGGCCGCCGTCGTCCACCACGGCGGGGCGGGCACGACGACCGCGGTGACCCGGGCGGGCGCTCCGCAGGTCGTGGTGCCCCAGAAGGCGGATCAGCCCTACTATGCCGGTCGGGTGGCTGACCTGGGTGTCGGCGTGGCGCATGACGGTCCGACCCCGACCGTCGAGTCCCTGTCCGCGGCGCTGGCCACGGCGTTGACCCCGGGGATCCGGGCGCGAGCGGCGGCGGTGGCCGGCACGATCCGCACCGACGGGACGACGGTGGCCGCGAAACTGCTCCTCGAGGCGATCAGCCGGCAGAGATCGTCGGTTCCCGCGTGA	MRVLFSSYGTRGDVEPLVALAVRLRELGAEVRMCASPDYVERLAEVEVPMVPIGQPVRAGARKGAAPPGAPEAVAEVIAEQFDRVPPFAEGCDAVVASGLVSTAVAVRSVAEKLGIHHYAYAVLSPSFLRAPGVTDSRDLRARANQGAYRQFGGPLNSHRAAVGLPPVEKVIDYAFTERPWLAADPVLDPLRPTDPDVVQTGAWILPDQRPLSAELEGFLRAGSPPVYVGFGSGPAPAEAARVAIEAVRAQGRRVVLSSGWAGLGRIDEGDDCLVVGEVNHQVLFGRVAAVVHHGGAGTTTAVTRAGAPQVVVPQKADQPYYAGRVADLGVGVAHDGPTPTVESLSAALATALTPGIRARAAAVAGTIRTDGTTVAAKLLLEAISRQRSSVPA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	95.62	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000441.1|Teicoplanin_13 # 13716 # 14018 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.657	BGC0000441.1|Teicoplanin_13 	13716	14018	+	Loose	450	23.0978	tet(45)	40.0	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTCGTGATGCCGTCCGTCCGGAGGGTGACAAGGGTCGGCGTCGACCCCGATTCCGGGTCGTTCAGCATCCATCCCGGGACGTCACGCGGAGTGTTTTTCTTTCTCCGCCGGTACATCGGAAAGGTGGCGCTGTTTCCTTTTGTCGCCTTCCCGATATTGCTGATCGCGGTCGGAGCTGAATTGGTGCCGAAACAGGTCATCGACGGCGGCGTCCGCAGGACCGGTCGCGGCGGTGACGGGACCGCTCCGGGTCCGGACCGCCGGCCGGTGCGCCGGGTGGCTCTTGAAGGGGGACGATGA	MVVMPSVRRVTRVGVDPDSGSFSIHPGTSRGVFFFLRRYIGKVALFPFVAFPILLIAVGAELVPKQVIDGGVRRTGRGGDGTAPGPDRRPVRRVALEGGR	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	21.83	gnl|BL_ORD_ID|146|hsp_num:0	17			294	405	tetracycline
BGC0000441.1|Teicoplanin_14 # 14015 # 20245 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=4bp;gc_cont=0.727	BGC0000441.1|Teicoplanin_14 	14015	20245	+	Loose	1000	117.472	almE	30.34	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAATTCCGCAGCGCAGGCCACATCGACGGTGCCGGAGCTGCTCGCCCGGCAGGTGACCCGGGCCCCCGATGCGGTGGCCGTGGTGGACCGGGACCGGGTTCTGACGTACCGGGAACTCGATGAGCTCGCGGGCCGGTTGTCCGGACGTCTGATCGGCCGGGGCGTCCGCCGCGGGGACCGCGTGGCGGTCCTGCTGGACCGTTCGGCGGACCTGGTGGTGACGCTGCTCGCGATCTGGAAGGCCGGGGCGGCGTATGTGCCGGTCGATGCCGGCTATCCCGCGCCGCGTGTGGCGTTCATGGTGGCGGACTCGGGAGCCTCCCGCATGGTGTGCTCGGCCGCGACGCGTGACGGCGTACCGGAGGGGATCGAGGCGATCGTCGTCACGGATGAGGAGGCGTTCGAGGCCTCGGCGGCCGGGGCGCGACCGGGAGATCTGGCGTACGTGATGTACACCTCCGGCTCGACCGGCATCCCGAAGGGCGTGGCGGTTCCGCATCGCAGCGTCGCGGAGCTGGCCGGGAATCCCGGCTGGGCGGTGGAGCCGGGCGACGCGGTCCTGATGCACGCGCCGTACGCCTTCGACGCGTCGCTGTTCGAGATCTGGGTGCCGCTGGTTTCCGGGGGCCGGGTGGTGATCGCCGAGCCGGGGCCGGTGGACGCCCGGCGCCTGCGGGAGGCGATCAGCTCCGGGGTGACCAGGGCGCATCTGACCGCCGGCAGCTTCCGCGCGGTGGCGGAGGAGTCGCCGGAGTCCTTCGCCGGGCTGCGCGAGGTGCTGACCGGCGGTGACGTGGTGCCGGCACACGCCGTGGCGCGGGTCCGCTCGGCCTGTCCCCGGGTGCGGATCCGGCACCTGTACGGCCCGACGGAGACGACGCTGTGCGCCACATGGCATCTTCTGGAGCCGGGGGACGAGATCGGCCCGGTGTTGCCGATCGGCCGTCCGCTCCCGGGCCGGCGCGCTCAGGTGCTCGACGCGTCGCTGCGGGCCGTGGCGCCGGGCGTGATCGGTGACCTGTACCTGTCCGGCGCCGGTCTGGCTGACGGCTACCTGCGCCGGGCAGGGCTGACAGCGGAGCGATTCGTGGCCGACCCGTCCGCGCCCGGGGCGAGGATGTACCGCACCGGCGACCTCGCGCAGTGGACCGCCGACGGTGCGTTGCTGTTCGCGGGCCGGGCCGACGACCAGGTGAAGGTTCGCGGCTTCCGGATCGAGCCGGCCGAGGTCGAGGCCGCGTTGACCGCGCAGCCGGGCGTCCACGAGGCCGTGGTCCGAGCGGTCGACGGGCGCCTGGTCGGCTATGTGGTGGCGGAGGGGGACGCGGAACCGGCTGTCCTGCGCGAGCGTGTCGGTGCGGTGCTGCCGGAGTACATGGTCCCGGCCGCGGTGATCACACTGGACGCGCTGCCGCTGACCGGCAACGGCAAGGTGGACCGGGCGGCTCTGCCGGCTCCGGTCTTCGCGGCGGACGCTCCGGGGCGCGAACCCGGCACCGAGGCGGAGCGCGTGCTGTGCGGGCTGCTGTCCGAGGTGCTCGGCCTGAACCGGGTCGGAGTCGACGAGAGCTTCTTCGAGCTGGGCGGAGACTCCATCGCGGCGATCCGGCTGGCGGCGCGTGCGTCCCGGGCGGGCCTGCTCGTGACGCCCGCCCAGATCTTCAAGGAGAGGACTGTCGCACGGCTGGCGGCCGTGGCGGGCGCTGTACCGGCCGGGCCACCCGTCGACCGCCCCCTCATCGCGCTGACCGCGGAGGAGGAGGTCGAGCTGGCGGCCGCCGTCCCGGGCGCGGTGGAGGTCTGGCCGCTGGCACCGCTGCAGGAGGGGTTGCTCTTCCAGTCGACCATCGACACCGAGGGCCTCGACATCTACCAGGCGCAGTGGATTCTCCAGCTGAACGCGCCGCTGGACGTGCGCCGGCTACGGGTCGCGTGGGAAGCGGTCTTCGCGCGGCACGCCGAGCTTCGAGTGAGCTTCGTCCGGCTGGCGTCCGGGAAGACGGTGCAGGCCGCCGCCGGGCACGTCGTCCTGCCGTGGCGGGAGGTGGATCTGACCGATGCGGGCGATGTCGACGCGGCCCTGCAGGAGCTGGCCGGGCGGGAGCAGGAACAGCGCTTCGACCTTGCCCGCGCGCCGTTGTTCCGGTTGGTGCTGGTCCGGTACGGCGAGGACCGGCACCGGCTGCTGGTCGTCCATCACCACATCCTGACCGACGGTTGGTCGGTGGCGGTCATCCTCAACGAGGTGGCCGAGGCCTATGCGGCCGGTGGGCGGCTGCCCGACCGGACGGGTCCGGTGTCCTATCGGAACTACCTGGCCTGGCTGGACCGGCAGGACAGGGAGGCGGCGCGCGCGGCCTGGCGGGCCGAGCTGTCCGGCCTCGACGAGCCCGTGCCGATCGCCAGGGCGGCCGCCGGGACCGGGTACGAATACCGTGTCGCGTTCCTGCCGGCGGATGTCTGCACGAGGCTGACGGCGTCGGTCCGTGACCACGGGCTGACGCTGAACACGGTGGTGCAGGGCGCGTGGGCGATGGTGCTGTCGCGACTTGTCCGGCGTACCGATGTGGTATTCGGCACCACGGTGGCCGTCCGTCCCGCGGAGCTCCCGGGCGTGGAGTCGATACCGGGCCTGATGATGAACACGGTGCCGGTCCGGGTGACGCTGGACGGTGGGCAATCGCTCCTCGACCTGCTCACCGGCCTGCAGCGGCGGCAGGCGGCCCTGATGCCGCACCAGCATCTGGGGCTGCCGGAGATCCAGAGGACGGCCGGGCCGGGCGCGACGTTCGACACGCTGCTGGTGTTCGAGAACTACCCGCGGGATTTCGCCGGCCAGTTCACCTACCTGGGCACGATCGAGGGGACGCACTATCCGCTCACCCTCGGCATCATCCCGGGAGAGCGTCTCAGGATCCAGCTCGCCTACCGGCACGGGCAGATCGAGGAGACCCTCGCCGCGTCGGTCCTGGACGGGTTCGTCGCAGCTCTCCGCGCGGTGGCCGCCGACCCGTCCGGGTTGGTGGGCCGGACCGGTGTGGGCCGCGGCCCGGTGCACGGCTTAGCCCCGGCACTGGTGGCGGCGGAGTCGCTGCCCGTGCTGGTGGGGCGGGTGGTGGAGCAGCGGTCGCACGAGGTGGCCGTGGTGGACGGCGACGGCGAACTGTCCTTCGGGCAGTTGTGGGACCAGGCGGTGGGCTTGGCGGACCTGCTGACGGCACGTGGAGTGGGACCCGAGTGCCGGGTGGGTGTGCTGGTGGGGCGGTCGGCGTGGTGGGTGGTCGGGATGCTGGGCGTCTCGCTGGCGGGTGGCGCCTTCGTCCCGGTGGATCCGGCGTACCCGGCCGAACGCATCCGGCTGATCCTGGCCGACGCCGATCCCGCGCTCGTGGTGTGTGCGGGGAAACCCGCGAGGGCGGTGCCCGCGGCGTTCGCGGATCGGCTGCTGGTGGTCGACGAGATGGATCTGACCGGGGGATCGGCGGCTCGATTGCCGCGGGTACGTCCGGGTGACGCGGCATATGTGATCTATACGTCGGGGTCGACGGGCAGGCCGAAGGGGGTCGTCGTCCCGCACGCGGGACTGGGGAACCTGGCGCTGGCGCAGATCGACCGGTTCGGTGTGTCGCCGTCGTCCCGGGTCCTGCAGTTCGCGGCGCTGGGCTTCGACGCGATGGTGTCGGAAGTGTTGATGGCGTTGCTGTCCGGGGCGCGGCTGGTGATGGCGCCGGAACACCAGCTGCCGCCGCGCGTGTCGCTGGCCGAGGCGCTGCAGCGGTGGGATGTCACGCACGTGACCGTTCCGCCGTCGGTGCTGGCCACGGCGGAGGCGTTGCCGGCCCGGCTGGAGACCGTGGTGGTGGCCGGGGAGGCATGTCCGCCAAGCCTGGCGGACCGCTGGTCGGCGGGTCTGCGGCTGGTCAATGCGTACGGGCCCACCGAGGCCACGGTGTGCGCGGCGATGAGCATGCCGCTGGTGGCGAGCCGGCCCGTGGTCCCGATCGGGACGCCGATCGCCGGGGGACGCTGCTATGTGCTGGACGCGTTCCTGCGGCCGCTGCCGCCGGGCCTCACCGGTGAGCTGTACGTGGCCGGGATCGGGCTGGCTCGCGGGTATCTGGGACGGGCCGCGTTGACGGCCGAGCGGTTCGTCGCCGACCCGTTCGTCCCGGGTGAGCGGATGTACCGGACCGGAGATCTGGCGTACCGGACCGGCGAGGGTGAGCTGGTGTTCGCCGGGCGTGCCGACGACCAGGTGAAGGTTCGTGGATTCCGGATCGAGCCCGGTGAGGTCGAGTCGGCCCTGTCCGGTCACCCCGGGGTTGCCCAAGCCGCGGTGATCGTGCGCGGTGACCGCCTACTGGCCTATGTGTCGCCGGCTGGCGTCGATCCGCAGGCGGTGCGCGAAGACCTCGCATCGCGGTTGCCGCCGTACATGGTGCCCGCGGTGGTGGTGCCGCTGGAGGCGTTGCCCACCACCCCGAACGGGAAGATCGACCGGGGCGCGCTGCCTGATCCCGACTTCGCGGCCGGGGCAGATGTCCGGGAGCCGCGCACCGAGGTCGAGCGGGCGTTGTGCGATCTCTTCGCCGAGGTGCTCGGTCTGGACCGGGTCGGCGTCACCGACAGCTTCTTCGAGGTGGGCGGCGACTCCATCACCTCGATGCAGTTGGTGGCACGGGCCCGGCGTGCGGGTCTGACGTTCGCCGCGCACGACGTGTTCGAGGAGCGGACCCCGGAGCGGCTCGCGCAGGTGGCGGCGCAGGCGCCGCGGCCGGAACGCGGCCACATGATCGGCGACGGTGTGGGCGAGGTGGCGCGGACGCCGGTCATGCGGTTGCTGGGCGATGCGGTGGTGGCCGCGGGATTCGCGCAGTGGGTCGTGGTCGCCGTGCCCGCAGGGCTCGGGGAGCGCGCGTTGGTGGCGGCGTTGACGGCGGTGGTGGACGCGCACGACATGCTGCGGGTGCGGGTGGACTCGGGGCGGTTGGTGGTGCGCGCCCGTGGGTCGGTCGATGTGGCCGGTGCGGTGGAGCGGGTCGAGGCCGACACCGGCGAGATCGACGAGGTGGCGCGTCGCTGTGCGGTGGCGGTGGCCGCACGGCTGGACCCCGCTGCCGGTGTGGTGGTGCGGGCGGCGTGGGTGGACGCCGGCCCGGATCGCTCCGGCCGCTTGGTGCTGGCCGCGCATCACCTGGCCGTCGACGGAGTGTCGTGGCGTGTTCTGGTACCGGACCTGCAGGCGGCGTGTGAGGCGGTGGCCGCCGGGCGGCAGCCGGCCCTGGAACCGGTGGGAGTGTCGTTCCGGCGGTGGGCGGACCTGTTGGGGCAGTGGGCGGTTTCGCCGGAGCGGGTGGGGGAGTTGGCGCGATGGCGGGCGGTGGTGGGTTCCGGGGACCGGCGGATCGGTGAGCCCGGCCCGTCCGCCGGGGCCGTGCGTTCCCGCTCGTGGGTGGTGTCGGGGTCACGGGCTCAGGTGCTGGTGGGACGCGCGCCGGTGGTGTTCTTCTGCGGGGTCCATGAGGTCGTGCTGGCCGGACTGGCGGGCGCGGTGGCACGGTGGCACGGCGGGGATGTGGTCCTGGTCGATGTCGAGGGTCACGGCCGTCACCCGGTGGGCGGACTGGACCTGTCCCGGACGGTGGGTTGGTTCACCAGCGTCCACCCGGTGCGGCTGGATGTCGCCGGCATCGACTGGGCGGGCGTGCTGGCCGGTGGACCGGCGGCCGGGGAGCTGTTGAAAAGGGTCAAGGAGCAGTCGCGGGCGGTGCCCGGCGACGGGCTCGGTTACGGGTTGCTGCGTTTTCTCAACGACGAGACGGGCCCGGTACTGGCGGCGTTGCCATCGCCGCAGATCGGATTCAACTTCATGGGACGGCATGTGGCCGGTGTGCGGGAGTGGCAGCCGGTCGGGGATGTGGGCGGCGCGCTGGGCCCGGGCGTCGGGTTGCCGCATGTCCTCGACGCCGACGCGGTGGTCGAGGACGGCCCCCGGGGCCCGCTGCTGAGGTTGGTGCTGAGCTGGCCGGACGGTGTGCTGCGGGAGGACGAGGTCGAGCGGCTGGGCCGCGGTTGGTCGGACATGTTGTCCGGACTGGCCGGCCAGGCAGATGATCCGTCGGCGGGGGGACACACCGCGTCCGATTTCGACCTCCTCGACCTGGACCAGGACGAGATCGAGAACTTCGAAGCAATAGCGGCCGAATTCGGTGGAGGTCAGGAATCGTGA	MNSAAQATSTVPELLARQVTRAPDAVAVVDRDRVLTYRELDELAGRLSGRLIGRGVRRGDRVAVLLDRSADLVVTLLAIWKAGAAYVPVDAGYPAPRVAFMVADSGASRMVCSAATRDGVPEGIEAIVVTDEEAFEASAAGARPGDLAYVMYTSGSTGIPKGVAVPHRSVAELAGNPGWAVEPGDAVLMHAPYAFDASLFEIWVPLVSGGRVVIAEPGPVDARRLREAISSGVTRAHLTAGSFRAVAEESPESFAGLREVLTGGDVVPAHAVARVRSACPRVRIRHLYGPTETTLCATWHLLEPGDEIGPVLPIGRPLPGRRAQVLDASLRAVAPGVIGDLYLSGAGLADGYLRRAGLTAERFVADPSAPGARMYRTGDLAQWTADGALLFAGRADDQVKVRGFRIEPAEVEAALTAQPGVHEAVVRAVDGRLVGYVVAEGDAEPAVLRERVGAVLPEYMVPAAVITLDALPLTGNGKVDRAALPAPVFAADAPGREPGTEAERVLCGLLSEVLGLNRVGVDESFFELGGDSIAAIRLAARASRAGLLVTPAQIFKERTVARLAAVAGAVPAGPPVDRPLIALTAEEEVELAAAVPGAVEVWPLAPLQEGLLFQSTIDTEGLDIYQAQWILQLNAPLDVRRLRVAWEAVFARHAELRVSFVRLASGKTVQAAAGHVVLPWREVDLTDAGDVDAALQELAGREQEQRFDLARAPLFRLVLVRYGEDRHRLLVVHHHILTDGWSVAVILNEVAEAYAAGGRLPDRTGPVSYRNYLAWLDRQDREAARAAWRAELSGLDEPVPIARAAAGTGYEYRVAFLPADVCTRLTASVRDHGLTLNTVVQGAWAMVLSRLVRRTDVVFGTTVAVRPAELPGVESIPGLMMNTVPVRVTLDGGQSLLDLLTGLQRRQAALMPHQHLGLPEIQRTAGPGATFDTLLVFENYPRDFAGQFTYLGTIEGTHYPLTLGIIPGERLRIQLAYRHGQIEETLAASVLDGFVAALRAVAADPSGLVGRTGVGRGPVHGLAPALVAAESLPVLVGRVVEQRSHEVAVVDGDGELSFGQLWDQAVGLADLLTARGVGPECRVGVLVGRSAWWVVGMLGVSLAGGAFVPVDPAYPAERIRLILADADPALVVCAGKPARAVPAAFADRLLVVDEMDLTGGSAARLPRVRPGDAAYVIYTSGSTGRPKGVVVPHAGLGNLALAQIDRFGVSPSSRVLQFAALGFDAMVSEVLMALLSGARLVMAPEHQLPPRVSLAEALQRWDVTHVTVPPSVLATAEALPARLETVVVAGEACPPSLADRWSAGLRLVNAYGPTEATVCAAMSMPLVASRPVVPIGTPIAGGRCYVLDAFLRPLPPGLTGELYVAGIGLARGYLGRAALTAERFVADPFVPGERMYRTGDLAYRTGEGELVFAGRADDQVKVRGFRIEPGEVESALSGHPGVAQAAVIVRGDRLLAYVSPAGVDPQAVREDLASRLPPYMVPAVVVPLEALPTTPNGKIDRGALPDPDFAAGADVREPRTEVERALCDLFAEVLGLDRVGVTDSFFEVGGDSITSMQLVARARRAGLTFAAHDVFEERTPERLAQVAAQAPRPERGHMIGDGVGEVARTPVMRLLGDAVVAAGFAQWVVVAVPAGLGERALVAALTAVVDAHDMLRVRVDSGRLVVRARGSVDVAGAVERVEADTGEIDEVARRCAVAVAARLDPAAGVVVRAAWVDAGPDRSGRLVLAAHHLAVDGVSWRVLVPDLQAACEAVAAGRQPALEPVGVSFRRWADLLGQWAVSPERVGELARWRAVVGSGDRRIGEPGPSAGAVRSRSWVVSGSRAQVLVGRAPVVFFCGVHEVVLAGLAGAVARWHGGDVVLVDVEGHGRHPVGGLDLSRTVGWFTSVHPVRLDVAGIDWAGVLAGGPAAGELLKRVKEQSRAVPGDGLGYGLLRFLNDETGPVLAALPSPQIGFNFMGRHVAGVREWQPVGDVGGALGPGVGLPHVLDADAVVEDGPRGPLLRLVLSWPDGVLREDEVERLGRGWSDMLSGLAGQADDPSAGGHTASDFDLLDLDQDEIENFEAIAAEFGGGQES	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	373.38	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000441.1|Teicoplanin_15 # 20242 # 23427 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.715	BGC0000441.1|Teicoplanin_15 	20242	23427	+	Loose	1000	120.168	almE	25.1	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACAACTCCGACTACGTCCCCAGGATCGGCGCTCGCGGAGGTCTGGCCGCTGTCACCGATGCAGGAGGGGATGCTCTACCATGCCTCGTTCGACGACGCGGCCCCCGACATCTACGTCATCCAGCAATCGCAGATCATCGACGGCCCTCTGGACACCGAGCGATTCCGGAGGTCCTGGGAGGTCCTTCTCCACCGGCACGCGGCGCTGCGAGCGAGTTTCCACCGCCGGAAGTCCGGTGAGACCGTCCAGCTGATCCCCCGTGAGGTCCGGCTTCCCTGGGCCGAACGTGACCTGTCCGGCCTGCCCGAGAAGGCGGCGCTGGCCGAGGTGGGCGAGATCGCGGCGAAGGAGCGCGCCGAAAGGTTCGACCTCACGAAGCCTCCCCTGCTGCGGTTGATGCTGATCCGCCTCGGCCCGCAGCGGCACTGTCTGGTGACCACGAGCCATCACCTGCTCATGGACGGGTGGTCGCGGGCCATCCTGGAATCGGAGCTGCTCCATGTCTACGCGTCCGGTGGCACCGTCTCGGGGCTGCCGCCCGCCGGCTCGTACCGTCACTATCTGTCATGGTTGGGTCGGCAGGACCGGGAGGCCGCCCGATCGGCATGGCGCGCGGAGCTGTCCGGCGCCGACGGATCCGCGCTCGGAATCGCGGAGCGGCCAGGGAAGGCTCCGGAGCTGCCGGCACGCGAGGTGCTCCGCCATTCACCGGAGTTCACGTCCGCTCTCGTGGACTTCGCCCGCCGCCACGGGTTGACGCTCAACACGCTGGTGCAGGGCGCCTGGGCGGTGGTGCTGGCCCGATTGGCGCGCCGCACGGACGTGGTGTTCGGCGCGACGGTGTCGGGACGCCCCGCGGAGCTGCCCGGCGTGGAACAGCTTGTGGGCCTGTTCATCAACACCGTGCCGGTGCGAGTCCGGCTGGACGCCGGGCAGCCGGTCCTGGAGATGTTGACGGAGCTGCAGAAACGGCAGTCCGCGCTGATCTCGCATCAGCATCTCGGATTGCCGGAGATCCAGAAGCTCGGCGGGGCGAGTTTCGACACGATCGTCGTCTTCGAAAACTATGTCGATCCGGCCGCGGCGCCGGATTCTCCGCGCGGCCTGCGCCTGACCCTGCGAGAGTTCCACCAGGCGTCGCCGTATGCGATCACGCTGGGAGTGATGCCGGGCGAGAGCCTCGAGACCGACGTGCAGTATCCCCCGGAGACGCTCGATGCCCGGATCGCCGAGGAAGCCCTGTACGGGCTGGCCCGCGTCCTGGAACAGATCATCGCCGAGCCGGGAGCGGCGGTGGGCCGCCTCGACGTGGTGAGTGCGGCCGGCCGGCAGCTGACCGTCGAGCGGTGGAACGAGACCGGCGACGCGGTGGACGCGCCGTCCCCGGTCGATCTCTTCCGCCGGCAGGTGCGGCGGGCACCCGACGCGACGGCCGTGACGGCCGGGGACCGGGCCTGGTCGTTCAAGGAGCTCGACGAATGGTCCGGCCGGCTGGCGCGGGCCCTGACGGATCGGGGTGTCCGGCGCGGCGACCGGGTCGGGGTGATGCTGGAGCGGTCGGCCGAGGTGCTGGCGGCATGGCTCGGGGTGTGGAAGGCGGGAGCCGCGTTCGTGCCGGTCGATCCGGGCTACCCGGCGGACCGGGTGGAGTTCATGCTGGCCGACTCCGCGGTCGCGGCGGTGCTGTGCCGGGAGTCGACCGCGGGTGCGGTGCCGGCGGGTCACGAGCTGATCGACATGGACCGGGTCGGCGAGGGCGTGGCCGCGCCGGTCGCGATCGGAGCCGACGATCTGGCGTACGTCATGTACACGTCCGGATCCACCGGCAAGCCCAAGGGCGTGGCCGTCGCGCACGGGGGTGTGGCGGCATTGGCCGGTGATCCGGTCTGGGAGGTGGGGGCCCGCGACGCGGTGCTGATGCACGCTCCGCACACCTTCGACGCGTCGCTCTACGACGTGTGGGTGCCGCTGGTCTCCGGCGCGCGGGTGATGCTCGCCGAGCCGGGCGTGGTCGACGCGCAGCGGCTCGCCGCACACGTGGCGGATGGTCTCACCGCGGTGAACTTCACCGCCGGTCAGTTCCGGGCGCTGGCACAGGAGTCGCCGGAATCCTTCGCCGGACTGCGCGACGTGCTCGCGGGTGGAGACGTGGTGCCGCTCGGCGCGGTGGAGCGGGTCCGGCAGGCGTGCCCCGGGCTACGGGTCTGGCACACGTACGGCCCGACGGAGACCACGCTGTGCGCGACGTGGAAGAAGATCGAGCCGGGTGACCGGCTGGGCTCGACGCTGCCGATCGGCCGGCCGCTGCCGGGCCGTCGGCTGTACGTGCTGGACGTCTTCCTGCGTCCGCTGCCGCCGGGCGTCGCGGGTGATCTCTACATCGCGGGCGCCGGCGTGGCCCAGGGCTACCTCGGGCGTCCGGCGCTGACCGCCGAGCGGTTCGTCGCCGACCCGTTCGCCGCGGGCGAGCGGATGTACCGGACCGGGGACGTGGCGTACTGGACCGGTGACGGCGAGCTGGTGTTCGCCGGGCGCGCCGACAACCAGGTCAAGATCCGTGGCTATCGGGTGGAACCGGGCGAGATCGAGACGGTGCTGGCCGAGCAGCCGGGCGTCGACCAGGCGGTGGTGCTGGCCCGCGACGGCCGTTTGATCGGCTACGTGGTGCCCGGCGGCGAGGTGGATCCGGTACGGCTGCGCGAGCGGGTCGCCCGGGTGTTGCCGGAGTACATGGTCCCGGCGGCGGTGATGGTCCTGGACGCCCTGCCGGTGACTCCGAACGGGAAGCTGGACCGGGAGGCTCTGCCGGATCCGGACTTCAGCCGACGCGTCTCCGGCCGGGAGCCGCGTACCGGGGTCGAGCGGGCGCTGTGCGGTCTCTTCGCCGAGGTGCTGGGTCTGGAACGGGTCGGGGTCGACGACAGCTTCTTCGAACTCGGCGGAGATTCGATCACCTCGATGCAGCTCGCCGCACGCGCCCGCCGCGACGGGATGGCCTTCGGCGCGCGAGAGGTGTTCCAGCACCGGACGCCGGCCGGGATCGCGGCGATCGTCGATTCCGGGAACGAGCCGGCGGCCGGTGGCGACGGCGAGGCGACGTGGACGCCGGTGCGGCGGTTCGGCCTCGTCGACCTGGACCAGCAGGAGGTCGAAGAACTCGAGTCCGAGTTCGGCGACCGTTGA	MTTPTTSPGSALAEVWPLSPMQEGMLYHASFDDAAPDIYVIQQSQIIDGPLDTERFRRSWEVLLHRHAALRASFHRRKSGETVQLIPREVRLPWAERDLSGLPEKAALAEVGEIAAKERAERFDLTKPPLLRLMLIRLGPQRHCLVTTSHHLLMDGWSRAILESELLHVYASGGTVSGLPPAGSYRHYLSWLGRQDREAARSAWRAELSGADGSALGIAERPGKAPELPAREVLRHSPEFTSALVDFARRHGLTLNTLVQGAWAVVLARLARRTDVVFGATVSGRPAELPGVEQLVGLFINTVPVRVRLDAGQPVLEMLTELQKRQSALISHQHLGLPEIQKLGGASFDTIVVFENYVDPAAAPDSPRGLRLTLREFHQASPYAITLGVMPGESLETDVQYPPETLDARIAEEALYGLARVLEQIIAEPGAAVGRLDVVSAAGRQLTVERWNETGDAVDAPSPVDLFRRQVRRAPDATAVTAGDRAWSFKELDEWSGRLARALTDRGVRRGDRVGVMLERSAEVLAAWLGVWKAGAAFVPVDPGYPADRVEFMLADSAVAAVLCRESTAGAVPAGHELIDMDRVGEGVAAPVAIGADDLAYVMYTSGSTGKPKGVAVAHGGVAALAGDPVWEVGARDAVLMHAPHTFDASLYDVWVPLVSGARVMLAEPGVVDAQRLAAHVADGLTAVNFTAGQFRALAQESPESFAGLRDVLAGGDVVPLGAVERVRQACPGLRVWHTYGPTETTLCATWKKIEPGDRLGSTLPIGRPLPGRRLYVLDVFLRPLPPGVAGDLYIAGAGVAQGYLGRPALTAERFVADPFAAGERMYRTGDVAYWTGDGELVFAGRADNQVKIRGYRVEPGEIETVLAEQPGVDQAVVLARDGRLIGYVVPGGEVDPVRLRERVARVLPEYMVPAAVMVLDALPVTPNGKLDREALPDPDFSRRVSGREPRTGVERALCGLFAEVLGLERVGVDDSFFELGGDSITSMQLAARARRDGMAFGAREVFQHRTPAGIAAIVDSGNEPAAGGDGEATWTPVRRFGLVDLDQQEVEELESEFGDR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	190.83	gnl|BL_ORD_ID|4935|hsp_num:0	5928			129	1629	colistin A; colistin B
BGC0000441.1|Teicoplanin_16 # 23471 # 35674 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGAGGA;rbs_spacer=7bp;gc_cont=0.752	BGC0000441.1|Teicoplanin_16 	23471	35674	+	Loose	1000	108.612	almE	28.42	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCCAGGCGCGCATCGAGGACATCTGGCCGCTGTCGCCGCTGCAGGAGGGACTGCTCTTCCACACCGTCTACGACGACGAGGGGCCGGACGTCTACGTGGGCCACTGGATCCTCGATCTCGACGGCCCGGTGGACGCGGCCCGGCTGCGCGCGGCGTGGGAGGCGCTGCTGGCCCGGCACGCCGCGCTGCGGGCCTGCTTCCGGCAGCGCCGGACCGGCGAGACCGTGCAGGTCGTCGCCGGCCGGGTGGAGCTGCCGTGGCGGGTGGTCGACCTGGCCCACCTCGACGATCCCGAGCACGCCGTGCGGGAACTGGCCGACGAGGACCGGCTGAGGCCCTTCGACGTCGCGAAGCCGCCGCTGCTGCGGCTGACCCTGATCCGGCTCGCCGACGACCGGCACCGCCTGGTGGTGACCTGCCATCACGCGGTCATGGACGGCTGGTCGTTGCCGATCGTCTTCGACGAGCTGACCGCGTTGTACGCGGCCGGCGACGGCCCGGCACAGCTGCCGGCGGTGACGCCCTACCGGGAGTACCTCGCCTGGCTGAGCCGGCAGGACAAGCCGAGCGCGCTGGCGGCGTGGGCCGCGGAGCTGCGTGGCGCGCAGGAGCCGACGTTGGTGGCCCCCGCCGATCCGGGACGGGCGCCGGGCATGCCGGAGAGCGTCGAGGTGCAGCTGTCGCCGGAGCTCACCCGCTCGCTGGCGGAGCTGGCCCGTGGCCGGGGGCTGACGCTGAACACGGTGATCCAGGGCGCCTGGGCGCTGGTGCTGGCGCGGCTGACCGGCCGGACGGACGTGGTGTTCGGGGCGACGGTGTCGGCGCGTCCGGCGCACCTGCCCGGCGTGGAGGCAATGGTCGGCCTGTTCCTCAACACCGTGCCGGTGCGGGTACGGCTGCGGGGTTCGGCGCCGGTCGTCGAGATGCTGGCGGAGCTGCAGAAGCGGCAGTCCGCTCTCATCCCCGAACAGTTCGTCGGACTGGCGGACATCCAGAAGGCGGCCGGGCCCGGCGCGGTCTTCGACACCCTGCTGGTCTTCGAGAACTTCCCCCGCGAGCTCGACGATTCGCGCTCGGCCGACGCGTTCGGCATCCGGGTGCACCAGGGCCGCGAAGCCGCGCACTATCCACTGACGCTGGTCGCGGTCCCCGGCGAGTCGATGCTGTTCAAGCTCGACTACCTGACGGAGCTGTTCGACGCGGCCACCGCGGCGTCCATCCTGGAACGGTTCACCCGGGTCCTGCGCCGGCTGACGGACGCGGGCGAGCTCACGGTGGCCGCGATCGACGTGACCAGCGCGGCGGAGCGCGACCGGGTGGCGCGATGGGGCGCGGCCGTCGGTGCGCGGCCGGACCGGCTGGCGCTGGACCTGTTCGCACGCCAGGTCGCGCAGCGCCCCGACGAGGTGGCGGTCGCCGATGGGGACCGGGTGATGTCGTTCGGGGAGCTGGCCGAGCGCGCGGACCGGCTCGCCGGTCACCTCAGCGCGCGCGGGGTCCGGCGCGGGGACCGGGTGGCCGTGGTGATGGAGCGGTCCGGCGAGCTGATCGCGACGTTGCTCGCGGTGTGGCGGGCCGGGGCGGCGTTCGTACCGGTGGATCCGGCCTATCCCGCGGAGCGGGTGAAGTTCCTGCTGACCGACGCGGAGCCGGTGGCGGCGGTGTGCACGGCCGCGTTCCGGGCCGCCGTGCTGGACGGCGGGCTCGAGGCGATCGTGGTGGACGATCCGGGGACGTGGCCGGCGGTGGCGCCGTGCCCGCCGGTCCCCACCGGACCCGACGACCTCGCCTACGTGATGTACACCTCGGGCTCGACCGGGACGCCCAAGGGCGTCGCGGTGTCGCACGGCGACGTCGCGGCGCTGGTCGGCGACCCGGGATGGCGGACCGGTCCCGGCGACACCGTGCTGATGCACGCCTCGCACGCGTTCGACATCTCGCTGTTCGAGATCTGGGTGCCGCTGCTGTCCGGCGCCCGGGTGATGATCGCCGGACCGGGCGCGGTGGACGGCGCGGCGCTGGCCGCTCAGGTGGCCGCCGGGGTGACGGCCGCGCACCTGACCGCGGGCGCCTTCCGGGTGCTGGCCGAGGAGTCGCCGGAGTCGGTCGCCGGGCTGCGCGAGGTGCTGACCGGCGGTGACGCGGTGCCGCTGGCGGCGGTCGAACGGGTGCGGCGGGCGTGTCCGGACGTCCGGGTGCGGCACCTGTACGGCCCGACCGAGACCACCCTGTGCGCCACCTGGTGGCTGCTCGAACCGGGCGACGAGACCGGCCCGGTGCTGCCGATCGGTCGCCCGCTCGCGGGCCGGCGCGTCTACGTCCTCGACGCGTTCCTGCGGCCCCTGCCGCCCGGGACGACCGGCGAGCTGTACGTCGCCGGGGCCGGTGTGGCGCAGGGCTACCTGGGCCGCCCGGCGCTGACCGCCGAGCGGTTCGTCGCCGACCCCTTCGCTCCCGGTGGCCGGATGTACCGCACCGGCGACCTGGCGTACTGGACCGAGCAGGGCACGCTGGCGTTCGCCGGACGGGCCGACGACCAGGTCAAGATCCGTGGCTACCGGGTGGAGCCCGGCGAGGTCGAAGCGGTCCTGGGCGGCCTGCCGGGTGTCGCCCAGGCCGTGGTGTGCGTCCGCGGCGAGCACCTGATCGGTTATGTGGTGGCCGAGGCCGGCCGGGACCTCGACCCGGAACGCCTGCGCGCCCGGCTCGCCGCGACCCTGCCCGAGTTCATGGTCCCGGCCGCGGTGCTGGTGCTGGCGGACCTGCCGCTGACGGTCAACGGCAAGGTGGACCGGCCGGCCCTGCCCGAGCCGGACTTCGCCGCCAAGTCGACCGGCCGGGCCCCGGCCACCGCGGCCGAGCGGATCCTCTGCGACGTGTTCGCCGGCGTCCTGGGCCTGGACCGGGTCGGCGTCGAGGACAGCTTCTTCGCGCTGGGCGGCGACTCGATCTCGTCGATGCAGGTGGCCGCCCGCGCCCGGCGCGAGGGCATCGCCCTGACCCCGCGGCAGGTGTTCGAGCACCGGACCCCGGAACGGCTGGCCGCGCTGGCGCCGGCGGCCGGATCGGCACGACCGGACCGGTCCGCGGCGGATGCCGGCCTCGGCGAGATCCCGTGGACGCCGGTGATGCGCGCCCTCGGCGACGACGCGGTGCGCCCCGGCTTCGCGCAGGCCCGAGTCGTCGTCGCGCCGGCCGGCCTCGACCCGGACGCGCTCACCGGCGCCCTGCGGGCGGTGCTGGACACCCATGACGTGCTGCGCGCGCGGGTGGAGCCGGACCGGCGGCTGATCGTGCCCGAGCGCGGCGCGGTGGCCGCGGCGGACCTGCTGACGCGGGTGGCGGTCGACAGTGACGGCATCGACGCCCGCGCCGAGCGCGAGGCGGCGACGGCGGCGGGCACGCTGGATCCGTCGGCCGGGATCATGCTGCGGGCGGTGTGGCTCGACGCCGGCGACGCCGAGCCGGGCCGGCTGGCGCTCGTGGCGCATCACCTGGTGGTCGACGCGGTGTCGTGGAGCATCCTGCTGCCGGACCTGCAAGCGGCGTACCAGGAGGTGCTCGCCGGCGCGACCCCGGCTCTGGAACCCGCGGCGACGTCGTACCGGCAGTGGGCGCGGCGGCTGACCGAGCAGGCGTCCAGCCCGAGCACCCTGGCCGAGCTCGACCACTGGGTCACCGTGCTGGACGCGGCGGAACCACCGCTGGCGGAGCACCACGGGCAGGCGCACTCGTGGTCGGCGACCCTGTCCGGCGCCGTGGCGGGCCACCTGGTCAGCCGGATGCCGGGCGCGTTCCACTGCGGGATCCAGGAGGTGCTGCTCGCCGGCCTGGCCGCGGCGGTGGCCCGCTGGCGCGGCGACGACGCCGGGGTGCTGGTGGACGTGGAGGGCCACGGCCGGCACGCCGCCGACGGCGAGGACCTGTTGCGTACGGTGGGGTGGTTCACCAGCGTGCACCCGGTCCGCCTGGACGTCTCCGGCGTCGACCTGGCGGCCGCGGCGGCCGGCGACGCGGCCGCGGGTGAGCTGCTGAAATCGGTGAAGGACCAGGTCCGCGCGGCGCCCGGCGACGGGTTCGGGTTCGGGCTGCTGCGCCACCTCAACCCGGACACCGCCGAGCGGCTCGCCGCGTTGCCCGCCCCGCAGATCGGGTTCAACTACCTCGGCCGGTCCGGGGTGGCCGCCGAGGCCGTCCCGTGGCAGGTGCGCGGCGGATCGCTCGGCGCCGGGGAAGCCGGACCGGACCTGGTCCTGGCACACCCGCTGGAGGCCGGCGCGGACGTGCGGGACACCCCGGACGGCCCGCTGCTGCGGCTCACCCTGGACGGCCGGGATCTCGCCCCGGTCACGGTGGAGCTGCTCGGCGAGGCCTGGCTGGAGTTGCTGACCGGTCTGGCCACCCACGCCGGCGACCCGCGGGCCGGCGGGCACACCCCGGCCGACTTCGACCTGGTCGAGGTGACGCAGCGGGACGTGACGGCGCTGGAGGCCGCGGCGCCGGGCCTGACCGACATCTGGCCGCTGTCGCCGCTGCAGCGGGGCATGCTCTTCGAGCGGGCGCTGGACGAGGACGGCGTCGACGTCTACCAGAGCCAGCGCATCCTGGACCTCGACGGGCCGCTCGACGCGGACCGGCTGCGCGCGGCCTGGCGGACGCTGGTCGCCCGGCACGAGTCGCTGCGCACCAGCTTCCATCAGCTGGAGTCCGGCGAGACGGTGCAGGTCGTCGTGGACCAGGCGGACATCGGCTGGCGGGTGGCCGACGTGTCACACCGGGCTGAGGCGGACGCGGCCGCGGAGGTCGGACGACTGCTCGCCGAGGACCAGGCGCAGCGGTTCGACGTCACCCGGGCGCCGCTGCTGCGGCTGTTGCTGGTCCGGCTCGGCGCGGACCGGCACCGGCTCGTGGTGACGTCGCACCACATCGTCCTGGACGGCTGGTCGACGCCGATCATCCTGGGCGAGATGTCGGCGGCGTACGCGGGTGCGCCGAGCACGGCGACGGCGCCCTCGCCGCGGGACTACCTGGCGTGGCTGAACCGCCAGGACGACGCGGCGACCCGCGCGGCGTGGCGCTCCGAGCTCGCCGGCTGCGACGAACCGACCCTGGTGGACGCCGACGCGGACAAGACCATGGTGATGCCGGGGGAGCACTGCGAAGGACTGTCGGAGCAGGCCACCCGCCGTCTCACCGAGTTCGCACGGGGTCATGCGGTGACGCTGAGCACGATCCTGCAGGGCGCCTGGGCGCTGGTGCTGGCGCGGCTGGCGGGCCGGACCGACGTGGTGTTCGGGACGGTGGTGTCCGGACGCCCCGCCGAGGTGCCGGACGTCGACCGGATGGTGGGGATGTTCATCAACACCGTCCCGGTCCGGGTGCGCCTCGACGGCGGCCGGCCGGTGCTGGACCTGCTGCACGACCTGCAGGCACGCCAGTCCGCGCTGACCGAGCACCAGCACCTGGGGCTGCCGGACATCCAGCGGGCGGCGGGTCCCGGCGCGCTGTTCGACACCATCATGATGGTCGAGAACTACCCGATGGACGCCGCCGGCCTGGGCGGCGAGGGTGGTGTCAGGATCGGCTCGGTCCTCACCCGGACCGGCACCAGCTATCCGCTGACGATGAGCGCGAGCCCCGGCGAGCGCCTGCAGATCCGGGTGTCCTACCGGCCCGACCGCATCGAGCGGGAGACCGCCGCCGAGGCGGCCGGGCAGGTCGTACGGGTCATCGAACGCATCGTGGCGGAGCCGTCGCTCGCGGTGGGCCGCCTGGGTGTGACCGGCGAATCGGTGCGCGAGCGCGTGGTGGAGCGCTGGAACGCGACCGGCGTGGCGGCCGGCGGGTCGTCGGTGCTGACCGGGTTCCGGCGGCGTGCGCGCAGCTCACCGGACGCGGTGGCGGTCAGCGGCGGCGGGCGGACCCTGTCCTACGCCGCCCTGGACCGGGAATCCGACCGGCTCGCGGGGCATCTGGCCGGCCGGGGTGTGCGGCGTGGCGACCGCGTCGGCGTGGTGATGGAACGCGGCACCGATCTGTTCGTCGCCCTCCTCGCGATCGGCAAGGCGGGCGCGGCGTACGTCCCGGTGAACCTGGACTACCCCCGGGACCGGATCGAGCGGATGCTGACCGACGCCGGCGTATCGGTGGCGGTCTGCGTGCAGGCGACCAGCGGCGCGGTGCCGGACGGCCTCGCGCCGGTGGTCATGGACTCACCGGCGATCGCCGCGGCGCCGTCCGAGGCCCCGCCGATCACGGTGGGCGCGCACGACCTGGCGTACGTGATGTACACCTCCGGGTCCACCGGGGTGCCGAAAGGCGTCGCGGTGCCGCACGGCAGCGTGGCGGCGCTGGCCGGTGACCCGGGCTGGTCGGTCGGCCCCGGCGACGGCGTGCTGATGCACGCCCCGCACGCGTTCGACGCGTCGTTGCTGGAGATCTGGGTGCCGCTGCTGAGCGGGGCCCACGTGGTGGTCGCGGACCCGGGCGCGGTGGACGCGCAGCGGCTGCGCGAGGCGATCGACCGCGGGGTGACCACCGTCCATCTGACGGCCGGGTCGTTCCGGGTGCTGGCGGAGGAGTCGCCGGACGCCTTCCGCGGACTGCGGGAGGTTCTGACCGGCGGCGACGCGGTGCCGCTCGCCTCCGTCGTACGGTTGCGCGAGACCTGCCCCGAGATCCGGGTCCGGCACCTCTACGGCCCCACCGAGACCACCCTGTGCGCCACCTGGCACCTGATCGAGCCGGGGGTCGCCACCGGCGACACCCTGCCGATCGGCCGGCCGCTGGCCGGGCGGCGAGCGTACGTGCTCGACGCGTTCCTGCAACCGGTGGCCCCGAACGTGACCGGCGAGCTCTATCTGGCCGGCGCCGGGCTGGCGCGCGGCTATCTGGGCGCCGCCGCCGCGACCGCGGAGCGGTTCGTCGCCGACCCGTTCGCCGCCGGTGAGCGGATGTACCGCACCGGGGACCTGGCGCGCTGGACGGAACAGGGCGAGCTGCTGTTCGCCGGCCGCGCCGACGCCCAGGTGAAGATCCGCGGCTACCGGGTCGAGCCGGCGGAGATCGAGGCGGCGCTGACCGCGATCCCCGAGGTCGCGCAGGCGGTCGTGGTGGCCCGCGAGGACGGCCCGGGCGAGAAACGGCTGATCGCCTACGTCACCGCGGCCGGGCAGCCGGGACCGGACCCCGCCGCGGTACGCGAACACCTGGGCGAGCGGCTGCCGGAGTTCATGGTGCCGGCCGCGGTGGTGGTGCTGGACGGCTTCCCGCTGACGATCAACGGCAAGATCGACCGAGCGGCCCTGCCCGCCCCCGAACGCAGCGGGAAGCCGGCCGGCCGCGAGCCGCGTACCGAGGTCGAGCGGGTGTTGTGCGACCTGTTCGCCGACCTCCTCGGGCTGGACCGGGTCGGGGCCGACGACAGCTTCTTCGAACTGGGCGGCGACTCGATCGTGTCGATGCAGCTGGCCGCCCGCGCACGTCGCGAGGGCGTCGTCTTCGGCGCGAAGGACGTCTTCGAGCAGAAGACGCCGGCGGCCATCGCCGCGGTCGCGGTGCGCGGCGGTCAGCGGCCGGCCGGTCCCGACGACGGGGTCGGCGAGGTCGCCTGGACGCCGGTGATGCGGGGCCTGCTCGACCGTGACCCCGGCACGATGAACCGCAGCGCCATGGCGCAGTGGGTGACCGTGGGCGCGCCCGACACCCTGTCGCGCGACGTGCTGGCGGCCGGGCTGGGAGCCGTGCTCGACGCCCATGACATGCTGCGCAGCCGCGTCGTCGCGGCCGGGACGGAAGAGCCGCGGCTGGTGGTGGCGCCGCGGGGCGCGGTGCACGCGGCCGGGCTGGTGGACCGGGTCGAGGCGGGCGCCGGCGAGGTCGACGACCTCACCGAGCGCAGCGCCGCCGAGGCGGCCACGCGGTTGGATCCGGGCGCCGGCGTGATGGTCCGGGCGGTGTGGGTCGACGCGGGCCCCGGCCGCGTCGGACGGCTCGTGGTGGTGGCGCACCACCTGGTGGTCGACGCGGTGTCGTGGCGGATCCTGCTGCCGGACCTGCGCGCGGCGTGCGAGGCGGTGGCCGCGGGCCGGGAGCCGGCGCTCGATCCGGTGGACGTCTCGTTCCGGCGCTGGGCGCGGACGCTGACCGATCAGGCGGCCACCCGGACCGCGGAGCTGGCCACGTGGACGCGGATCCTGGGCGGGGCGCAGCCGCGGTTCGGCGCGCTCGACCCCGGACGCGACACCATCTCGACCGCCGGCCGCCGGACGTGGACGGTGCCGCAGGACCGGGCCGGCGTGCTGGTGGAGAGGGTCACCTCGGCCTTCCACTGTGGTGTGCACGAGGTGCTGCTGGCCACCCTGGCGGGCGCGGTGGCCCGATGGCGCGGCGGCGCCGCCGTCGTGGTGGACGTCGAAGGTCACGGCCGCCGGCCGCTCGGCGAGATGGACCTGTCGCGCACGGTCGGCTGGTTCACCGACGTGCACCCGCTCCGGCTGGACGTGACCGGGATCGACACGGCCGAGGTGATCGCCGGTGGCGGCGCGGCCGGCCGCCTGCTGAAGACCGTCAAGGAGAACGTGCGTGCCGTGCCCGACGGCGGGCTCGGCTACGGGATGCTGCGCCACCTCAACGCCGAGACCGGGCGGGTGCTGGCGGCACAGCCGGCAGCCGAGATCGGGTTCAACTACCTGGGCCGCTTCTCCGAGGGGCCCGGCGGTGACGTGCAGCCCTGGCAGCAGCTGGGGACGATCGGCGGTACGGCGGAGCCGGACATGCCGTTGCGGCACGCCGTGGAGATCGACGCGGCCGTGCTCGACGCGGCCGACGGGCCCCGGCTGGAGCTGACCGTCACCTGGGCCGGGCGGCTTGTCGGCGCGGCCGAGGCCGAGTCGCTCGGCAGGGCTTGGCAAGACGTGCTGGCCGGTCTGGCGGTACACGCCGGCGACGTCCGCGCCGGCGGGCACACCCCGTCCGACTTCCCGCTGACCGCGCTGAGCGGGCAGGAGGTGGCGCAGATCGAGGCCGCCGTGCCGGACCTGCTCGACATCTGGCCGCTCTCCCCGCTGCAGGAGGGCCTGCTGTTCCATGCCGTCGACGAGCGCGGCCCGGACGTCTACGCCAGCATGCGGACCCTGGCCGTCGACGGCCCGCTGGACGTGGCCCGGTTCCGCGCGTCCTGGCAGGCCGTGCTGGACCGGCACGCCGCCCTGCGGGCGAGTTTCCATCAGCTCGAGTCCGGCGCGGCCGTGCAGGCGATCGCCCGCGAGGTGACGCTGCCCTGGCAGGAGACCGACCTGTCGGATCTGCCCGAGGACGTGGCGCTGGCGGAGTTCGACCGGCTCGCGGCGCAGTTGCGCGACGAGCGGTTCGACCTGACCCGGGCGCCGCTGCTGCGCCTGCACCTGGTGCGTCTCGGCGAGCGCCGGCACCGGCTGGCCTTCGCGTCGCACCACATCTCGTGCGACGGGTGGTCACTCCCGATCGTCTCCACCGAGGTGATGGCGGCGTACGAGGGTCGCGGCCTGCCGGCGCCGACGTCGTACCGTGACTACCTGGTCTGGCTGGCCCGCCAGGACAAGGAGGCCGCCCGGCAGGCGTGGCGCGGCGAACTGGCCGGGCTCGACGAGGCCACCCACGTCGTGCCGCCGGACACGATCACCGCGCCGATCGCGCCGCAGCGGGTACGGTTCGGGCTCGACGACGAGCTGAGCCGGCGCCTGGTGCGGTTCACCCGCCGCCACGGCGTCACGATGAACACCCTCTTCCAGGGGATCTGGTCGTTGCTGCTGGCCCGGCTGACCGGCCGCGACGACGTGGTCTTCGGTTCCGCCGTGGCCGGGCGGCCCGCGGAGATCCCCGGCGTCGGGTCCGTGGTCGGGCTGTTCATGAACACCGCGCCGGTCCGGGTGCGCCTCGACGGCGCCGAACCGTTCCTGGACATGCTGACCGACCTGCAGCGGCGGCAGGTCGCGATGATGGCCCACCAGCACCTCGGGCTGAGCGAGATCAAACAGGTCGCCGGTCCGGGGGCGGCGTTCGACACGCTGGTGGTGTTCGAGAACTACCCGCGCCCGCCGCGCCCGTCCGACGACCCGGACGCGGTGGTCATGCGCCCGGCGGAGATCCCGGAGGACAGCGGGCACTACCCGGTGTCGATGCGCGCCTCCGAGGACGGCGGCGTCCACGGCGAGTTCATCTTCCGTCCGGACGCGTTCGACCGGGCCGAGGCCGAGGGGATGCTCGCCGCGATCATCGAGGCCCTGCGGCAGGTGGTGGCCGAACCGGGGATTGCGGTGGGGCGCATCGGTCTGGTCGGCGCGGCCGAGCGCCGGCAGGTGGTGCGGGAGTGGAACGAGACCGATGCGCCGCTGACCGCGCAGCCGCTGCCGATGCTGTTCCGCCGGCAGGCGCAGCGCTCCCCGGACGCGGTGGCGGTGCGCGACGCGGCGCGCAGCCTGTCGTTCGGCGCGCTGCTGGGCGAGGCCGAGGGGCTCGCCCGGCGGCTGGTGGCCTCCGGCGTACGGCGGGGAGACCCGGGTGGCCGTGCTCTGGAACGCTCGGCGGAGCTGGTGGTGGCCCTGCTCGGGGTGTCGCTGGCCGGCGGGGTGTTCGTGCCCGTCGACCCGGACTACCCCGGCGACCGGATCGCGCTGATGCTGGCGGATGCGGCGCCGCAGGTGCTGGTGTGCACGGCGCGGACCCGCTCGGTCGTGCCGGGCGACTTCGCCGGCGCGGTGCTGGCGCTGGACGAGCCGTCCGCGGCCGGCCCGCAGGTGTCGCTGCCGCGGGTGGCGGCGCGGGACGGGGCGTACGTGATCTACACGTCCGGGTCGACGGGTGTGCCCAAGGGCGTGCTGGTCACCCACGCCGGGCTCGGCAACCTGGCGAGCGCGCAGATCGAGCGGTTCGGCGTGACGTCGTCCTCGCGGGTCCTGCAGTTCGCCGCGCTCGGGTTCGACGCCGCCATCTCCGAGGTGTGCATGGCCCTGCTCTCGGGCGGGAGCATCGTGCTGGCCGACGCCGAGCACATGCCGCCGCGGGTGTCGCTGGGCGACGCGGTACGCCGGTGGGACATCACCCACGTCACCGTGCCGCCGAGCGTGCTGGCCGTCGAGGACGACCTGCCGGACGACCTCACCCTGATCGTGGCCGGCGAGGCCTGCCCGCCCGCGCTGGTGGACCGCTGGTCGCCGGGCCGCCGGATGATCAACGGCTACGGGCCCACCGAGACGACCGTGTGCGCGACGATGAGCTCCCCGCTGTCCCCGGGACGCGGCGCGGTGCCCATCGGCGGCCCGATCGCCAACATGCGGACCTACGTGCTCGACGCCTTCCTGCAGCCGGTGCCGCCGGGCATGACCGGCGAGCTCTACGTCACCGGGGTCGGGCTCGCCCGCGGATATCTCGGGCGTCCGGGGCTGACCGCGGAACGGTTCGTGGCCGACCCGTTCTCGCCGGGTGGCCGGATGTACCGCACCGGCGACCGGGCCCGCTGGACCGGCGACGGCGAGCTGGTCTTCGCCGGCCGGGTCGACGCGCAGGTCAAGGTGCGCGGATACCGGATCGAGCCGGGGGAGATCGAGGCCGTGCTGGCCGAGCACCCGGGGGTCGCCCAGGTGGTCGTCGTGGCCCGCCAGGACGGGCCGGGCGAGAAGCAGCTGGTGGCCTATGTCGTCCCGGCGGCCGGCCCGACCGCCGAGGCGAGCACCCTGATCTCCGCGCTGCGCGAGGCGGCGGCCGCCCGCCTGCCGGAGCACATGGTGCCGGCGGCGTTCGTGCCGCTGGACGCGATGCCGCTGACGCCCAACGGCAAGGTCGACCACCGGGCGCTGCAGGCTCCCGACTTCGCCGGGATGTCGGCCGGGCGGGACCCGCGTACGGCCTTGGAGGCCAAGCTGTGCGAGCTGTTCGCCGAGGTGCTCGGCCTGGAGCAGGTGGGCGCCGACGACAGCTTCTTCGAGCTCGGCGGCGACTCGATCACCTCGATGCAGCTGTCCACCCGGGCCCGCCGGGAGGGGCTGGAGCTGACCCCGTGGCAGGTGTTCGACGAGAAGACGCCGGAACGGCTGGCGGCGCTCGTCAAAGAGATCCCGGCCGACGGCGGGGCCACCGGGGCGCCGGAGCCCGCGGCGGGCACGCTCGTCGCGCTCTCGCCTGAACAGATGGACCAACTCGAGGCCGGACCGGCCGGCGAATGA	MTQARIEDIWPLSPLQEGLLFHTVYDDEGPDVYVGHWILDLDGPVDAARLRAAWEALLARHAALRACFRQRRTGETVQVVAGRVELPWRVVDLAHLDDPEHAVRELADEDRLRPFDVAKPPLLRLTLIRLADDRHRLVVTCHHAVMDGWSLPIVFDELTALYAAGDGPAQLPAVTPYREYLAWLSRQDKPSALAAWAAELRGAQEPTLVAPADPGRAPGMPESVEVQLSPELTRSLAELARGRGLTLNTVIQGAWALVLARLTGRTDVVFGATVSARPAHLPGVEAMVGLFLNTVPVRVRLRGSAPVVEMLAELQKRQSALIPEQFVGLADIQKAAGPGAVFDTLLVFENFPRELDDSRSADAFGIRVHQGREAAHYPLTLVAVPGESMLFKLDYLTELFDAATAASILERFTRVLRRLTDAGELTVAAIDVTSAAERDRVARWGAAVGARPDRLALDLFARQVAQRPDEVAVADGDRVMSFGELAERADRLAGHLSARGVRRGDRVAVVMERSGELIATLLAVWRAGAAFVPVDPAYPAERVKFLLTDAEPVAAVCTAAFRAAVLDGGLEAIVVDDPGTWPAVAPCPPVPTGPDDLAYVMYTSGSTGTPKGVAVSHGDVAALVGDPGWRTGPGDTVLMHASHAFDISLFEIWVPLLSGARVMIAGPGAVDGAALAAQVAAGVTAAHLTAGAFRVLAEESPESVAGLREVLTGGDAVPLAAVERVRRACPDVRVRHLYGPTETTLCATWWLLEPGDETGPVLPIGRPLAGRRVYVLDAFLRPLPPGTTGELYVAGAGVAQGYLGRPALTAERFVADPFAPGGRMYRTGDLAYWTEQGTLAFAGRADDQVKIRGYRVEPGEVEAVLGGLPGVAQAVVCVRGEHLIGYVVAEAGRDLDPERLRARLAATLPEFMVPAAVLVLADLPLTVNGKVDRPALPEPDFAAKSTGRAPATAAERILCDVFAGVLGLDRVGVEDSFFALGGDSISSMQVAARARREGIALTPRQVFEHRTPERLAALAPAAGSARPDRSAADAGLGEIPWTPVMRALGDDAVRPGFAQARVVVAPAGLDPDALTGALRAVLDTHDVLRARVEPDRRLIVPERGAVAAADLLTRVAVDSDGIDARAEREAATAAGTLDPSAGIMLRAVWLDAGDAEPGRLALVAHHLVVDAVSWSILLPDLQAAYQEVLAGATPALEPAATSYRQWARRLTEQASSPSTLAELDHWVTVLDAAEPPLAEHHGQAHSWSATLSGAVAGHLVSRMPGAFHCGIQEVLLAGLAAAVARWRGDDAGVLVDVEGHGRHAADGEDLLRTVGWFTSVHPVRLDVSGVDLAAAAAGDAAAGELLKSVKDQVRAAPGDGFGFGLLRHLNPDTAERLAALPAPQIGFNYLGRSGVAAEAVPWQVRGGSLGAGEAGPDLVLAHPLEAGADVRDTPDGPLLRLTLDGRDLAPVTVELLGEAWLELLTGLATHAGDPRAGGHTPADFDLVEVTQRDVTALEAAAPGLTDIWPLSPLQRGMLFERALDEDGVDVYQSQRILDLDGPLDADRLRAAWRTLVARHESLRTSFHQLESGETVQVVVDQADIGWRVADVSHRAEADAAAEVGRLLAEDQAQRFDVTRAPLLRLLLVRLGADRHRLVVTSHHIVLDGWSTPIILGEMSAAYAGAPSTATAPSPRDYLAWLNRQDDAATRAAWRSELAGCDEPTLVDADADKTMVMPGEHCEGLSEQATRRLTEFARGHAVTLSTILQGAWALVLARLAGRTDVVFGTVVSGRPAEVPDVDRMVGMFINTVPVRVRLDGGRPVLDLLHDLQARQSALTEHQHLGLPDIQRAAGPGALFDTIMMVENYPMDAAGLGGEGGVRIGSVLTRTGTSYPLTMSASPGERLQIRVSYRPDRIERETAAEAAGQVVRVIERIVAEPSLAVGRLGVTGESVRERVVERWNATGVAAGGSSVLTGFRRRARSSPDAVAVSGGGRTLSYAALDRESDRLAGHLAGRGVRRGDRVGVVMERGTDLFVALLAIGKAGAAYVPVNLDYPRDRIERMLTDAGVSVAVCVQATSGAVPDGLAPVVMDSPAIAAAPSEAPPITVGAHDLAYVMYTSGSTGVPKGVAVPHGSVAALAGDPGWSVGPGDGVLMHAPHAFDASLLEIWVPLLSGAHVVVADPGAVDAQRLREAIDRGVTTVHLTAGSFRVLAEESPDAFRGLREVLTGGDAVPLASVVRLRETCPEIRVRHLYGPTETTLCATWHLIEPGVATGDTLPIGRPLAGRRAYVLDAFLQPVAPNVTGELYLAGAGLARGYLGAAAATAERFVADPFAAGERMYRTGDLARWTEQGELLFAGRADAQVKIRGYRVEPAEIEAALTAIPEVAQAVVVAREDGPGEKRLIAYVTAAGQPGPDPAAVREHLGERLPEFMVPAAVVVLDGFPLTINGKIDRAALPAPERSGKPAGREPRTEVERVLCDLFADLLGLDRVGADDSFFELGGDSIVSMQLAARARREGVVFGAKDVFEQKTPAAIAAVAVRGGQRPAGPDDGVGEVAWTPVMRGLLDRDPGTMNRSAMAQWVTVGAPDTLSRDVLAAGLGAVLDAHDMLRSRVVAAGTEEPRLVVAPRGAVHAAGLVDRVEAGAGEVDDLTERSAAEAATRLDPGAGVMVRAVWVDAGPGRVGRLVVVAHHLVVDAVSWRILLPDLRAACEAVAAGREPALDPVDVSFRRWARTLTDQAATRTAELATWTRILGGAQPRFGALDPGRDTISTAGRRTWTVPQDRAGVLVERVTSAFHCGVHEVLLATLAGAVARWRGGAAVVVDVEGHGRRPLGEMDLSRTVGWFTDVHPLRLDVTGIDTAEVIAGGGAAGRLLKTVKENVRAVPDGGLGYGMLRHLNAETGRVLAAQPAAEIGFNYLGRFSEGPGGDVQPWQQLGTIGGTAEPDMPLRHAVEIDAAVLDAADGPRLELTVTWAGRLVGAAEAESLGRAWQDVLAGLAVHAGDVRAGGHTPSDFPLTALSGQEVAQIEAAVPDLLDIWPLSPLQEGLLFHAVDERGPDVYASMRTLAVDGPLDVARFRASWQAVLDRHAALRASFHQLESGAAVQAIAREVTLPWQETDLSDLPEDVALAEFDRLAAQLRDERFDLTRAPLLRLHLVRLGERRHRLAFASHHISCDGWSLPIVSTEVMAAYEGRGLPAPTSYRDYLVWLARQDKEAARQAWRGELAGLDEATHVVPPDTITAPIAPQRVRFGLDDELSRRLVRFTRRHGVTMNTLFQGIWSLLLARLTGRDDVVFGSAVAGRPAEIPGVGSVVGLFMNTAPVRVRLDGAEPFLDMLTDLQRRQVAMMAHQHLGLSEIKQVAGPGAAFDTLVVFENYPRPPRPSDDPDAVVMRPAEIPEDSGHYPVSMRASEDGGVHGEFIFRPDAFDRAEAEGMLAAIIEALRQVVAEPGIAVGRIGLVGAAERRQVVREWNETDAPLTAQPLPMLFRRQAQRSPDAVAVRDAARSLSFGALLGEAEGLARRLVASGVRRGDPGGRALERSAELVVALLGVSLAGGVFVPVDPDYPGDRIALMLADAAPQVLVCTARTRSVVPGDFAGAVLALDEPSAAGPQVSLPRVAARDGAYVIYTSGSTGVPKGVLVTHAGLGNLASAQIERFGVTSSSRVLQFAALGFDAAISEVCMALLSGGSIVLADAEHMPPRVSLGDAVRRWDITHVTVPPSVLAVEDDLPDDLTLIVAGEACPPALVDRWSPGRRMINGYGPTETTVCATMSSPLSPGRGAVPIGGPIANMRTYVLDAFLQPVPPGMTGELYVTGVGLARGYLGRPGLTAERFVADPFSPGGRMYRTGDRARWTGDGELVFAGRVDAQVKVRGYRIEPGEIEAVLAEHPGVAQVVVVARQDGPGEKQLVAYVVPAAGPTAEASTLISALREAAAARLPEHMVPAAFVPLDAMPLTPNGKVDHRALQAPDFAGMSAGRDPRTALEAKLCELFAEVLGLEQVGADDSFFELGGDSITSMQLSTRARREGLELTPWQVFDEKTPERLAALVKEIPADGGATGAPEPAAGTLVALSPEQMDQLEAGPAGE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	731.47	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0000441.1|Teicoplanin_17 # 35694 # 41276 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.744	BGC0000441.1|Teicoplanin_17 	35694	41276	+	Loose	1000	105.531	almE	26.65	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCGTTGACGACACTCGTGCAAAGCCCCGCTCCAGCGTGGAAGACGTCTGGCCGCTGTCGCCGCTGCAGGAGGGCATGCTTTACCACACCGCCCTGGACGGGGACGGGCCGGACACCTACACCGTGCAGACCGTCTACGGCATCGACGGCCCGCTGGACGCCGGGCGGCTGAGAGCGTCGTGGCAGGCCCTGGTGGACCGGCATGCCGCCCTGCGGGCCTGCTTCCGCTACGTCAGCGGCGCGCAGATGGTGCAGGTCATTCAGCGGGACGTCGAGCTCCCGTGGCGGGAGACCGACCTGTCCGGGCTGCCGGAGGACCTCGCCGACGGTGAGGTGGCCCGCCTGGCGGAGCAGGAGATGGCCGAGCGCCTGCGCCTGGAGGCCGCGCCGCTGATGAAACTGCACCTGATCCGGCTCGGCCCGCAGCGCCACCGGCTCGTGCACACCCTGCACCACGTGCTGGTGGACGGCTGGTCGATGCCGATCCTGCACCGTGAGCTCGCGGCGATCTACGCGGCGGGCGGGGACGCGTCCGGGCTGCCGCCCGCGGTGTCGTACCGCGACTATCTGGCCTGGCTGGGCCGGCAGGACAAGGAGTCGGCGCGGGCGGCGTGGCGGGACGCGCTCGCCGGGCTGGACACCCCGACCACGGTCGCGCCGGCCGATCCGGCCCGCGTGCCGGACATCGACACGGCGATGGTGGAGCTGTCCCCCGAGCTGACCGACGACCTGCTCCGGCTGGCGCGTGGCCACGACCTCACGCTCAACACCGTCGTGCAGGGCGTGTGGGCGGTCGTGCTGGCGCAGCTGGCCGGCCGTACCGACGTGGTGTTCGGCGCGACCGCCTCGGGGCGGCCGGCCGAGCTGGCCGGGGTGGAGGCGATGGTCGGGCTGCTGCTGGCCACCCTGCCGGTGCGGGTCCGGCTCGACGGGCGCCAGCGGGTCGTCGACATGCTCGCCGACCTGCAGCGCGACCAGTCGGCGCTGCGCGCGCACCAGCATCTCGGGCTGCAGGAGGTGCAGGCCGTCGTCGGGCCCGGAGCGGTCTTCGACACGCTGGTCATCTACGAGAACTTCCCGCGTACGGGCCTCGGCGGATCGGCCGACGACGGCCTGGTCATGCGGCCGGTGCAGAAGGGGCGCGACTCCTCGCACTACCCGTTCACACTGGTCACCGGTCCGGGCGAGCGGATGCCGGTGATCCTCTACTACGACCGGGGGCTGTTCGACCAGGCGGCCGCCACATCGGTGCTCGGCGCGATCGTCCGCGTGCTGGAGCGGCTGGTCGCCGAGCCCGGTGTGCTCGTCGGCCGGCTGACGCTGCTGGGCGAGGCCGAGCGCGCCGTGGTGGTCGACGACTGGAACGCGACCGCGGGCCCGGTCCCCGGCGACTCCATGGTGGACGTGTTCGACCGGCGGGTGGCCGCCGCGCCGGACACGGTGGCGATCACCGACGCCGACGGCGCCGACCTCACCTATGCCGAGGTCGATCAGGCGTCGAACCGGTTGGCGGCCCACCTCGCCGATCGGGGCGTCCGCCGCGGCGACCGCGTCGGGGTGGCCGTGGAGCGGTCCGCGGACCTGCCGATCGTGTTCCTGGCGATCTGGAAGGCCGGCGCCGCGTACGTCCCGGTGGACGTCGGGTACCCGGCCGAGCGGATCGCGCTGATCCTCGCCGGCTCCGCGGTCTCGACGGTGATCTGTACGCAGGCCACCGAGGCGGCGGTGCCGCAGAACGTGCCGCAGCGCGCCACGATCGTCCTCGATGCGCCGCCGACGCGGGCGGCCGTGGACGCCTGTGCCGGCACCGCGCCGACGTTCCGGCCGAGCGCCGCCGACCTGGCGTACGTCATGTACACCTCGGGCTCCACCGGCGTCCCGAAGGGCGTGGCCGTCCCGCACGGCGCGGTCGCCGGCCTGGCCGGCGACGCGGGCTGGCGGATCGGCCCCGGCGACGGCGTGCTGATGCACGCGACGCACGTGTTCGACCCCTCGCTCTACGAGATGTGGGTGCCGCTGGCCACGGGTGGCCGGGTCCTGGTGGCCGCTCCCGGAGTGGTCGACGCGGGCGGGATCCGGCAGGCCGTGGCACGCGGCGCGACCGCCGTCCACCTCACCGCCGGCACCTTCCGCGCGCTGGCGGAGGCGTCCCCGGACTGTTTCGCCGGCCTGCGCGAGGTCGGCACCGGCGGCGACGTGGTGCCCGCGCACACCGTGGCCCACCTGCGGCGGGCCCAGCCACAGCTGCGGGTGCGCAACACGTACGGGCCGACCGAGACCACCCTGTGCGCCACCTGGAAGCCGATCGAGCCGGGCGCGCAGCTCGGGCCGGAGCTGCCGATCGGCCGTCCGATGACCAACCGCAGGATCTACATCCTGGACGCCTTCCTGCGCCCGGTCGCCCCCGGGGTGGCCGGCGAGCTGTACATCGCCGGCACCGGACTGGCCCGCGGATATCTCTCCCGGCCGGACCTGACCGCCGAGCGGTTCGTGGCGTGTCCGTTCCTCGCCGGCGAGCGCATGTACCGGACCGGGGACCTGGCGCGCTGGAACCGCGACGGCGAGGTGGTCTTCCTCGGGCGCGCCGACGACCAGGTGAAGATCCGCGGCTACCGGGTGGAGCTGGCCGAGGTGGAGGCGGTGCTGGCGGCCCAGCCGGGAGTCCGCGAGGCGGTCGTCGTGGCCCGCGAGGACCGGCCGGGCGAACGGCGTCTGGTCGGCTACGTCGTCTCCGACGCCGGTGAGCTGGACACCGAACAGATCCGCCAGCAGATGGCCCGGGTGCTGCCCGGCTACATGGTTCCGGTGGCGGTCATCGGGCTGGTCAGCCTGCCGATCACCGCCAACAGCAAGGTGGACCGCCGGGCCCTGCCCGCCCCGGACCTCGCCGGCCACGCGTCGGCGAAGGCGCCGGAGAGCGCGACCGAGAAGGTGCTGTGCGCGCTCTACGCCGAGATCCTCGGCGTCGAGCGGGTGGGCGTCGACGACGCCTTCCACGACCTGGGCGGCAGTTCGGCGCTGGCCATGCGGCTGATCGCGCGGATCCGCGAGGAGCTGGGCGTGGACCTGCCGATCCGCCAGCTGTTCTCCTCGCCCACACCCGCGGGGGTGGCCCGGGCGCTGGCCGCGAAGTCGCGCCCCGCGCTGGAGGCGGTCACCCGGCCGGAGCGGGTGCCGCTCACCGCCCGGCAGCTGCGCGCCTGGCTGCTGGCCCGCCCGTCGGAGGAGACCCGGGGCCGGCACCTCTCGGTCGCGCTGCGCCTGCGCGGCCGGCTGGACGTGGCCGCCCTGGAGGCGGCGCTGCGCGACGTCGCGGCCCGGCACGAGATCCTGCGGACCACCTTCCCGGGCGACGCGCAGACCGTCCACCAGCACATCCACGACGCCGCGCCGGTCCGGCTGACGCCGGTCCCGGCCACCGAGGAGGACCTCCCCGCACGGCTGGCCGAGCGGGGCGAGCAGCTGTTCGACCTCACCCGGGACATGCCGTGGCGGTGCGAGCTCTTCGCGCTGTCGGAGAAGGAGCACGTGCTGTCGGTGACGGTGCACCGCATCGCCGCCGACGACGACTCGATGGACGTGTTCTTCCGGGACCTCGCGGCCGCGTACGGCGCGCGGCGGGCCGGCCGGGCCCCGGAGCGCGCGCCGCTGGCCCTGCAGTTCGCCGACTACGCGATCTGGGAGCAGCGGCTGCTCGACGGCGAGCGCGAGCAGGACAGCCTGATCAACGACCAGATCACCTTCTGGCGCAACCACCTGGCCGGCATCGACCAGGAGACCGTGCTGCCGTTCGACCGAGCGCGGCCGGCCATCCCGTCGCGCCGGGCCGGCACGGTCGCGCTGCGGCTGGACGCCGGTCCGCACGCCCGGCTGGCCGAGGCGGTGGAATCGGCCGGCGCGGACATGCCGCAGCTCGTGCAGGCCGCGCTGGCCATGCTGCTGACCCGGTACGGCGCGGGCACCGACCTGGTGATCGGCACGACGCTGCCGCGCGACGAGGACCTGATCGACCTGGAGCCGATGATCGGGCCGTTCGCCCGGCCGTTCCCGGTGCGTACCGACCTGTCGGCGGATCCGACCTTCCTGGAGGTCGTCGCCCGGGTGCAGGAGGCGGTCCGCGAGGCGCGCCAGCACCTGGACGTGCCCTTCGAGAAGATTCCCGAGCTGCTGGCCCTGCCCGGCTCGCTGTCGCGCCACCCGGTGTACCAGGTCGGGCTGCAGGTGCGCGAGGAGGACAACGGCGCGTGGGACGCCGCGGAACTGCCCGCCCTGCGCACCAGCGTCGAACCCACCGGGGTCGAGGCCATCGAGCTGGACCTGGCGTTCGCGCTCACCGAGCGCCGCAACGACGATGACGACGAGGACGGCATCGAGGGCGCCCTGCACTATGCCGCCGACCTGTTCGACCACGACACGGCCGCGTCGCTGGCCCGGCGGCTGGTCCGCGTCCTGGAACAGGTGGCCGAGGATCCCGGGCGGCGGATCAGCGACCTGGACATCCTCCTCGACGACGCCGAGCGCGGCGCTCCGGCGATCGCGCCGGCGCGCTGGGCCGGGGCGGTGCCGGCGGCGGTCGCCGACCTGGTCGCGGCCGGCCCGCTCGGTGCGCTGGTGCTCGACGAGGCACAGCGCCCGGTGGCGCCCGGGACCGTCGGCGACCTGTGGGTGACCGGTCCCGCGGTGGACGCGGACACCGGCGGCCGGCCGAGCGTGCCGTGTCCGTTCGGGACCCCGGGGCACCGGATGCTGCACACCGGTCTGCTCGCCCGTAAGTCGCCGGCCAGGACGCTGGTCGTCGTGGGGGAGCGGCGCGGGGCGAGCGCCTCGGCGAAGACCGGTGACTACGAGGTGCTGCTGCCGCTGCGCGCCGCGGGTGACCGGGCGCCGCTGTTCTGCATCCACGCCAGCGGCGGCCTGAGCTGGAACTACGGTCCGCTGCTGCGGCACCTGCCGCCGAACCAGCCGGTCTACGGGGTGCAGGCGCGTGGCCTGGCCCGTACCGAGCCGCTGCCCGGCAGCGTGGAGGAGATGGCCGCCGATTACGTCGAGCAGATCCGCACCGTGCAGCCGACCGGGCCGTACCACCTGCTCGGCTGGTCTCTGGGCGGGCGGATCGCGCAGGCGATGGCCGTGCTGCTGGAGGCGGACGGGGAGAAGGTCGGCCTGCTCGCCCTGCTCGACGCCTATCCCGTCTACATGGGAAGGAAGGCCACCGGCACGGTCACCGAGGAGGCCGCCCGCGACGAAGACGCCCTGGAACGGCGCAAGCAGCAGGAACTGGAGCTCGCCGGTCAGCTGGTCCAGGGGGCCGGCGCCCGGTCCCGCTTGGAGGCGGTCATGCGCAACCTCTGGGAGGTCGGGCCGGCCCACACCGCCTCGCCGTTCGCCAGTGATGTCCTCCTCTTCGTCGCCTCCGTGGACCGTCCCGCGCATCTGCCGGTGTCCGAGGCGATAGCCAGCTGGAAAGACTTCACCGGGGGGACGATCGCGACCAACCACTACGAGATGGTGCAGCCCGCGGCGTTGGCCCAGATCGGGGCCATCGTCGCCGAGAAACTCCGGTCCCGGCCGGATGCGTGA	MTVDDTRAKPRSSVEDVWPLSPLQEGMLYHTALDGDGPDTYTVQTVYGIDGPLDAGRLRASWQALVDRHAALRACFRYVSGAQMVQVIQRDVELPWRETDLSGLPEDLADGEVARLAEQEMAERLRLEAAPLMKLHLIRLGPQRHRLVHTLHHVLVDGWSMPILHRELAAIYAAGGDASGLPPAVSYRDYLAWLGRQDKESARAAWRDALAGLDTPTTVAPADPARVPDIDTAMVELSPELTDDLLRLARGHDLTLNTVVQGVWAVVLAQLAGRTDVVFGATASGRPAELAGVEAMVGLLLATLPVRVRLDGRQRVVDMLADLQRDQSALRAHQHLGLQEVQAVVGPGAVFDTLVIYENFPRTGLGGSADDGLVMRPVQKGRDSSHYPFTLVTGPGERMPVILYYDRGLFDQAAATSVLGAIVRVLERLVAEPGVLVGRLTLLGEAERAVVVDDWNATAGPVPGDSMVDVFDRRVAAAPDTVAITDADGADLTYAEVDQASNRLAAHLADRGVRRGDRVGVAVERSADLPIVFLAIWKAGAAYVPVDVGYPAERIALILAGSAVSTVICTQATEAAVPQNVPQRATIVLDAPPTRAAVDACAGTAPTFRPSAADLAYVMYTSGSTGVPKGVAVPHGAVAGLAGDAGWRIGPGDGVLMHATHVFDPSLYEMWVPLATGGRVLVAAPGVVDAGGIRQAVARGATAVHLTAGTFRALAEASPDCFAGLREVGTGGDVVPAHTVAHLRRAQPQLRVRNTYGPTETTLCATWKPIEPGAQLGPELPIGRPMTNRRIYILDAFLRPVAPGVAGELYIAGTGLARGYLSRPDLTAERFVACPFLAGERMYRTGDLARWNRDGEVVFLGRADDQVKIRGYRVELAEVEAVLAAQPGVREAVVVAREDRPGERRLVGYVVSDAGELDTEQIRQQMARVLPGYMVPVAVIGLVSLPITANSKVDRRALPAPDLAGHASAKAPESATEKVLCALYAEILGVERVGVDDAFHDLGGSSALAMRLIARIREELGVDLPIRQLFSSPTPAGVARALAAKSRPALEAVTRPERVPLTARQLRAWLLARPSEETRGRHLSVALRLRGRLDVAALEAALRDVAARHEILRTTFPGDAQTVHQHIHDAAPVRLTPVPATEEDLPARLAERGEQLFDLTRDMPWRCELFALSEKEHVLSVTVHRIAADDDSMDVFFRDLAAAYGARRAGRAPERAPLALQFADYAIWEQRLLDGEREQDSLINDQITFWRNHLAGIDQETVLPFDRARPAIPSRRAGTVALRLDAGPHARLAEAVESAGADMPQLVQAALAMLLTRYGAGTDLVIGTTLPRDEDLIDLEPMIGPFARPFPVRTDLSADPTFLEVVARVQEAVREARQHLDVPFEKIPELLALPGSLSRHPVYQVGLQVREEDNGAWDAAELPALRTSVEPTGVEAIELDLAFALTERRNDDDDEDGIEGALHYAADLFDHDTAASLARRLVRVLEQVAEDPGRRISDLDILLDDAERGAPAIAPARWAGAVPAAVADLVAAGPLGALVLDEAQRPVAPGTVGDLWVTGPAVDADTGGRPSVPCPFGTPGHRMLHTGLLARKSPARTLVVVGERRGASASAKTGDYEVLLPLRAAGDRAPLFCIHASGGLSWNYGPLLRHLPPNQPVYGVQARGLARTEPLPGSVEEMAADYVEQIRTVQPTGPYHLLGWSLGGRIAQAMAVLLEADGEKVGLLALLDAYPVYMGRKATGTVTEEAARDEDALERRKQQELELAGQLVQGAGARSRLEAVMRNLWEVGPAHTASPFASDVLLFVASVDRPAHLPVSEAIASWKDFTGGTIATNHYEMVQPAALAQIGAIVAEKLRSRPDA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	334.53	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000441.1|Teicoplanin_19 # 41978 # 42625 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.623	BGC0000441.1|Teicoplanin_19 	41978	42625	+	Loose	920	26.1794	OpmD	31.25	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACACGATCTGGGGCCTCGCGCCGGACGACGACGCGGTGCTCTACCGCCGGAAAGAAGACATCGCCGCTCTTGATCACCTGAGGGTGGCTCATCGGCACGGCCGGTTCCTCGACTCCATCTACCGTAAGTTGCCGGACGGTCGTTGGCTGACCGCCCATGTGGAGGGCAGGCAGAAGCTGGCCGTCAACGATCACTCGCCGGACAGCGACCATGACCTGGTTGGCGAGGTGGCGGACGACATCAGGTCGATCATCGACGAGTTCGACCCGACGCTTGTCGTCACCTGTGCGGCCATCGGCGAACACCCCGACCATGAGGCGACGCGAGATGCCGCGCTGTTCGCCACGCACGAGAAGAACGTTCCGGTACGGCTGTGGGAGGACCTGCCGTATGCGGTCTTCAAATCAGGTGCGGTCGAATTGCCGCAGGGTTTTCGTCTCGGCTCTGCGGATGTCAGCTCGGTGAAGCCGGAGATGCGGTCGCAGAAATTCCAAGCTGTGGAGCGGTATTCGTCTCAAATGGTGCTGCTCAACGGAAGTGAAAACAATCTGTTCGACCGGCTGGACGAGCATGCTCGGCAGAATGCACCACACGGCGGATACGGCGAGACGACCTGGCCGGTCGTCCGCAGCGACGACAGCTGA	MHTIWGLAPDDDAVLYRRKEDIAALDHLRVAHRHGRFLDSIYRKLPDGRWLTAHVEGRQKLAVNDHSPDSDHDLVGEVADDIRSIIDEFDPTLVVTCAAIGEHPDHEATRDAALFATHEKNVPVRLWEDLPYAVFKSGAVELPQGFRLGSADVSSVKPEMRSQKFQAVERYSSQMVLLNGSENNLFDRLDEHARQNAPHGGYGETTWPVVRSDDS	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	44.15	gnl|BL_ORD_ID|450|hsp_num:0	442			1053	1230	acriflavine; tetracycline; norfloxacin
BGC0000441.1|Teicoplanin_21 # 44746 # 46692 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGAGA;rbs_spacer=9bp;gc_cont=0.684	BGC0000441.1|Teicoplanin_21 	44746	46692	+	Loose	1190	383.645	novA	39.59	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGACGTGGTGTTGCGCTTCGGGGGGGTGTCGAAGAACGATGACGACCCCGATCCCTGGCAGACCCTGATCGGGCCGGGGACGCTGCGCAGAGTGCTCGCCTACTTCCGCCCGCACATCGGCAAGGTGGCGCTCTTCGTTCTCGTCGCCGCGCTGGAGTCGCTTGTCGTCGTCGTAGTTCCGTTGTTGCTGATGGAACTGGTCAACGGCGGCATCCTCAAGGACGACGCCGGGGTCGTGGCATCGATGGCCGGCCTGGCCGCCGGCCTCGCCCTGGTGGGCGCGCTGTTGCAGCTGGTGTCAGCCTATATTTCCGGGCAGATCGGGCAGGGGGTCAGCTACGACCTCCGGGTTCAGGCGCTGCGTCACGTTCAGCAGCTGCCGATCGCGTTCTTCACCCGTACCCAGACCGGGGTGCTGGTGGGCCGGCTGCACACGGAACTGATCATGGCGCAGCAGGCGTTCAGCCAGCTCCTGATGGCAGCCACCAGCGCCGTCACGGTGATCCTGGTGATGGCCGAGCTGTTCTACCTGTCATGGCTTGTCGCCGTGGTCACCCTGGTGCTGATTCCGCTGTTCCTCGTGCCCTGGATCTACGTGGGCCGGGTGATCCGGCGGCGCACCGGACGGCTGATGGACGCGAATACCGGCCTTGGTGGACTCCTCCAGGAGCGGTTCAACGTTCAGGGGGCGATGCTCTCCAAACTCTTCGGCCGTCCCCGCGAGGAGATGGCCGAGTACGCCGATCGTGCCGAGCGCATCCGCCGCATCGGCGTGAGTCTCTCGGTGTACGGGCGGCTCGCCTTCGTCATGATGGCGCTGATGGCCTCGCTCGCCACGGCGCTCGTCTACGGCATCGGTGGCGGGCTCGTGCTCGCCGGGGCGTTCCAGCTCGGCACGCTCGTCGCCCTCGCCACTCTGCTCGGGCGGTTGTTCGGGCCGATCACGCAGCTGTCCGGGATGCAGGAAACCGCGCAGACCGTCGTGGTGAGCTTCTCCCGGATCTTCGAGGTGCTCGATCTGAAGGGGCTGATCGAGGAGCGTCCCGGTGCGGTCGCGCTCGCCAAGGACACGGCGCCGGAGATCGAGTTCGACGACGTGGCGTTCCGCTATCCGACCGCCGACGAGGTCTCGCTGCGCTCGCTGGAGTACGTACGCGCCGAACGGGAGCGCGGGGAGACGACGCCGGAGGTGCTGCGCGGTGTCAGCCTGCACGTGCCGGCCGGCACCCTCACCGCGCTCGTCGGCCCGTCCGGCGCCGGCAAGAGCACGCTCACCCACCTGGTGTCACGGCTGTACGACCCGACCGGCGGGGTCATTCGCGTCGGTGGGCACGATCTGCGCGACCTCACCTTCGACTCGCTGCGCGAAGCGGTGGGCGTGGTCAGCCAGGACGCCTACTTCTTCCACGACACGATCCGGCAGAACCTGCTCTACGCCCGCCCCACCGCCACCGAGGACGAACTGATCGAGGCATGTCGAGGGGCCCAGATCTGGGACCTGATCGCCTCGCTCCCGGGCGGGTTCGACACCGTCACCGGCGATCGTGGCTACCGCCTGTCGGGCGGCGAGAAGCAACGCCTGGCCATCGCCCGGCTGCTGCTGAAGGCGCCGACGATCGTCGTGCTCGACGAAGCCACCGCTCACCTGGACTCCGAGTCCGAGGCCGCCGTGCAGCGGGCACTCAAGACCGCCCTGCACAACCGCACCTCGTTGGTGATCGCCCACCGGTTGTCCACGATTCGCGAGGCCGACCAGATCCTCGTGATCGACGACGGACGGGTCCGGGAGCGCGGAACGCACGACGAGCTGCTGGCCGAGGGGGGTCTGTACGCGGAGCTTTACCACACGCAGTTCGCCAAGGCCGGAAGCGACGCAGCCGAACCGGCGAGCGACGCAGCCGAGCTGCACCACAGGGAGCCCGAGCCGGTGCACGGCGGAGGATGA	MDVVLRFGGVSKNDDDPDPWQTLIGPGTLRRVLAYFRPHIGKVALFVLVAALESLVVVVVPLLLMELVNGGILKDDAGVVASMAGLAAGLALVGALLQLVSAYISGQIGQGVSYDLRVQALRHVQQLPIAFFTRTQTGVLVGRLHTELIMAQQAFSQLLMAATSAVTVILVMAELFYLSWLVAVVTLVLIPLFLVPWIYVGRVIRRRTGRLMDANTGLGGLLQERFNVQGAMLSKLFGRPREEMAEYADRAERIRRIGVSLSVYGRLAFVMMALMASLATALVYGIGGGLVLAGAFQLGTLVALATLLGRLFGPITQLSGMQETAQTVVVSFSRIFEVLDLKGLIEERPGAVALAKDTAPEIEFDDVAFRYPTADEVSLRSLEYVRAERERGETTPEVLRGVSLHVPAGTLTALVGPSGAGKSTLTHLVSRLYDPTGGVIRVGGHDLRDLTFDSLREAVGVVSQDAYFFHDTIRQNLLYARPTATEDELIEACRGAQIWDLIASLPGGFDTVTGDRGYRLSGGEKQRLAIARLLLKAPTIVVLDEATAHLDSESEAAVQRALKTALHNRTSLVIAHRLSTIREADQILVIDDGRVRERGTHDELLAEGGLYAELYHTQFAKAGSDAAEPASDAAELHHREPEPVHGGG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	105.37	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1779	novobiocin
BGC0000441.1|Teicoplanin_25 # 49440 # 50636 # 1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=AGAGGA;rbs_spacer=8bp;gc_cont=0.677	BGC0000441.1|Teicoplanin_25 	49440	50636	+	Loose	850	27.7202	tet(K)	38.0	3000178	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGAGTGGTGACGGCTCGCCTCCGATCCACACCCGCCGGCAGGGTTTCGATCCGGCCGACGAACTGCGCGCCGCCGGAACGCTGACGAAGATTTCCATCGGCTCCGGAGCGGACGCCGAGACCACCTGGCTGGCGGCCGGGCACGCCGTCGTGCGCCAGGTTCTGGGCGATCACAAGCGATTCAGCACCCGGCGCCGCTTCGACCGACGTGACGAGATCGGCGGGACGGGCGTCTTCCGCCCGCGTGAGCTGGTCGGCAACCTGATGGACTACGACCCACCGGAGCACACCCGGCTCCGGCACCTGCTGACCCCGGGATTCACCCAGCGCCGGATGCGTCGTCTGGCGCCGCGCATCGAAGAGATCGTGACCGACCGCCTCGACGCCATGGAGCAGGCGGGGCCGCCGGCGGACCTGATCGAGCTGTTCGCCGACGAGGTGCCCGGAGCCGTGCTGTGCGAGCTGATCGGAGTACCCCGCGACGATCAGGCCATGTTCCTGCAGCTGTGTCACCGGCATCTCGACGCCTCGCTGAGTGCCAGGAAACGGGCGGCCGCCGGGGAGGCGTTCGCCCGCTACCTGGTGGCCATGATGGCCAGGGAACGCAAGGACCCCGGCGACGGGTTCATCGGCTCGATCGTCGCCGAACACGGCGACACGATCACGGATGAGGAGCTGAGAGGCGTCTGTGTGCAGCTGATGCTGGCCGGTGACGACAACGTCTCCGGCATGATCGGGCTGGGGGTGCTGGCGTTGCTGCGACATCCCGAGCAGATCGCCGCGTTGCGCGGGGACGATCAGTCGGCGGATCGAGCTGTCGACGAGCTGATCCGGTACCTGACGGTCCCATACGCCCCGACACCGCGGACCGCCGTGGAGGACGTCATGGTTGCCGACCAGGTGATCAAGGAGGGCGAGACGGTTCTCTGCTCTCTCCCGATGGCCAACCGTGACCGCGCCCTGCTGCCGGATGCCGACCGCCTCGACGTGACCCGTACGCCCGTTCCGCATGTCGCGTTCGGACACGGTATCCATCACTGTCTGGGCGCCGCTCTGACGCGCCTGCAACTGCGAATCGCCTATACCGCCCTGTGGCGGCGCTTTCCCGCTTTGCAACTGGCGGACCCCGCCCAGGAAATAATGTTCCGGACGAGTACCCCGGCGTATGGATTAACCAGTCTGCTGGTTGCCTGGTAG	MSGDGSPPIHTRRQGFDPADELRAAGTLTKISIGSGADAETTWLAAGHAVVRQVLGDHKRFSTRRRFDRRDEIGGTGVFRPRELVGNLMDYDPPEHTRLRHLLTPGFTQRRMRRLAPRIEEIVTDRLDAMEQAGPPADLIELFADEVPGAVLCELIGVPRDDQAMFLQLCHRHLDASLSARKRAAAGEAFARYLVAMMARERKDPGDGFIGSIVAEHGDTITDEELRGVCVQLMLAGDDNVSGMIGLGVLALLRHPEQIAALRGDDQSADRAVDELIRYLTVPYAPTPRTAVEDVMVADQVIKEGETVLCSLPMANRDRALLPDADRLDVTRTPVPHVAFGHGIHHCLGAALTRLQLRIAYTALWRRFPALQLADPAQEIMFRTSTPAYGLTSLLVAW	MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYMLTFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMGGLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLEFINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE	86.71	gnl|BL_ORD_ID|1337|hsp_num:0	1345			297	447	tetracycline
BGC0000441.1|Teicoplanin_26 # 50931 # 52406 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.685	BGC0000441.1|Teicoplanin_26 	50931	52406	+	Loose	600	57.3806	Streptomyces venezuelae rox	29.89	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGGTGGAAGAGTTCGACGTGGTGGTGGCCGGTGGCGGGCCGGCCGGTTCGACCGTGGCCACGCTGGTGGCCATGCAGGGCCATCGGGTGCTGCTGCTGGAGAAGGAGACCTTCCCCCGGTACCAGATCGGCGAGTCGTTGCTGCCCTCCACCGTCCACGGGGTGTGCCGGATGCTCGGCGTCTCGGACGAGCTGGCGGCAGCCGGCTTCCCCGTCAAGCGCGGCGGCACCTTCCGCTGGGGCGCCCGCCCGGAGCCGTGGACGTTCTCCTTCGCCGTCTCGCCCCTGATGAACGGCCCGACGTCGTTCGCGTACCAGGTCGAACGGGCGCGCTTCGACGAGATCCTGCTGCGTAACGCGCAGCGCAAGGGCGTCGACGTGCGCGAGGGATGCTCGGTCACCGGGGTGATCGAAGGCGACGAGCGGATCACCGGGGTGCGTTACACCGACCCCGACGGCGGCGAGCACGAGGTGTCGGCGCGGTTCGTGGTCGACGCGTCGGGCAACAAGAGCCGGCTGTACTCCCAGGTCGGCGGCGTCCGCAACTATTCGGAGTTCTTCCGCAGCCTGGCGCTGTTCGGTTACTTCGAGAACGGCAAGCGGCTGCCGGAGCCGTACTCGGGCAACATCCTGAGCGTCGCGTTCGACAGCGGCTGGTTCTGGTACATCCCGCTGAGCGACACGATGACCAGCGTCGGCGCGGTGGTGCGCCGGGAGATGGCGGAGAAGATCCAGGGCGACCGGGAGAAGGCGCTCCAGGCCCTGATCGCCGAATGCCCGCTGATCTCCGACTACCTCGCCGACGCGCGCCGGATCACCACCGGCCGGTACGGAGAACTGCGGGTCCGCAAGGACTACTCGTATCACCAGACCAGCTACTGGCGGCCCGGGATGATCCTGGTCGGGGACGCCGCGTGCTTCGTGGACCCGGTGTTCTCCTCGGGCGTGCACCTGGCGACCTACAGCGCGCTGCTGGCGGCGCGGTCGATCAACAGCGTGCTCGCCGAGGACCTGGACGAGAAGACCGCGCTGAGTGAGTTCGAGGCCCGCTACCGCCGCGAGTACGGGGTGTTCTACGAGTTCCTGGTGTCCTTCTACCAGATGAACGTCAACGAGGAGTCGTACTTCTGGCAGGCCAAGAAGGTCACCAACAACAAGCACACCGAGATCGAGTCGTTCGTGGAGCTGATCGGCGGGGTGTCGTCGGGTGAGGCGGCGCTGGCCACGGCCGGCCGGATCGCCGAGCGCAGCGCCGAGTTCGCCGCGGCCGTGGACCAGATGGCCGCCAGCGCCGACGGCAACATGGTGCCGATGTACAAGTCGGAAGTGGTCAAGCAGGTGATGCAGGAGGGCGGCCAGGTGCAGATGAAGGCGGTGCTCGGCGCGGACGCCGAGCCCGAGCTGCCGCTGTTCCCCGGCGGGCTGGTGGTCTCGCCCGACGGGATGAAGTGGCTGCCCTACCGTCCCGCCTGA	MPVEEFDVVVAGGGPAGSTVATLVAMQGHRVLLLEKETFPRYQIGESLLPSTVHGVCRMLGVSDELAAAGFPVKRGGTFRWGARPEPWTFSFAVSPLMNGPTSFAYQVERARFDEILLRNAQRKGVDVREGCSVTGVIEGDERITGVRYTDPDGGEHEVSARFVVDASGNKSRLYSQVGGVRNYSEFFRSLALFGYFENGKRLPEPYSGNILSVAFDSGWFWYIPLSDTMTSVGAVVRREMAEKIQGDREKALQALIAECPLISDYLADARRITTGRYGELRVRKDYSYHQTSYWRPGMILVGDAACFVDPVFSSGVHLATYSALLAARSINSVLAEDLDEKTALSEFEARYRREYGVFYEFLVSFYQMNVNEESYFWQAKKVTNNKHTEIESFVELIGGVSSGEAALATAGRIAERSAEFAAAVDQMAASADGNMVPMYKSEVVKQVMQEGGQVQMKAVLGADAEPELPLFPGGLVVSPDGMKWLPYRPA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	486	rifampin; rifaximin; rifapentine
BGC0000441.1|Teicoplanin_27 # 52514 # 53746 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000441.1|Teicoplanin_27 	52514	53746	+	Loose	2000	26.9498	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	30.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGGATCACGACATCGATGAGGTCGCGCCGGTCGTGGAGCCGACGGCGAACTACATGAGGAGAACGGTCTGCGACCCGCACGAGGACATGTTCGCTCTGCGGGCGCACGGTCCGCTGATCCGGATCGGCGGGGATGCCGCGGTCCAGATGGGCGCGGATTATCTCTGGCAGGCGATGGGCTACGACGTCGTGCGGCAGATCCTCGGTGATCATGAGAACTTCACGACGCGGCTGCGGCTGACCGCGTCCGAACCGATCAGCGGGGAAGGCGCGACCAAACCGCAGGAGCTGGTCGGACAGATCTCGACCTACGATCCGCCCGAGCACACCCGCCTGCGCCGGATGCTCACGCCGGAGTTCACGGTCCGGCGCGTCCGCCGGCTGGAGCCCGCGATCCAGGAGCTCATCGACGACCGCATCGATGCGATGGAGGCCGCGGGACCGCCCGTGGACGTGCAGACGGTCTTCGCCGATCCGGTCGGCGGCGGCGCGCTGTGCGAACTGCTCGGCATCCCACGCGATGATCGGAACCAGTTCATGCGCCGGGTCCGGCAGAACGTCGATCTCAGCCGCGGATACAAGGCCCGGGCGGCCGACAGCGCGGCGTTCAACCGGTACCTGCAGAGCCTCATCACCCGGCAGCGCAAGGACCCCGACGAGGGGTTCCTCGGCATGCTGGTGCGCGACCACGGCGACGACATCACGGACGAGGAGCTCAAGGGCGTGTGCACGGCGCTGCTCCTCGGCGGTGTCGAGACCGTCGCGGGGATGCTGGGCTTCGGGGTCCTCGCGCTGCTGGACCATCCCGACCAGAGGCGGCTGCTCTTCGCCGGCCGCGAGGAGGCCGACCGCCTGGTCAACGAACTGTTGCGGTATCTGTCGGCGGTGCAGCAGCCGACTCCGCGGATGGCCGTCAAGGACGTGGTCGTCGATGGGCAACAGATCAGGGCGGGGGAGTACGTGCTGTGCTCGATCCTCATGGCCAACCGGGACGAAGCGCTGACACCCCATCCCAACGTTCTGGACGCGGAGCGTGAGCCGGCGCCACACATCGGATTCGGGCACGGCATCCATCACTGCATCGGGGCGGCGGTGGCGAGAACCGTGCTGCGGATGGCCTACCAGACCCTGTGGCGACGACTTCCCGGGCTGCGCCTCGCGATACCCGCCGGGCAGGTGAAGCTCAGGAACGCGTTCATCGACAGTCCGGATCAGTTGCCGGTCACCTGGTAG	MDHDIDEVAPVVEPTANYMRRTVCDPHEDMFALRAHGPLIRIGGDAAVQMGADYLWQAMGYDVVRQILGDHENFTTRLRLTASEPISGEGATKPQELVGQISTYDPPEHTRLRRMLTPEFTVRRVRRLEPAIQELIDDRIDAMEAAGPPVDVQTVFADPVGGGALCELLGIPRDDRNQFMRRVRQNVDLSRGYKARAADSAAFNRYLQSLITRQRKDPDEGFLGMLVRDHGDDITDEELKGVCTALLLGGVETVAGMLGFGVLALLDHPDQRRLLFAGREEADRLVNELLRYLSAVQQPTPRMAVKDVVVDGQQIRAGEYVLCSILMANRDEALTPHPNVLDAEREPAPHIGFGHGIHHCIGAAVARTVLRMAYQTLWRRLPGLRLAIPAGQVKLRNAFIDSPDQLPVTW	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	34.57	gnl|BL_ORD_ID|4719|hsp_num:0	2914			201	381	rifampin
BGC0000441.1|Teicoplanin_28 # 53863 # 55089 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.729	BGC0000441.1|Teicoplanin_28 	53863	55089	+	Loose	600	408.297	rgt1438	58.5	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGTGTGTTGTTGTCGACGACCGGAGGGCGCGGCGACGTCGAACCGCTGGTCGCGCTGGCGGTGCGGTTCCGCGAACTGGGTGTGGACGCGCGGGTCTGCGCACCGCCGGACTGCGCGGACCGGCTGGCCGGCGTCGGTGTGCCACTGGTGGAGGTCGGCGAGTCGGTGCGCGCGATGATGCACGGAGGGAAGCGGCCGTCGCCCGAGGACGCGCCCCGGCTCGACGCCGAGGCCATCGCTACGCAGTTCGACAAGGTCCCGGCGGCCGCCGAGGGCTGCGCCGCGGTGGTGACGACCGGCCTGTTGTCCGCCGCGGTCGCGGTGCGGTCCGTGGCCGAGAAGCTGCGCATCCCCTACGTCTACGCCGCCTACTGCCCGATCTATCTGCCGTCGCCGTACTACCCGCCGCCGCCGGCCCTGGGCGGCCCGCCCGTACCGGAACTGACCGACAACCGGGCGCAGTGGAACAGGCACAGCCAGGGTGCCTACCGGCGGTTCGGCGCCGCGCTCAACAGCCACCGGGCGGCGATCGGCCTGCCGCCGGTGGAGAACATCTACGACTACGCCTTCAGCGATCACCCGTGGCTGGCGGCCGATCCGGTCCTGGCCCCGCTGCAGCCGACCGATCTCGACGTGGTGCAGACCGGCGCGTGGATCCTGCCCGACCAGCGGCCGTTGTCGGCGGAGTTGGAGGGGTTCTTGAGGGCTGGCTCGCCTCCGGTGTACGTGGGTTTCGGCAGTGGGCCGGCGCCTGCCGAGGCCGCGCGGGTGGCCATCGAGGCGGTTCGGGCTCAGGGCCGCCGGGTGGTGCTGTCCAGTGGTTGGGCCGGGTTGGGCCGGATCGACGAGGGGGATGACTGTCTGGTGGTGGGCGAGGTGAACCATCAGGTGCTGTTCGGCCGGGTGGCCGCCGTCGTCCACGCCGGCAGTGCGGGCACGACGACCGCGGTGACCCGGGCGGGCGCTCCGCAGGTCGTGGTGCCCCAGATGACGGATCAGCCCTACTATGCCGGTCGGGTGGCTGACCTGGGTGTCGGCGTGGCGCATGACGGTCCGACCCCGACCGTCGAGTCCCTGTCCGCGGCGCTGGCCACGGCATTGACCCCGGGGATCCGGGCGCGAGCGGCGGCGGTGGCCGGCACGATCCGCACCGACGGGACGACGGTGGCCGCGAAACTGCTCCTCGAGGCGATCAGCCGGCAGAGATCGTCGGTCTCCGCGTGA	MRVLLSTTGGRGDVEPLVALAVRFRELGVDARVCAPPDCADRLAGVGVPLVEVGESVRAMMHGGKRPSPEDAPRLDAEAIATQFDKVPAAAEGCAAVVTTGLLSAAVAVRSVAEKLRIPYVYAAYCPIYLPSPYYPPPPALGGPPVPELTDNRAQWNRHSQGAYRRFGAALNSHRAAIGLPPVENIYDYAFSDHPWLAADPVLAPLQPTDLDVVQTGAWILPDQRPLSAELEGFLRAGSPPVYVGFGSGPAPAEAARVAIEAVRAQGRRVVLSSGWAGLGRIDEGDDCLVVGEVNHQVLFGRVAAVVHAGSAGTTTAVTRAGAPQVVVPQMTDQPYYAGRVADLGVGVAHDGPTPTVESLSAALATALTPGIRARAAAVAGTIRTDGTTVAAKLLLEAISRQRSSVSA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	99.27	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1230	rifampin; rifaximin; rifabutin; rifapentine
BGC0000441.1|Teicoplanin_29 # 55235 # 56206 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.683	BGC0000441.1|Teicoplanin_29 	55235	56206	+	Loose	450	25.7942	ANT(9)-Ia	31.25	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGGATCCCGAGACCGTACGCATCGCGCTGGGGTTGGAGGAACGGACCGCGGCGTGGCTCACCGAGCTCGATGAGCTCGGTCCGCCCGCCGAGCCGGTACGGCTGCCGCGCGGCGAGGAGGCACGTGATCTGCTACGGCGTCTGGAGGTGCCGGAGCTCGACGCCGAGGAGATCGTGGCGGCCGCTCCCGATCCGGATCGTGACCCGGCCCTGTGGTGGCTGCTCGAACGCACCCACCACGCGATCGTCCGGCACATGGGCGACCACCGGGCGAAGCCACGCGGCGGTCCGCCCCTGCCGTACGAGGGCGGCGCCGCCGCACGCTACTTCCACGTGTACGTCTTCCTCGCGACGGTGCCGGCGGTGCGCCGCTTCCACGCGGAACGGGGTATCCCCGACGAGGTCGGCTGGGAGACCCTGAGCAGGTTGGGGGAGCTGGTGGCCATTCATCGCCGCAAGTACGGCCAGGGCGGCATGAACATGCAGTGGTGGACCACCTACCACCTGCGCGGCATCCTCTACCGGCTCGGCCGCCTGCAATTCAGTCTGGCCACCGGAAAGGACGGCACGCCGCACCTCGGCCTGCACGTTCCCGAGTGGGGCGGACCGCTGTTGCCCAAGGCCTATGACGAATCGTTGCATCGTGCCCGCCCGTTCTTCGACCGGCATTTTCCCGAGCACGGCGCCCGGGTGGCCTGGGGAAGCTCGTGGATGCTCGATCCGCAACTGGAGGAGTATCTCACCGAGGACTCCAACATCATTCAGCTTGCGCGGTTCTGGACGCTCACCGACTCCGCGCCGGAGCCCGGTAACGCGGACGGGGACTCCTCGATCCTGGAGTTCGTGTTCCGCTACAACGGCCAGCCGCTGGATGAACTTCCGCAGCGTTCCTCGCTGGAGCGCGCGGTGATCGCCCATCTGAAGGCCGGACGTCACTGGCACATGCGGACCGGCTTCGTGAAGCTGCCGTAA	MDPETVRIALGLEERTAAWLTELDELGPPAEPVRLPRGEEARDLLRRLEVPELDAEEIVAAAPDPDRDPALWWLLERTHHAIVRHMGDHRAKPRGGPPLPYEGGAAARYFHVYVFLATVPAVRRFHAERGIPDEVGWETLSRLGELVAIHRRKYGQGGMNMQWWTTYHLRGILYRLGRLQFSLATGKDGTPHLGLHVPEWGGPLLPKAYDESLHRARPFFDRHFPEHGARVAWGSSWMLDPQLEEYLTEDSNIIQLARFWTLTDSAPEPGNADGDSSILEFVFRYNGQPLDELPQRSSLERAVIAHLKAGRHWHMRTGFVKLP	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	124.23	gnl|BL_ORD_ID|1270|hsp_num:0	1386			543	678	spectinomycin
BGC0000441.1|Teicoplanin_30 # 56350 # 57942 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.683	BGC0000441.1|Teicoplanin_30 	56350	57942	+	Loose	500	27.7202	L1 beta-lactamase	30.91	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	GTGAATGAGGAGCGCCTCTTTCTCCGGCCCAACACCATTATCGAGCCTCTGGTAGACAGATTTTATGCCTCGATGTACGCGACGGCTCCGGTCACGGCCACCATGAGTCTCGCGTTCCGGTGGATTCCGATGCTGGAGTCCTACCTGCAGGCCCCGGAATGGCATTACAAGGGCAGCCGGGACCCGAAGTTCCGCGGCGGGTTCTTCGTCAACATCGAGGACTCCCGGGCGGACGAGGTGCGGGCGCTGCTCGCCGCGATCCGGCGCGACCGCGCCGACATGATCCGCTTCGCCGAGGCGATCGCGGAGGCCGAGAAGATCGTCCGGGAGGAGGCGACCGGGTACGACCTCCGGCCGCTCTACCCGAAGCTGCCCGCCGAGCTGGCGGGCCTGGTGGAGATCGCCTACGACACCAGCAACGCCGCCTCGCTGCACTTCCAGGAGCCGCTGGTCTACCACAGCAAGGCCTACACCGAGCAGCGGCAGTCGGTGCAGCTGTCCGTGGAGACCGGCATCGAGCGGCCGTTCGTGATGAGCACGCCGCGGCTGCCCTCGCCGGACGTGCTGGAGCTGCCCATCCCGTTCCGGCACCCGGGCCTGGAGCAGCTGTTCCTGTCCCGGATCCGGCCCACCACCCTGACCGCGCTGCGGGAGGCGCTGGAACTCGGCGATTCGCAAGCGGCCCAGCTCGCCGGCCTGCTGGTCCCGGAGCCCGCGCTCGCCGCGGACCGGCACATCGCGGCCGGCGCCCGGATCCGCTACTGGGGGCACGCCTGCCTGCTCATGCAGACCCCGGACGTGGCCATCATGACCGACCCGTTCATCAGCGCGGACACCGACGCGACCGGCCGGTACACCTACAACGACCTGCCCGACCGCATCGACTACGTGCTGATCACCCACGGGCACTCCGACCACCTCGTCCCGGAGACGCTGCTGCAGCTGCGCGGCCGGGTGGGCACGTTCGTGGTGCCGAGGACCTCCCGCGGCAATCTGTGCGACCCGTCGCTGGCGCTCTACCTCAAGAGCTTCGGGTTCTCCGCCGTCGAGGTGGACGACTTCGACGAGATCTCCTTCCCGGGTGGCAAGATCGCGGCCACGCCGTTCTTCGGCGAGCACGCCGACCTGGACATCCGCGCCAAGGCGACGTACTGGATCAACCTCGGCGGGAAGTCGATCTATGTGGGGGCGGACTCCTCCGGCCTCGACCCGGCGCTCTACCGCTACGTCCGCCGGCACCTCGGGCGGGTCGACATCGCCTTCCTCGGCATGGAGTGCGACGGCGCCCCGCTGAACTGGCAGTACCAGGCGTTCCTCACCAAGCCGATCCCGAACAAGATGAGCGACAGCCGCAAGATGTCCGGCTCCAACGCGGAACAGGCCAGCGCGATCGTCACCGAGCTCGGCGCCGACGAGGTGTACATCTACGCGATGGGCGAGGAGAGCTGGCTCGGCCACGTCATGGCCACCAGCTACAACGAGGACTCCTTCCAGCTGCGGCAGATCGCCGAGTTCGAGACCTGGTGCGCGAACAACGGGGTGAAGTCGGGCCACCTGCTCGACCGGCACGAATGGCACTGGTCGCACCCCTGA	MNEERLFLRPNTIIEPLVDRFYASMYATAPVTATMSLAFRWIPMLESYLQAPEWHYKGSRDPKFRGGFFVNIEDSRADEVRALLAAIRRDRADMIRFAEAIAEAEKIVREEATGYDLRPLYPKLPAELAGLVEIAYDTSNAASLHFQEPLVYHSKAYTEQRQSVQLSVETGIERPFVMSTPRLPSPDVLELPIPFRHPGLEQLFLSRIRPTTLTALREALELGDSQAAQLAGLLVPEPALAADRHIAAGARIRYWGHACLLMQTPDVAIMTDPFISADTDATGRYTYNDLPDRIDYVLITHGHSDHLVPETLLQLRGRVGTFVVPRTSRGNLCDPSLALYLKSFGFSAVEVDDFDEISFPGGKIAATPFFGEHADLDIRAKATYWINLGGKSIYVGADSSGLDPALYRYVRRHLGRVDIAFLGMECDGAPLNWQYQAFLTKPIPNKMSDSRKMSGSNAEQASAIVTELGADEVYIYAMGEESWLGHVMATSYNEDSFQLRQIAEFETWCANNGVKSGHLLDRHEWHWSHP	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	179.66	gnl|BL_ORD_ID|1480|hsp_num:0	1619			195	471	
BGC0000441.1|Teicoplanin_31 # 58159 # 59955 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=7bp;gc_cont=0.711	BGC0000441.1|Teicoplanin_31 	58159	59955	+	Loose	1000	49.2914	almE	23.12	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGGCTACGACATGGCCACCGCACCCGATCTCGTAACTCTGATCCGTCAGCATGTCGCCGGGCGGCCGGACGCCGACGCCGTCGGCTTTCTCACCGACCCGGACGACATCCGCGGCGGGGTCGTGTCGTGGACCTACGGGCAGCTCGACCGGGAGGCTCGCGGGTACGCGGCCTGGTTGCAGCAGCGCCTGCCCGCCGGCTCGCGGGTGCTGCTGCTGTATCCCAACGGGCTCGACTTCGTCGCGGCGTTCTTCGGCTGCCTGTATGCCGGCATGATCGCGGTACCGGCGCCGCTGCCCGGCCGTTATCGCCATCACCAACATCGGGTCGCGACCATCAGCGCCGATGCCCGGGTCAGCGCGGTCCTGACCACGGCGGCGCATCTGGGGGAGGTCCGCGACTGGGCTCGGGCGTGCGGACTGGACCACCTGCTGATCGCGGTCGGCGACGAACCGGAGTTCGGCGATCCGGCGGGCTGGACGCCGGCGTCACCGGAACGTGCGACCATCGCGCTGTTGCAGTACACGTCCGGGTCGACCGGCGACCCGAAGGGAGTCGTGGTCACCCACGACAACATCCTGTACAACTTGGATGCCTGCGTCCGGGGCCTGCGCTGGCCGGACGACTGGCGGGTGGGCGGGTGGCTTCCGCTCTACCACGACCTGGCGATGCAGGGGCTGCTCAACATGGCCGTCGTGCGCGGCGGCTATGCCTTGCTGATGGAGCCGGTCTCGTTCGTGCGCGATCCGGTGCGCTGGCTGCGGACGATAGCCGAACACGACATCCAGGTGACGTTCGCGCCCACCTTCGCGTACCAACTGTGCCTCGACCGGGTCACCGACGAGCAGCTGGCCGCTCTCGATCTGTCCGGCTGGAAGATCGCCGGGAACGCCGCGGAGCCGGTGAACCCGGCGATCCTGGCCGCGTTCGCTGAGAAGTTCGCGCCGGCCGGGTTCCGCCCCGAGTCCTTCGCGCCCATCTACGGGATGGCGGAGGCCACCGGCTACATCAGCGGGGAGGTGGGGCGTGCGCCGCTGGTGCGTACCGTCGGCCTCGACGCGCTCGCCCATGGCCGGCTCGCCGACCCGGCGCCGGACGAGCCGGTACGCGAAATCGTCAGCTGCGGCACTCCGAACGAGGCGTGCGACATCCGTGTGGTGGACCCGGAGACGTCGCGCGTGCGGCCCGACGGGTGGTTGGGCGAGATCTGGATACGCGGGCGCAGCGTGTCCCCGGGCTACTGGAGCGATGCCGGGCCGGCCTTCGCCGCGGTGACGGCCGAGGGGGAGGACGGCTTCCTGCGTACCGGCGACCTCGGCGTGCTGCAGGACGGTGAGCTGTACGTGCACGGCCGGCTCAAGGAGACGTTCACCGTGCACGGTCGCCACCTCTACCCGCACGACGTCGAGCAGGAACTGCGCGCACGGCACCCGGAACTCGGCAAGTGCGGCGCGGTCTTCCCGGGACGGGCTCCCGGCGCCGGCGGCGCGCGGGGCGTGGTCGTGACCCATGAGGTGACCAACGCGGCGCGGGATCGGCTGCCGGAGCTGGCCGCCGGGTTACGGCATACCGTGGGGCGGGCATTCGGCGTCGAGGTCTCCGCGGTGCTGCTGCTACGTCCGGGTGCCGTGCTGCGTACCACCAGCGGGAAGATCCGCCGCTCGGCCATGCGTGAGCTGTTCCACGAGGGAAAGCTGACCGCTCTCTACCAGCATCCTCCGGCGCCGCGGGAGCCGCTGCCCTACGTGGGGGATCCGTCGCCGGCGACCAGGGTGACCAGCCTTTCGCGTCCGTGA	MGYDMATAPDLVTLIRQHVAGRPDADAVGFLTDPDDIRGGVVSWTYGQLDREARGYAAWLQQRLPAGSRVLLLYPNGLDFVAAFFGCLYAGMIAVPAPLPGRYRHHQHRVATISADARVSAVLTTAAHLGEVRDWARACGLDHLLIAVGDEPEFGDPAGWTPASPERATIALLQYTSGSTGDPKGVVVTHDNILYNLDACVRGLRWPDDWRVGGWLPLYHDLAMQGLLNMAVVRGGYALLMEPVSFVRDPVRWLRTIAEHDIQVTFAPTFAYQLCLDRVTDEQLAALDLSGWKIAGNAAEPVNPAILAAFAEKFAPAGFRPESFAPIYGMAEATGYISGEVGRAPLVRTVGLDALAHGRLADPAPDEPVREIVSCGTPNEACDIRVVDPETSRVRPDGWLGEIWIRGRSVSPGYWSDAGPAFAAVTAEGEDGFLRTGDLGVLQDGELYVHGRLKETFTVHGRHLYPHDVEQELRARHPELGKCGAVFPGRAPGAGGARGVVVTHEVTNAARDRLPELAAGLRHTVGRAFGVEVSAVLLLRPGAVLRTTSGKIRRSAMRELFHEGKLTALYQHPPAPREPLPYVGDPSPATRVTSLSRP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.55	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1479	colistin A; colistin B
BGC0000441.1|Teicoplanin_32 # 60326 # 61381 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.717	BGC0000441.1|Teicoplanin_32 	60326	61381	+	Loose	1000	25.7942	MCR-9.1	26.47	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGTCGTTGTGATGGCGCCGGAGGCCACTTCGGCGGATGTGGACGCGGTCGTCCGGCTGGTCGAGTCGGTGGGCGGGCAGGCGTTCGTCAGCCGCGGGCTGTCCCGGACCATCGTCGGCCTGGTCGGCGACGTGGCCGACTTCGAGGCGCTCAACCTGGGCAGCCTGGCGGGCGTGCTGCGGGTGATCCGGGTGTCGGTGCCGTACAAGCTGGTCAGCCGGGAGCACCACCCGGCGCGCTCGGTGATCCGGGCCGGCGGCGTGCCGATCGGTCCCGGCACGCTGACCGTGATCGCCGGGCCGTGCGCGGTGGAGGTCCCCGGACAGACGCTGGAGGCGGCCCGGATGGCGCGCTCGGCCGGGGCCTCGATGCTGCGCGGCGGGGCGTTCAAGCCGCGGACCTCACCGTACTCCTACCAGGGGTTGGGGGAGCGGGGCCTGCGCATCCTGGCCGACGTGCGGGCCGAGACGGGGCTCGCCGTGGTCACCGAGGTGATCGATCCCGGCAGTGTGGACATGGTCGCGTCGTACGCCGACATGCTCCAGATCGGCGCCCGGAACATGCAGAATTTCGCGCTGCTGCAGGCGGTCGGGTCGGCCGGCAAACCGGTGCTGCTCAAGCGCGGGTTCAGCGCCACGATCGAGGAATGGCTCAGCGCCGCCGAGTACATCGCGCAGCGCGGCAATCTGAACATCGTGTTGTGTGAGCGCGGGATCCGGACGTTCGAGACCGCTACCCGTAACACGCTGGACATCAGCGCGGTGCCGGTCGCCCAGCGGCTCTCCCACCTGCCGGTGATCGTGGATCCGTCGCACTCCGGCGGCCGCCGCGATCTGGTGGTGCCGCTGACCCGCGCGGCGATCGCGGTGGGCGCGGACGGGTTGCTCATCGACGTCCACCCGGAGCCGAAGACCGCTCTGTGCGACGGTGACCAGGCGCTGCCGGAAGCCGACATCCGGGAGATCGCCGACATCGTGGCGAGCCTGCCCGCGTTCCTGGGGCGGGAGCCGGCCGTGCCCTCGGGTGAATTCCGACACGTTCCCGCCGCGGTGTGA	MVVVMAPEATSADVDAVVRLVESVGGQAFVSRGLSRTIVGLVGDVADFEALNLGSLAGVLRVIRVSVPYKLVSREHHPARSVIRAGGVPIGPGTLTVIAGPCAVEVPGQTLEAARMARSAGASMLRGGAFKPRTSPYSYQGLGERGLRILADVRAETGLAVVTEVIDPGSVDMVASYADMLQIGARNMQNFALLQAVGSAGKPVLLKRGFSATIEEWLSAAEYIAQRGNLNIVLCERGIRTFETATRNTLDISAVPVAQRLSHLPVIVDPSHSGGRRDLVVPLTRAAIAVGADGLLIDVHPEPKTALCDGDQALPEADIREIADIVASLPAFLGREPAVPSGEFRHVPAAV	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	65.12	gnl|BL_ORD_ID|2245|hsp_num:0	3383			999	1101	colistin A; colistin B
BGC0000441.1|Teicoplanin_34 # 63879 # 66257 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GAAGG;rbs_spacer=4bp;gc_cont=0.746	BGC0000441.1|Teicoplanin_34 	63879	66257	+	Loose	390	29.6462	evgA	28.57	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGCTCGTCAGCGGCGCGGTGGGCACCGGGAAGACCGCGCTGCTGCAGGCGATGGCCGCGCGTGCCGGCCGCCGGGGCGGCTGGTCGTTCGTGGTCACCGGTTCGGCCCGCGAGCGCGGGCACCCGTTCGGCGTGCTGGACCGCCTGATCCGGTCGATGTGCGCGGCCGGGATGGCCGAGCCGTTCCCGGGCGGCATGGACTGCGGCGAGAACTTCTTCGTGATGATGGACCGGGTGGGCGCCGCGATCCGGGAGTTCGCCGGCGACCGGCCGGTGCTCGTCGGTATCGACGACGTTCACTTCGTCGACGAGCAGTCGCTGCGGGCCGTCAGCTACCTCATCCGGCGGATCGAGTCGAGCGGTGTGGTGCTGGTGCTCAACGAGAGCACCTCGTACGAGCGTGACATGGCCGGTCTGCGCGCCGAGATGCTGCACCTGCCGTTCTGCTACCGGATCCGGCTCACCCCGCTGACCTCCACCGAGGTCGCCGAGCGGCTGAGCGAGCGGTTCGGCGGCGTGCCCGACCGGGCGTCCGTGCAATTCGGCGTGCAGGTCAGCGGGGGGATCCCGCTCATCCTGCAGGCCCTGATCGACGATCTCGCCGACTCCGGCCCGGGCGTGTGCGAGCCGGGCGCCAACTTCCGCCAGGCCGTGTTGCGCAGCCTGCACCGGTGCGCGCCGTCGACCACCGCGGTGGCCCAGGCCATCGCGGTCCTCGGCGACTACGCGGCGCCGGAGCTGGTCGCCGAGCTCGGCGGTGTGGACGCCGCCCTGATCGAGGAGAGCATCCGCGACCTGCGGGAGATGGGCCTGCTGGAGCACGACTGGTTCCGGCACCCGCACACCCGGGCCGCGGTGCTGGCCGGCATCCCGGTGCCGCAGCTGCCCGAGATGCACCGGCGCGCCGCGGAGCTGCTGCATCAGAGCGGGGCGCCGGCCGGCGCCGTGGCGGAGCACCTGATCGCCGCGCAGGACGGCGGCCGGGCGCCGTGGCGGGTGGTCATCCTGTCGGAGGCGGCCCGCGAGGCGCTGGCCGCCGGCGACGTGGACAGCGCGGTGCTGAGCCTGCGACATGCCGTCGCGGCCAGCTCCGACGAGACGCAGCGGGCGCACGCGGGCGTGCTGCTCGCCGAGGCGCAGTGGCACACCGACCCCAGCCGGGCGGCGCGCCGCCTGGGCGAGCTGAGCCAGGACGCGCGGGCCGGCCGGTTCACCGGCCCCGACACCCTGATCGCGGTCAACCAGCTGCTCTGGTGGGGCGAGTTCGCCGAGGCCGACGAGCTGCTGCGGCTGGCCGGGGACGAGGAGTGCGGCGACTCCAGCCTCGCTCACCTGTGGGCGATCTTCAGCCGGGCCGCCGGGGGGACGGAGATCTGCGACGAGCACACCCCGTCCGGCGGCTCGCCGCTGGCGCGATCCGGTCCGATGGCCGTGGTCACCTACCTGAGCTCGGCGGCGAGCCTGGCCTCCGAGAGCGTGGCGGCCGATCGCACCGAGATGCTGCTCGGCATCCGGGCCGGCGCCCCGCTCACTCCCGCCCTGTACGCCCTGGTCGTCCTGGTGCAGTCCGGCCGGCTGGAGGAGGCGATCACCTGGTGCGGTCGCCTGCTGAAGGAGGAGTGGATCCACCGGACGCCGATGCGGCGGGTGATGATCCAGACGATCGAGTCGGTGGCCATGCTCCGGGCCGGCGACAGCGCGGGCGCCCTGCGGGGCATCCGGGAGGTGTTCGACGCCGTTCCGCCACCGGCGTGGGGCGTGGTGGCGGGCCTGCCGCTGTCGGTCGCGGTGCGGGCCAGCACCGAACTGGGCGACACCCATGCCGCCCGGTCGTACCTGGCGGTCCCGGTGCCACCGGCGATGTTCGACACGCCGTTCGCGCTGCCGTACCTGCTGGCGCTCGGCTGGTACCACCTGGCCATGGGCCACCCGGAGAGCTCGCTGAGGCACACCCGGTCGTGTCTGGACCTGACCGCGCGCTGGGGCGTCGACGCGGGGCGGATCACCGCCGGGCCGGCCGGGCTGGACGTGTCCCGGCCGTCGCCGCCACCGGCCGCGGACCGGGTGGACGCGGGCCACCGGACCCCGGCCGCGGTCCGGGAACCGGCGCCGGATCAGCGGGAGGCCACGCCGGTGCCGCCGCACGCCGGCCCGGACCCGGCGGAGCCCGCGGCGGCGCACCGCGGAGCCGAGGACGGCGCCAGGCTCACCGACGCGGAACAGCGGGTGGCCGCGCTGGCCGCCGCCGGCAACACCAACCGGCAGATCGCCGAGCGCCTGTTCATCACCGTGAGCACCGTCGAGCAGCATCTCACGAAAATCTATCGGAAGCTGAATCTGCGCAGCCGTTCCGGGTTGCGGCGATACAGCCACTGA	MLLVSGAVGTGKTALLQAMAARAGRRGGWSFVVTGSARERGHPFGVLDRLIRSMCAAGMAEPFPGGMDCGENFFVMMDRVGAAIREFAGDRPVLVGIDDVHFVDEQSLRAVSYLIRRIESSGVVLVLNESTSYERDMAGLRAEMLHLPFCYRIRLTPLTSTEVAERLSERFGGVPDRASVQFGVQVSGGIPLILQALIDDLADSGPGVCEPGANFRQAVLRSLHRCAPSTTAVAQAIAVLGDYAAPELVAELGGVDAALIEESIRDLREMGLLEHDWFRHPHTRAAVLAGIPVPQLPEMHRRAAELLHQSGAPAGAVAEHLIAAQDGGRAPWRVVILSEAAREALAAGDVDSAVLSLRHAVAASSDETQRAHAGVLLAEAQWHTDPSRAARRLGELSQDARAGRFTGPDTLIAVNQLLWWGEFAEADELLRLAGDEECGDSSLAHLWAIFSRAAGGTEICDEHTPSGGSPLARSGPMAVVTYLSSAASLASESVAADRTEMLLGIRAGAPLTPALYALVVLVQSGRLEEAITWCGRLLKEEWIHRTPMRRVMIQTIESVAMLRAGDSAGALRGIREVFDAVPPPAWGVVAGLPLSVAVRASTELGDTHAARSYLAVPVPPAMFDTPFALPYLLALGWYHLAMGHPESSLRHTRSCLDLTARWGVDAGRITAGPAGLDVSRPSPPPAADRVDAGHRTPAAVREPAPDQREATPVPPHAGPDPAEPAAAHRGAEDGARLTDAEQRVAALAAAGNTNRQIAERLFITVSTVEQHLTKIYRKLNLRSRSGLRRYSH	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	388.24	gnl|BL_ORD_ID|936|hsp_num:0	1015			429	597	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000441.1|Teicoplanin_35 # 66456 # 67559 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=11bp;gc_cont=0.707	BGC0000441.1|Teicoplanin_35 	66456	67559	+	Loose	500	26.5646	SMB-1	29.03	3000854	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SMB beta-lactamase	ATGACGGCCACCCTCGAACGCGCTTCCGCCTCGCCCGTCGGCATCCCGCCGGCCATCTCCCGGATGGTCGGGGTGGGCACCGCCGTCGCCGGGACGACGGTCTCCCAGCCGGCATTGCTGGATCTTCTCGGCATCGAGGACCCGAAGATCCGCTCGATCTACCTGAACAGCGCCATCGGCACCCGCCGCCTCACCCTGCCGGAGCCCGACGCGTCCGGCGTGCGCCGCCCCGAGCCGCAGGGCGCGCTGCTGGCCAAGCACAAGCGCCTCGCCGTCGAGATGGGCGGGCAGGCGCTGCAGGCCTGCCTCAAGAACATCGGCGCCTCCCTCTCCGACCTGCGGCACCTGTGCTGCGTGACGTCGACCGGCTTCCTCACCCCGGGCCTGAGCGCCCTGATGATCAAGGAACTCGGCATCGACCCGCACTGCAGCCGCTCCGACATCGTGGGGATGGGCTGCAACGCCGGCCTCAACGCGCTCAACGTCGTCGCCGGCTGGTCCGCCGCCCACCCCGGCGAGCTCGGCGTGGTCCTGTGCACCGAGGCGTGCTCGGCCGCGTACGCCCTGGACGGCACCATGCGCACCGCGGTGGTCAACAGCCTCTTCGGCGACGGCGCCGCCGCCCTGGCGCTGATCAGTGACGCTCCCGGGCAGTCGAGGCCCGGACCGCGGATCCTCAAGTTCGCCAGCTTCCTGATCACCGACGCGATCGACGCCATGCGCTACGACTGGGACAGCGACCTGGGCCGGTTCAGCTTCTTCCTGGACCCGCAGATCCCGTACGTCGTCGGCGCCAACGCGGAGACCGTGGTGGACCGCCTGCTCGCCGGCACCGGCCTGCGCCGCCGTGACATCGCGCAGTGGCTGGTGCACTCCGGCGGCAAGAAGGTGATCGACGCGGTCGTGGTCAATCTCGGACTGACCCGCCACGACGTCCGGCACACCACCCGGATCCTGCGCGACTACGGCAACGTCTCCAGCGGCTCGTTCCTCTTCTCCTACGAGCGGCTGGTCGAGGAGGGCGTCACCCGCCCCGGAGACTACGGAGTGCTGATGACCATGGGCCCCGGCTCGACCATCGAAACGGCGCTGGTCCAGTGGTGA	MTATLERASASPVGIPPAISRMVGVGTAVAGTTVSQPALLDLLGIEDPKIRSIYLNSAIGTRRLTLPEPDASGVRRPEPQGALLAKHKRLAVEMGGQALQACLKNIGASLSDLRHLCCVTSTGFLTPGLSALMIKELGIDPHCSRSDIVGMGCNAGLNALNVVAGWSAAHPGELGVVLCTEACSAAYALDGTMRTAVVNSLFGDGAAALALISDAPGQSRPGPRILKFASFLITDAIDAMRYDWDSDLGRFSFFLDPQIPYVVGANAETVVDRLLAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW	MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDGTTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTLRTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSCEQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMWTRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR	131.07	gnl|BL_ORD_ID|751|hsp_num:0	753			132	309	
BGC0000441.1|Teicoplanin_36 # 67556 # 68221 # 1 # ID=1_36;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.782	BGC0000441.1|Teicoplanin_36 	67556	68221	+	Loose	700	26.9498	vanK gene in vanI cluster	31.51	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	GTGACCGCGGCCGGCGTCGACGACCTGGTGCTGCGGATCGACGGGAGCGAGCCGGTCACGCCGGCCACCGTCGAGGCGGTGCTGGGCATCTGTGATCGGGCCGAGGACGGGTACGCCGCCGGGCTGCTGACCGTCCACGTCTCGGGCGTCCCGGCTCCCGGCTGGACGAGCGACCTCAGCGTCGGCCTGACGACCAAGTGGGAGCGCGCCGTCCGCCGGCTGGAGCGCCTCGGCCTGCTCACCGCCGGGGTGGCCACCGGCGACTGCGGCGGCGCGGCGCTGGACCTGCTGCTGGCCACCGACGTGCGGATCGCCGTCGCCGGCGCCCGGCTGGTCGTCCCGGTGAGCGGCGACGCGACCTGGCCGGGCATGGCGCTGTACCGGCTCGCCCGGCAGGGCGCCACCGCCGGGCTGCGCCGGGCCGCCCTGCTCGGCACCCCGCTCGACGCCGCTCGGGCGGTGGCGGCCGGGGTGATCGACGTGGTGGTGGACCGGCCCGAGCCGGCGCTCGCCGAGATCGCCGCCGCGGCGGCCGGCATCACCGGCACCGAGCTGGCCATCCGGCGGCAGCTGATGCTCGACGCCGCGGAGCACAGCTTCGAGGAGGCGGTCGGCTCGCACCTGGCCGCGTGCGACCGGACCCTGCGCCGGGCGGCGGCGTCATGA	MTAAGVDDLVLRIDGSEPVTPATVEAVLGICDRAEDGYAAGLLTVHVSGVPAPGWTSDLSVGLTTKWERAVRRLERLGLLTAGVATGDCGGAALDLLLATDVRIAVAGARLVVPVSGDATWPGMALYRLARQGATAGLRRAALLGTPLDAARAVAAGVIDVVVDRPEPALAEIAAAAAGITGTELAIRRQLMLDAAEHSFEEAVGSHLAACDRTLRRAAAS	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	58.93	gnl|BL_ORD_ID|4747|hsp_num:0	2245			489	702	vancomycin; teicoplanin
BGC0000441.1|Teicoplanin_38 # 69557 # 70354 # 1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.744	BGC0000441.1|Teicoplanin_38 	69557	70354	+	Loose	500	24.6386	ANT(6)-Ib	46.88	3002629	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	GTGACCGCGGCCCGGGTGCGGTACCACAGGACCGGCCACGTCGCCCGGGTCACGCTCGACCGTCCCGACGTGCTCAACGCCATGGATCTGCGGATGCACGAGGAACTGGCGCGGATCTGGGACGACATCGAGGCCGACGACCGGATCCGGGTCGTGGTGCTGACCGGCGCCGGGGACCGCGCGTTCTCGGTGGGCCAGGACCTCAAGGAGCGTGCCCGCCGCGACGCGGCGGGCACCCCGGGGTCCAGTTTCGGCAGCCGCGGCCAGCCCGGCTGGCCGCGGCTCACCGAGCGGTTCGGGTTCAGCAAGCCGGTGGTCGCGCGCGTCGACGGGTACGCCCTCGGCGGCGGCTTCGAGCTCGCGCTGGCCTGCGATCTGATCATCGCATCGGACCGCTCGGTGTTCGGGCTGCCGGAGGTGCGGCTCGGGCTCGTGCCGGGGGCCGGCGGCGTGTTCCGGCTGGTCCGGCAGCTGCCGCAGAAGACGGCGATGGGCTACCTGCTGACCGGCCGTCGCTTCGACGCGGCGACCGCGCTCCGGTTCGGGCTGGTCAACGAGGTGGTGCCGGCGCAGCGGTTGGACGCTTGCGTGGACGGCTGGGTCGATGATCTCGTCACAAGCGCGCCACTGTCGGTCCGGGCGATCAAGGAAGCCGCGCTGCGCTCGGTCGACCTGCCGCTGCCGGACGCCTTCACCGCCACGTACCGCTGGGAGCAGCGGCGCCGCGCCAGCGCGGACGCCGTCGAGGGGCCCCGGGCGTTCGCCGAGCGCCGGGCGCCGCGCTGGTCCGGCACCTGA	MTAARVRYHRTGHVARVTLDRPDVLNAMDLRMHEELARIWDDIEADDRIRVVVLTGAGDRAFSVGQDLKERARRDAAGTPGSSFGSRGQPGWPRLTERFGFSKPVVARVDGYALGGGFELALACDLIIASDRSVFGLPEVRLGLVPGAGGVFRLVRQLPQKTAMGYLLTGRRFDAATALRFGLVNEVVPAQRLDACVDGWVDDLVTSAPLSVRAIKEAALRSVDLPLPDAFTATYRWEQRRRASADAVEGPRAFAERRAPRWSGT	MKMRTEKQIYDTILNFAKADDRIRVVTLEGSRTNINIIPDDFQDYDITFFVTDMQSFINSDEWLNVFGERLIMQKPEDMELFPKEEKGYSYLMLFWDGVKIDLTLLPLEVLDEYFTWDKLVKLLLDKDNRVTNIPVPTDEDYYIEHPTARSFDDCCNEFWNTVTYVVKGLCRKEILFAIDHLNNIVRMELLRMISWKVGIEQGYSFSLGKNYKFLERYISPELWKKILATYNMGSYTEMWKSLELCMGIFRMVSKEVAQCLNYLYPDYDKNISNYVIRQKEKYQR	92.98	gnl|BL_ORD_ID|1018|hsp_num:0	1113			0	93	streptomycin
BGC0000441.1|Teicoplanin_39 # 70393 # 71754 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.728	BGC0000441.1|Teicoplanin_39 	70393	71754	+	Loose	1080	60.8474	rosB	25.36	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTTCGAAGCGCCGCCGTCGTCACTGGGCGGCCATGCCCTGCTCGCTTTCCTGATCGCGGTGGCGACGCTGCTGCTGGTCGCCCACCTGCTGGCCCGCCTGGCGGAACGGGTGCGGATGCCGGCCGTCGTGGGTGAGCTGGCCACCGGCGTCATCCTGGGCCCGTCCCTGCTGGGCCACCTGCTGCCCGGACTGACCGACTGGGTCTTCCCGCCCGGCACCGACCAGATGCACCTGCTCGACGCGGTAGGTCAGATCGGCATCCTGCTCCTGGTCGGACTCACCGGCACCCACCTGGACGTCGCCATGGTGCGGCGGCGCAAGGCCACCGCCGCGCGGATCAGCCTGGGCGGCCTGCTGCTGCCGCTGGCTCTCGGGGTCGGCGTCGGCTACCAGCTGGCCGGCTGGCTCAGCGGCGCCGTGGTCGGTGACCGGCTGGTCTTCGCCGGATTCATGGGCGTCGCGATGTGCGTGACAGCCATCCCGGTGATCGCCAAAACCCTCTCCGACATGCGGCTGCTGCACCGCGACGTGGGCCAGATGACGCTGGCGGCGGGCACCATCGACGACGCGGTCGGCTGGTTCCTGCTGTCCGTGGTGTCGATGGCCGCGACCGCCGGGCTCACCACCGGACACGTCGTCCAGGCGGTCGCCTACCTGCTCGGCTTCGTCGTCCTCGCGGTTCTGCTCGGCCGGCCGCTGGTCCGCCGCGTCATGCGGCTGGCCGACCGCGGCGAGGGATCCGGCTCCAGCATCGTCACCGCGGTCGTCGTCGTCCTGACCGGCGCGGCGATCACCCAGGCGCTGGGCATGGAGCCGGTCTTCGGCGCCTTCGTGGCGGGCATCCTGGTCGGGCTGCCCGCGGCGGCGAACCAGGCGAAGCTGGCGGCGCTGCGCACGGTCGTGCTCAGCGTGCTGGCGCCGCTCTTCCTCGCCACGGCCGGCTTCCGGATGGACCTGACCGCGCTGGCCGACCCGCAGGTCGCGATCGCCGCGGTGCTCGTGCTGGCCATCGCCATCGTCGGCAAGTTCGCCGGGGCGTACGCCGGGGCCCGCCTCAGCCGGCTGTCCCGCTGGGAGGGCCTGGCGATCGGCGCCGGGATGAACTCGCGCGGCGTGGTCGAGGTGGTGGTGGCGCTCACCGGCCTGCGACTGGGCGTGCTGAACACCGCCACCTACACGATCGTCGTCCTGGTCGCCATCGTCACCTCGGTGATGGCCCCGCCGCTGCTGCGCTACGCCTGTGCCCGCATCGCCCAGAACGAGGACGAGCGGCTGCGCAAGCTGCACCACGACACCTGGAACGGCGTCCCGGCCGGCGCCGGCCAGTCCCCCTCACCCGCAGGAGAGCAGGCATGA	MSFEAPPSSLGGHALLAFLIAVATLLLVAHLLARLAERVRMPAVVGELATGVILGPSLLGHLLPGLTDWVFPPGTDQMHLLDAVGQIGILLLVGLTGTHLDVAMVRRRKATAARISLGGLLLPLALGVGVGYQLAGWLSGAVVGDRLVFAGFMGVAMCVTAIPVIAKTLSDMRLLHRDVGQMTLAAGTIDDAVGWFLLSVVSMAATAGLTTGHVVQAVAYLLGFVVLAVLLGRPLVRRVMRLADRGEGSGSSIVTAVVVVLTGAAITQALGMEPVFGAFVAGILVGLPAAANQAKLAALRTVVLSVLAPLFLATAGFRMDLTALADPQVAIAAVLVLAIAIVGKFAGAYAGARLSRLSRWEGLAIGAGMNSRGVVEVVVALTGLRLGVLNTATYTIVVLVAIVTSVMAPPLLRYACARIAQNEDERLRKLHHDTWNGVPAGAGQSPSPAGEQA	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	80.46	gnl|BL_ORD_ID|466|hsp_num:0	507			42	1185	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000441.1|Teicoplanin_41 # 72485 # 73831 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.724	BGC0000441.1|Teicoplanin_41 	72485	73831	+	Loose	450	26.9498	CfiA23	37.93	3006915	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CfiA beta-lactamase	GTGGAATCGTCTGCGCTGCGCAAGTCGGAATTGCATCCGAGCATTTCGGACCCGGTTCTGGACACGATGAATTTCCTCAACGAGGTGACCCTGCGCTATCCCGAGGCGATCTCGTTCGCGCCGGGCCGCCCGTACGACGGCTTCTTCCAGACCGAGGAGGTCCTCGCCCACCTGCGCCGCTTTCTCGACCACCTGGCCGACCAGGGCGCCTCGCCCGCGCAGGTGCGCACGGCGGTCTACCAGTACGGCCCGACCGCCGGCCAGATCCGCGAGATCATCGCCGACTCGCTGCGCCGGGACGAGGGGATCGACGTGCCGGCCGAGTCCATCGTGGTCACCGTCGGCGCGCAGGAGGCGATGATGCTGGTCGTCCGCGCGCTGATCCGTGACCCGCGGGACGTGCTGCTGGTGCCCAGCCCCTGCTACGTGGGCATCACCGGGGTGGCCCGGCTGCTCGACGTGACGCTCGGCCCGGTGCCCGAGTCGCCGGACGGCTTCTCCCTGGAGAACGTGGCGGCGGCGATCCGGGCGCAGCGGGCCGCCGGGCGCCGGCCGCGAGCCTTCTACCTGGTGCCCGACCACGCCAACCCGTCCGGCACCACGCTGTCCGAGTCGGACCGGGCCGGGTTGCTGCACCTGGCCGCGAAGGAGGATCTGCTGATCCTGGAGGACACCCCGTACCGGCTGGTCAGCCCCGGCGAGCCGGTGCGCACGCTGAAGGCGCTGGACCGCCGCCGCTCGGTGGTGCACCTGGGGTCGTACTCAAAAACGATCTTTCCGGGCGCGCGGGTGGGCTTCGCCGTGGCCGACCAGACGGTGGTCGGCGACGACGGCCGGACCGGCCTGCTCGCCGACGAGCTCTCGAAGATCAAGAGCATGGTGACGGTCAACACCTCGTCGCTGAGCCAGGCGGTGGTGGCCGGCGCGCTGCTCGCGGCCGGCGGCCGGGTCTCCGAGCTGAACGCCAAGGCGGCCGGGCACTACGGCGACGCCATGCGCCGGGTGCTCGACCGGCTCGCCGACCGGTTGCCCGCGGCGCGGCGCGCGGAGCTGGGCGTGCGGTGGAACGAACCCAGCGGCGGCTTCTTCCTGAGCCTGACCGTCGGGTTCGAGGCCGACGACGCGGCGCTCACCCGGTCCGCCGAGCAGTTCGGCGTCATCTGGACCCCCATGCGGTACTTCCACCCGGACGGCGGTGGCCGCCGGGCGATCCGGCTGTCGGTCAGCTATCTGTCGCCGGAGGAGATCGACGAGGGGATCACCCGGCTGGTCGCGTTCATCGAGGCCGAGACCCGCCGGCACCGGGCCCGTCCCGGCACCCTCCCGGCGGGGCACGGCGCGGTGTGA	MESSALRKSELHPSISDPVLDTMNFLNEVTLRYPEAISFAPGRPYDGFFQTEEVLAHLRRFLDHLADQGASPAQVRTAVYQYGPTAGQIREIIADSLRRDEGIDVPAESIVVTVGAQEAMMLVVRALIRDPRDVLLVPSPCYVGITGVARLLDVTLGPVPESPDGFSLENVAAAIRAQRAAGRRPRAFYLVPDHANPSGTTLSESDRAGLLHLAAKEDLLILEDTPYRLVSPGEPVRTLKALDRRRSVVHLGSYSKTIFPGARVGFAVADQTVVGDDGRTGLLADELSKIKSMVTVNTSSLSQAVVAGALLAAGGRVSELNAKAAGHYGDAMRRVLDRLADRLPAARRAELGVRWNEPSGGFFLSLTVGFEADDAALTRSAEQFGVIWTPMRYFHPDGGGRRAIRLSVSYLSPEEIDEGITRLVAFIEAETRRHRARPGTLPAGHGAV	MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVNQYIESTSKP	179.92	gnl|BL_ORD_ID|3385|hsp_num:0	4454			621	708	
BGC0000441.1|Teicoplanin_42 # 73867 # 74985 # 1 # ID=1_42;partial=00;start_type=GTG;rbs_motif=GGTAG;rbs_spacer=15bp;gc_cont=0.800	BGC0000441.1|Teicoplanin_42 	73867	74985	+	Loose	750	28.4906	tet(54)	25.0	3004590	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCGCACTCTTCTCGTGATCGGAACCGGACTGATCGGTACGTCGGTGGCGCTGGCCGCGCGTCGCGCCGGGGTGGCGGTGTTCCTCGCCGACCGCGACGTCGCCGCGGCCCGGGTCGCCGAGGCGCTCGGCGCGGGCCTGGCCGAGCCGCCCCGCCGGCCGGTGGATCTCGCGCTCGTCGCGGTGCCGCCCGCCCAGGTCGGCCCGGTGCTGCGGGACGCGCAGGCCAATCGCGCGGCGCACAGCTACACCGACGTGGCCGGGGTCAAGGGGCAGCCGGAACGCGACGTCCTGCGGCTGGCCAGCGACCCGGCGTCGTACGTCGGCGGGCACCCGATGGCCGGGCGGGAACGTTCCGGCCCGCTGGCCGCCACGGCCGACCTGTTCGCCGGCAAGACCTGGGTGCTCACCCCGAACGAGCGCACCGGCGCCGCGGCGCTGGAGCGCGCCACCACGCTCGCCGAGATCTGCGGTGCGGCGCCGGTGCGGCTGGACAGCCGGGCGCACGACACCGTGGTGGCGCTGACCTCGCACGTCCCGCATCTGATGGCCAGCCTCACCGCGGCCCGCCTGCTGCACGGGCCGGCCGCCACCGAGGCGCTGGTGGGCCAGGGGGTCCGTGACGTCACCCGGATCGCGGCCGGCGACCCGGCGCTGTGGACCGACATCGTCCGGTCGAACGCGCCGGCGGTCGCCGCCGTGCTGCGCGGCGTCCGCGACGACCTCACCCGGCTCCTCGCCGCCACCGACATCCTGGCCGGCCACCACCCGGGCGGGCGGGCCCAGGCCGAGCACACCGTCACCGACCTGCTGGAGCGAGGCGTCGCCGGGGCGGCCCGGACCCGGCCGCCCGCCGGGGCGCCGGAGGGCTTCGCCGTGCTCCGGGTGGTCCTCGACGGCCGCCCCGGCAGCCTGGCCCGCCTGCTGGAGGCGGTCGCGGCGCACGGCGGCAGCGCGCGCCGGGCCGGCGCGGCGCCCGGACCGGATGCCGCCCTGGCCGTCGATGTGGAGCTACCGGCGGCCGGGGCCGACGCGGCGGCGGCCGCGCTCGCCGCGGCCGGCTGGGCGGTCAGCCGCCCCGGCCTCGCCTCCGCGGCGCGCCGAGGGCCGCACCGCTGA	MRTLLVIGTGLIGTSVALAARRAGVAVFLADRDVAAARVAEALGAGLAEPPRRPVDLALVAVPPAQVGPVLRDAQANRAAHSYTDVAGVKGQPERDVLRLASDPASYVGGHPMAGRERSGPLAATADLFAGKTWVLTPNERTGAAALERATTLAEICGAAPVRLDSRAHDTVVALTSHVPHLMASLTAARLLHGPAATEALVGQGVRDVTRIAAGDPALWTDIVRSNAPAVAAVLRGVRDDLTRLLAATDILAGHHPGGRAQAEHTVTDLLERGVAGAARTRPPAGAPEGFAVLRVVLDGRPGSLARLLEAVAAHGGSARRAGAAPGPDAALAVDVELPAAGADAAAAALAAAGWAVSRPGLASAARRGPHR	MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE	95.88	gnl|BL_ORD_ID|2726|hsp_num:0	3292			9	267	tetracycline; oxytetracycline
BGC0000441.1|Teicoplanin_44 # 76855 # 77142 # -1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=6bp;gc_cont=0.750	BGC0000441.1|Teicoplanin_44 	76855	77142	-	Loose	400	24.2534	AAC(3)-IVa	36.36	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGCCCCGGAAGAGACGATCACCGAACCCCGGCAGACGCCTCCTGCCGAGTCCATCGCGCGGATGCGCGCCCGCATCGACGAGATCGACGCGGCGATCATCGCGCTGTGGCGCGAGCGCGCCGAGCTGTCCCGCCAGGTCGGCGCGGTCCGCCTCGCCGAGGGCGGGACACGCCTGGTCCTGTCCCGGGAGACCGAGATCCTGCGACGGTTCCGGGCCGGCATCGGCGGCAGCGACGGAACGCAGCTGGGCCTGCTCGTGCTGCGCGCCGGGCGGGGCCGGCTCTGA	MAPEETITEPRQTPPAESIARMRARIDEIDAAIIALWRERAELSRQVGAVRLAEGGTRLVLSRETEILRRFRAGIGGSDGTQLGLLVLRAGRGRL	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	36.82	gnl|BL_ORD_ID|4915|hsp_num:0	639			333	429	dibekacin; sisomicin; apramycin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000441.1|Teicoplanin_46 # 78473 # 79528 # 1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=5bp;gc_cont=0.720	BGC0000441.1|Teicoplanin_46 	78473	79528	+	Loose	600	26.5646	ALG11-1	30.3	3006892	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG11 beta-lactamase	ATGACCGGCCACTTCCAGGACCTGACCGTCGACCACGTACGGATCTACTGCGCGGACCTCGACCCGTTGATCGCCCAATTCGGCAGCTACGGCCTCGACGTGCGGGCCGAGGGCGTCGGGCCGGGCGCGGAGCACTCGGTCGTTCTCGGGCACGGCGACATCCGGCTGGTGCTGACCCGGCCCGGCACCGGCGACCACCCCGGCGGGATGTACACCGCGCAGCACGGCTACGGCGTGTCCGACATCGCGCTCGGTACGGCCGACGCGGCCGGCGCCTTCCACGAGGCGGTCCGGCGCGGGGCACGGCCGATCGCCGCCCCCGAGCGGACCGCCGGCGTGGTCACCGCCTCGGTCGCCGGCTTCGGCGACGTCATCCACACCTTCGTCCAGCGCGAGCCGGGAGGACCGTGGTCGCTGCCGGGGCTGAACCCGGTGCACCGGCCCGGCACGCCCGGCATCGGCCTGCGGCTGGTCGACCACTTCGCGGTGTGCGTCGAGGCCGGCCGGCTCACCGAGGTCGTCGAGCACTACGAGCGGGTGTTCGGCTTCTCGGCCATCTTCACCGAGCGGATCGTGGTCGGCGAGCAGGCGATGGACTCCCAGGTCGTGCAGAGCGCCGGCGGGGCCGTGACGCTCACCGTGATCGCGCCGGACACCACCCGCCGGCCGGGGCAGATCGACACCTTCCTCAAGGACCACGGCGGCCCGGGGGTCCAGCACATCGCGTTCGAGACCGACGACGTGACCCGCTCGGTCGGCGCCATGAGCGACGCCGGCATCGAGTTCCTCACCACACCGGCCGCCTACTACGAGAGGCTGCGGGACCGGCTGCAGCTCACCCGGCACTCGGTCACCGAGCTGAGCCGGCTCAACGTGCTCGCCGACGAGGACCACGACGGCCAGCTCTACCAGATCTTCACCAAGTCCACGCACCCGCGGGGAACGCTGTTCTTCGAGATCATCGAGCGGGTCGGGGCCCGGACCTTCGGCTCCGGCAACATCAAGGCCCTGTACGAGGCCGTGGAGCTGGACCAGGCCGCGGCAGACGGCCGATGA	MTGHFQDLTVDHVRIYCADLDPLIAQFGSYGLDVRAEGVGPGAEHSVVLGHGDIRLVLTRPGTGDHPGGMYTAQHGYGVSDIALGTADAAGAFHEAVRRGARPIAAPERTAGVVTASVAGFGDVIHTFVQREPGGPWSLPGLNPVHRPGTPGIGLRLVDHFAVCVEAGRLTEVVEHYERVFGFSAIFTERIVVGEQAMDSQVVQSAGGAVTLTVIAPDTTRRPGQIDTFLKDHGGPGVQHIAFETDDVTRSVGAMSDAGIEFLTTPAAYYERLRDRLQLTRHSVTELSRLNVLADEDHDGQLYQIFTKSTHPRGTLFFEIIERVGARTFGSGNIKALYEAVELDQAAADGR	MAASAAVSLVVFLFVFVFTFAHAQDQPASWAQPQKPVRIFGNTWYVGTRGLSAILITSPTGAVLIDGAVREAASDIASNITSLGVRLEDIKLIVNSHAHNDHAGAIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFESPTSPPDRVANVKTIQDGEVLRAGGVEVTAHKTAGHTPGGTTWTWRSCEENRCVDIVYADSLTAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAERPK	118.98	gnl|BL_ORD_ID|3289|hsp_num:0	4358			264	462	
BGC0000441.1|Teicoplanin_47 # 79525 # 80619 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GACGG;rbs_spacer=3bp;gc_cont=0.760	BGC0000441.1|Teicoplanin_47 	79525	80619	+	Loose	300	28.1054	AAC(3)-Xa	32.0	3002544	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGACCACCGCTGTGCTGCGGCTGGACACGGTCGACGATTTCCGGCTGCGCGCCGAGGCGACGCTGACCGCCGCGGTCCGTGACTTCGTGGCCGGCGGCAGCGACTCGGAGACCACCCTGGCGGCCAACCGGGCGGCGCTGGACCGGGTGACGATCGTCCCGCGGGTGCTGACCGGCGGGCCCGACCCGGAACCGGGCGCCACGCTGGCCGGGGCCCGCAGCGCGCTGCCGCTGGCCGTGGCGCCGATGGCGTACCAGCGGCTGTTGCACCCGGAGGGGGAGCTGGCGACGGCGCGCGCCGCGGCGGCCGCCGGTGTCCCCTTCGTGGTCAGCACGCTCAGCAGCGTCCCGGTCGGCGAGCTGGCCGCGGCCGGCGGCGAACAGTGGTTCCAGTTGTACTGGCTCAACGACGACCGCGACACGATGAACCTGGTCCACCGGGCCGAGGACGCCGGCTGCCGGGTGCTGATGGTGACCGTGGACGTTCCGGTGATGGGCCGGCGCCTGCGGGACATCCGCAACGAGTTCGTGCTGCCCGCCGAGGTGCGGGCGGCGAACGTCGCGTCCGGGGCGATGAGCGCGGCGCACGATCGCGCCGACGCCGGCTCCGCCTTGATCGCGCACACCAACCGCGCGTTCCATCCGGCGCTCACCTGGGCGCACCTGGAGGCGCTGCGCTCGCGGACCACCCTGCCGATCGTGGTGAAGGGCATCCTGGACCCCGCGGACGCCCGCCGCGCGGCCGAGATCGGCGCGACCGGCGTGGTGATCTCCAACCACGGCGGCCGCCAGCTCGACGGCGCGCCGGCCAGCGTCACCATGCTGCCCGCCGCCGTCGCGGCCGTCCCGGACACCTGCCAGGTGTTCGTGGACAGCGGCATCCGCAGCGGCACCGACATCCTGCGGGCGCTGGCGCTCGGCGCGCACGGTGTGCTGATCGGGCGGCCGATGCTGTGGGGGCTGGCGGCGGGTGGCGAGACCGGCGCCGCCGGGGTGCTGGCCGTGCTGGACGCCGAGTTGCGCGCGGCGATGCGGCTGGCCGGTTGCGCCGACGTCGCGGCGGCCCGGCGGCTGACCGCCACCACCGGGTGCTGA	MTTAVLRLDTVDDFRLRAEATLTAAVRDFVAGGSDSETTLAANRAALDRVTIVPRVLTGGPDPEPGATLAGARSALPLAVAPMAYQRLLHPEGELATARAAAAAGVPFVVSTLSSVPVGELAAAGGEQWFQLYWLNDDRDTMNLVHRAEDAGCRVLMVTVDVPVMGRRLRDIRNEFVLPAEVRAANVASGAMSAAHDRADAGSALIAHTNRAFHPALTWAHLEALRSRTTLPIVVKGILDPADARRAAEIGATGVVISNHGGRQLDGAPASVTMLPAAVAAVPDTCQVFVDSGIRSGTDILRALALGAHGVLIGRPMLWGLAAGGETGAAGVLAVLDAELRAAMRLAGCADVAAARRLTATTGC	MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDVVGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRRPGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMTLLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVIVGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR	128.17	gnl|BL_ORD_ID|1365|hsp_num:0	1483			372	660	kanamycin A
BGC0000441.1|Teicoplanin_48 # 80755 # 81507 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=6bp;gc_cont=0.760	BGC0000441.1|Teicoplanin_48 	80755	81507	+	Loose	500	25.0238	SPG-1	33.33	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	ATGCCCGTACCTTGGTTCAGCGCGCCGCGCCCGCTCGCGGCCCCACGGTTGCGGCTGGTCTGTTTCCCGTACGCCGGGGGCAACGCCGCCACCTACCGCTCCTGGGCCGGACTCCTGCCGCCCGGGGTGGAGCTGGTCGCCGCGCTGCTGCCCGGCCGCGCCGAGCGCCTCGACGAGCCGCCCCTGGTGGATCTGGACGTGCTGCTGTCCGAGCTGGTGGCGGCGGCCGGCCCGCTGCTCGGCCCGGTCCCGCTGATCCTGTTCGGACACAGCCTCGGCGCGACCGTCGCGTACGAGTTCGGCCGCGCCCTGGCCACCGAGCACGGTTGCGTGCCCGCGGCCCTGCTGGTCTCCGGCGCCCCGGCGCCCCCGGTGCGCCGGCGCCGCACCGGCCGCGGCCTCTCCGACGACGACCTCGAACGGATCCTGGGCAAACGCACCGATCTCCCGGCCGGGTGGCTGACCGCCGAGCTCAAGCCGTTCGTGTTCCCGGCCCTGCGGGCCGACCTGCAGCTGCTCGACGGCTACCGCTGGCGGCCCGGCCCGCTTCCCGGCGTGCCGGTGGTCGCCTTCGGCGGGGATGCCGATCCGGACGTGTCCGCCGCCGATCTGCGGGCGTGGCAGCGGTGCACGACCGGCCCGGCCCGCACCCACGTGCTGGCCGGCGACCATTTCTTCATCGCGCACCAACCGTTCCGCGAGCTTCTCGCCGCCACGGTGGGCGAGTTCGCCGCCAGCCCGATCGCCCGGTGA	MPVPWFSAPRPLAAPRLRLVCFPYAGGNAATYRSWAGLLPPGVELVAALLPGRAERLDEPPLVDLDVLLSELVAAAGPLLGPVPLILFGHSLGATVAYEFGRALATEHGCVPAALLVSGAPAPPVRRRRTGRGLSDDDLERILGKRTDLPAGWLTAELKPFVFPALRADLQLLDGYRWRPGPLPGVPVVAFGGDADPDVSAADLRAWQRCTTGPARTHVLAGDHFFIAHQPFRELLAATVGEFAASPIAR	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	87.72	gnl|BL_ORD_ID|2032|hsp_num:0	2235			375	501	
BGC0000441.1|Teicoplanin_49 # 82083 # 83699 # 1 # ID=1_49;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=10bp;gc_cont=0.773	BGC0000441.1|Teicoplanin_49 	82083	83699	+	Loose	1050	28.1054	srmB	34.43	3002828	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGTTCGGTGAGCATGTGCGGACCCACCGGCAGCGACTCGGTCTCACCCAGGACGACCTGGCCGAGCGGGCCGGGCTGGGAGTGCGCAGCATTCGCAACATCGAGGCGGGCCGGGTTCGTGTGCCCCGGCCGTCCACGGTACGGCTGCTCGCCGACGCCTTCGCGCTGACCGGCCCTGCCCGGGACCTGTTCTGCTCGATCGCCGCTGCGCCCCGGGCCGTGCCGGTGGCCCCGAGCGACCCGCCGGTCGTGCCGCGGCAGCTGCCCGCCGCCAGCCCGGCGCATGTCGGGCGCCGAGCCGCGCTGGCCGCCCTCGACCAGCTGCTGGTCACCCCGTGTCGGCTCGCGGTCGTGCAGGGCCCCGCCGGGATCGGGAAGAGCACGCTGGCGCTGCACTGGGCGCACCGCGTCGCGTCCCGGTTCCCCGACGGCCAGCTCTATCTGGACCTGCAGGGCTACGGCCCGGCCCCGGCCCCGCTCGGCGTGGCGGATGCGCTGTGCCGCCTGCTGGACGGGTTCGGTGTGCCGGCGGCGCGCATCCCCGCCGACACCGACGCCCGCGCCGCACTGTTGCGCAGCGTGACGGCCGACCGGAGCTTCCTGCTCGTGCTCGACAACGCGCGCGACGCCGACCAGGTCCGGCCGCTGTTGCCGGGCGCGCCGGGCGCCGTCACCGTCGTCACCAGCCGGGCCGACCACGCCGGCCTGGTCACGACAGCGGCCGCGCGCCTGGTGCCCCTCGGCCTGTTCCACGAGCGGGACGCCATCGACCTGCTCACCCACCACCTCGGCGCGGAGCGGGTGGCGGCCGAGCCGGCGGCCGTCTCCGCCATCATCGGGCGCTGCGCGCGGCTGCCGCTCGCCCTCGCGATCATCGCCGGCCGCGGCGCGGCCCGCGCCGACTTTCCGCTCAGCGAGCTGACCGGCGGCCCCTCGGTGCTCGACGAGCTCACCGGCGACGACGTCGGCGCCGACTTCCGGACCGTCATCTCCTGGTCGTACCGGCTGCTCAGCACGTCCGCCGCGCGGCTGTTCCGGCTGCTCGGCGCGGCTCCCGGCCGGGACATCGGCCCCGCCGCGGCGGCCAGCCTGGCCGGCACACCAGTGCGGGCGACCCGCCGCGACCTGCGCGAGCTCACCGCCGCGCATCTGGCGCACGAGCACCGGTCCGGGCGGTACCAGGTGCACGCGCTGCTCCGGTCCTACGCCGTCGAGCTGTGCTCCGGTCACGACCCGGCGTCCGAGCGGGACACCGCCCGGCGCCGGCTCGTCGACCACTACCTGCATGCGGCGTACGCCGCCGCGCCGCTGCTCGCGCCACGGCTGGCGCGGGGGCCGCTGCCGGCCCGGTGCGACGGCGTCACCGCCGAGCGGCCCGCCGACAGCCGAGCGGCGTTCGACTGGTTCACCGACGAGTACCCGAATCTGGTCGAGGTCCTGGCCCTGGCCCGCGACCTGGGCCTGCACGCCCATGCCTGGCAGCTGGCCGGCGCGGTGGGCGCGTTCCGGCACCGCCGCGGCCGATGGCACGACGTGATCGGACCGCACCGGGACGCGCCGGCCGTGGCCCCCGGCGACCCCATCGCCAGCGGCACTCCGGGCACGGGCTCGGCCTGA	MFGEHVRTHRQRLGLTQDDLAERAGLGVRSIRNIEAGRVRVPRPSTVRLLADAFALTGPARDLFCSIAAAPRAVPVAPSDPPVVPRQLPAASPAHVGRRAALAALDQLLVTPCRLAVVQGPAGIGKSTLALHWAHRVASRFPDGQLYLDLQGYGPAPAPLGVADALCRLLDGFGVPAARIPADTDARAALLRSVTADRSFLLVLDNARDADQVRPLLPGAPGAVTVVTSRADHAGLVTTAAARLVPLGLFHERDAIDLLTHHLGAERVAAEPAAVSAIIGRCARLPLALAIIAGRGAARADFPLSELTGGPSVLDELTGDDVGADFRTVISWSYRLLSTSAARLFRLLGAAPGRDIGPAAAASLAGTPVRATRRDLRELTAAHLAHEHRSGRYQVHALLRSYAVELCSGHDPASERDTARRRLVDHYLHAAYAAAPLLAPRLARGPLPARCDGVTAERPADSRAAFDWFTDEYPNLVEVLALARDLGLHAHAWQLAGAVGAFRHRRGRWHDVIGPHRDAPAVAPGDPIASGTPGTGSA	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	97.82	gnl|BL_ORD_ID|110|hsp_num:0	128			1005	1188	spiramycin
BGC0000441.1|Teicoplanin_52 # 85629 # 85883 # -1 # ID=1_52;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.710	BGC0000441.1|Teicoplanin_52 	85629	85883	-	Loose	1050	22.7126	facT	32.43	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCTTTCATCGGCGGCTCCGACACCGCGACCCCGGGAGCCGACGATCTTCTTCTTCGAGGGTGAGCGGGCCGGGCTGGCCAAGCGCCGGTCCCCGCTGGCCGGCTTCTGGGCGCTGCTGGTGGGCGGCGTCCTGGTCACCGTGCTGACGGTGGCGCTGCGGCCGGCGACCGACGTGCGCGACTGCCCGAACTACGGCGGCAACGGCAACGCCAGCGCCTTCCCGACGAGATCTGGGACCTGTATTACCCGCTGA	MLSSAAPTPRPREPTIFFFEGERAGLAKRRSPLAGFWALLVGGVLVTVLTVALRPATDVRDCPNYGGNGNASAFPTRSGTCITR	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	15.03	gnl|BL_ORD_ID|1345|hsp_num:0	1469			1386	1497	factumycin
BGC0000441.1|Teicoplanin_53 # 86174 # 87115 # -1 # ID=1_53;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.720	BGC0000441.1|Teicoplanin_53 	86174	87115	-	Loose	350	25.0238	vanB	42.11	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGATCACGTATCGGACCACCGGTCTCCCCGGTCCCGCGCCCACGGCGACCGTATCGGTCAAGCCGATCGTGCTGCCCGCGGCGCGGCGCGGCGGGGACCTGCAGGTGCGGGTCTCCGCACCGGTCACCGGCACCAACCTGCCGGTGGTGGTGTTCGCGCACGGATACGGATCGAACCTCGACGGCTACGGACCGCTGGTCGATCACTGGGCGGCCCACGGCTTCGTGGTGGTCCAGGCCACCCACCTGGACTCCCGGCGCCTCGACGTCGCAGCGGACCGGTCCCGCAGGCCGCACCTCTGGCTCTACCGGGTGCGGGACATGAAACGGATCCTCGACGGACTCGACGTTCTGGAGGCCTCGGTGCCCGGGCTGACCGGCCGGGCCGACCATCGTCGTATCGTCGCGGCCGGGCACTCCTTCGGCGGCCAGACCGCCGGCATCCTGGTGGGTCTGCGCGTCGCCGATCCGATGACCGGCATCGCGCGGGACCTGTCCGATTCCCGGGTCATCGCGAGCATTCAGCTGGCCACCGCCGGCCGCGGCGGCGACGATCTGACCCCGTTCGCCCTCCAGGTCGCACCCTGGCTGCGCGACCAGGACTTCTCGCACATCACCGCACCCGGGCTCGTCGTCGCCGGCGACCAGGACGAACTCCCGCTGTCCACCCGCGGAGCGTCCTGGATGACCGACCCGTACACCCTGGCCCGCGGCGCCAGGAGCCTGCTGACCGTTTTCGGCGGCCAGCACTCGCTCGGCGGCATCTCCGGTTACGACGCGGCGGAGACCACCGACGAGCACCCGGACCGGGTCGCGCTCATCCAGCAGGTCACCCTCGCCTACCTGCGCCACGTCACCGGCGTCGACCACACCGGCTGGCGAACCGCCCAGGCCCTCCTGGCCGGTGACTCCCACCGGCTCGGCCGGCTCGAATCCAAGTGA	MITYRTTGLPGPAPTATVSVKPIVLPAARRGGDLQVRVSAPVTGTNLPVVVFAHGYGSNLDGYGPLVDHWAAHGFVVVQATHLDSRRLDVAADRSRRPHLWLYRVRDMKRILDGLDVLEASVPGLTGRADHRRIVAAGHSFGGQTAGILVGLRVADPMTGIARDLSDSRVIASIQLATAGRGGDDLTPFALQVAPWLRDQDFSHITAPGLVVAGDQDELPLSTRGASWMTDPYTLARGARSLLTVFGGQHSLGGISGYDAAETTDEHPDRVALIQQVTLAYLRHVTGVDHTGWRTAQALLAGDSHRLGRLESK	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	91.52	gnl|BL_ORD_ID|1005|hsp_num:0	1098			222	279	vancomycin
BGC0000441.1|Teicoplanin_54 # 87226 # 87558 # 1 # ID=1_54;partial=01;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=6bp;gc_cont=0.691	BGC0000441.1|Teicoplanin_54 	87226	87558	+	Loose	200	59.3066	Pseudomonas aeruginosa soxR	33.64	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTATCGGCGAGCTGGCCGCCCGCACCGGTGTCAGTGTCCGGGCACTGCGCTACTACGAGCAGCAGGATCTGCTCAGCGCCGAGCGCGGTTCGAGCAGCCATCGCCGGTACCCCGAGAGCGCGGTCGACCGGGTCCAGCTGATCCAGCGGTTGTACCAGGCCGGGCTGACCAGCAAGACCATCGTCGAGCTGCTGCCGTGCGTCGTCGGTGACCGCGCCACCCCGGCGATGCTCGAGCGGCTGGCAGCCGAACGCGAGCAGATCGATCAGCGCATCACCGATCTCGTCCGAACCCGGGACCGGCTCGACGCCGTGATCAGCAACGCGACC	MRIGELAARTGVSVRALRYYEQQDLLSAERGSSSHRRYPESAVDRVQLIQRLYQAGLTSKTIVELLPCVVGDRATPAMLERLAAEREQIDQRITDLVRTRDRLDAVISNAT	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	71.15	gnl|BL_ORD_ID|2395|hsp_num:0	2775			27	357	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
